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f  Frequency, Hz 
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Velocity gradient tensor 
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Mass fraction obtained from Horsfield model for branch i 
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Mass flow rate fraction at outlet k 
Pmus Pressure due to the respiratory muscles, Pa 
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Poiseuille (laminar) resistance, H2O/(l/s) 
RTB Global tracheobronchial resistance, H2O/(l/s) 
R  
Relaxation time ratio  
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Strain rate tensor. 
d
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ABSTRACT 
The objective of this dissertation research was to investigate gas transport, mixing 
and aerosol-drug delivery during high frequency oscillatory ventilation (HFOV) for 
various ventilator specific conditions that are vital to critical care clinicians. A large eddy 
simulation based computational fluid dynamics approach was used in a patient specific 
human lung model to analyze the effect of invasive HFOV on patient management. 
Different HFOV waveform shapes and frequencies was investigated and the square 
waveform was found to be most efficient for gas mixing; resulting in the least wall shear 
stress on the lung epithelium layer thereby reducing the risk of barotrauma to both 
airways and the alveoli for patients undergoing therapy.  Traditional (outlet) boundary 
conditions based on mass fraction or outlet pressures were found to be inadequate in 
describing the complex flow physics that occurs during HFOV. Physiological boundary 
conditions that used the time-dependent pressure coupled with the airways resistance and 
compliance (R&C) were derived and used for the first time to investigate the lung lobar 
ventilation and gas exchange for accurate HFOV modeling.  
A Lagrangian approach was then used to model gas-solid two-phase flow that 
allowed investigation of the potential of aerosol-drug delivery under HFOV treatment. 
We report, for the first time, computational fluid dynamics studies to investigate the 
possibilities of aerosol drug delivery under HFOV. Understanding the role of different 
carrier gases on the gas exchange and particle deposition, which may allow for optimum 
drug delivery and ventilation strategy during HFOV. Increasing the operating frequency 
resulted in a significant change in the global and local deposition indicating strong 
dependency on the frequency, which could be beneficial for the targeted drug delivery. 
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The global deposition as a fraction of the total injected particles at the endotracheal tube 
inlet was equivalent to the cases of normal breathing and conventional mechanical 
ventilation signifying a potential for efficient drug delivery during HFOV. In addition, 
HFOV had a unique characterization of the local particle deposition due to the rapid 
ventilation process and a strong influence of the endotracheal tube jet.  
Very often during ventilation therapy, a clinician uses a cocktail of various gases 
to enhance targeted therapy. To quantify this process for a futuristic HFOV based patient 
management, we undertook detailed studies to understand the role of carrier gas 
properties in gas exchange and particle transport during HFOV. A substantial 
amplification of the pendelluft flow was achieved by utilizing a low-density carrier gas 
instead of air, which resulted in gas exchange improvement. Reducing the carrier gas 
density was found to significantly alter the aerosol-drug delivery under HFOV 
management. As the density decreased, the deposition fraction in the upper 
tracheobronchial tree decreased, indicating enhancement of the lung periphery delivery. 
Furthermore, the filtered aerosol-drug in the ventilator circuit could be significantly 
reduced by using Heliox, and further reduction could be achieved by reducing the 
operating frequency. In general, high-frequency oscillatory ventilation therapy could be 
improved under Heliox with greater content of Helium, thereby reducing the lung 
hyperinflation risk.   
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CHAPTER 1 
INTRODUCTION AND 
OVERVIEW 
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1.1.Respiratory Function  
Natural inhalation is driven by the generation of a negative force, which is 
controlled by muscles and the lung compliance. The contraction of the diaphragm 
expands the thorax, creating a negative pressure inside the airways, which is below the 
atmospheric pressure at the nasal/mouth opening [1, 2], see Figure 1.1. The pressure 
difference drives the airflow from outside (ambient) throughout the extrathoracic 
passages all the way to the gas exchange zone in the lungs (i.e. alveoli). The exhalation 
process is passive; the diaphragm expands allowing the lung to recoil due to lung 
elasticity and return to its normal size creating higher pressure inside the airways relative 
to the ambient environment. Consequently, the pressure difference drives the gas in the 
opposite direction out of the lungs, see Figure 1.1. The process of inhalation/exhalation 
could be entirely collapsed during respiratory failure, which is life threatening if suitable 
support is not provided quickly enough.  
Respiratory failure is a syndrome in which the respiratory system fails to achieve 
adequate gas exchange [1-3]. Mortality rates associated with respiratory failure due to 
various pulmonary diseases is at par with mortality figures due to breast cancer or 
HIV [3-6]. Respiratory failure is classified as hypoxemic or hypercapnic, the former is a 
condition in which there is a deficiency of oxygen in the arterial blood; while the later 
occurs due to elevated levels of carbon dioxide elimination occurs, respectively. The 
failure of respiratory function is not considered a disease per se but a byproduct of other 
diseases or conditions  [1, 2]. These are summarized in Table 1.1 below.  
5 
 
Table 1.1 Common diseases cause respiratory failure.   
Disease  Cause and condition 
Chronic obstructive pulmonary disease 
(COPD) 
Airway damage resulting in pathological 
changes and limiting of the airflow in and 
out of the airways 
Acute respiratory distress syndrome 
(ARDS) 
Acute lung injury causing serious airway 
abnormality and shortness of breath  
Chest injury Damage to the tissues and ribs around the 
lungs due to chest injury, which causes 
inability to breath 
Toxic inhalation Inhalation of harmful and toxic agents 
such as smoke and fumes, resulting in lung 
injury 
Asthma Infections and allergies cause airway 
inflammation, in turn causing wheezing 
and shortness of breath 
Chronic bronchitis Inflammation of the bronchial airways 
resulting in sputum that could narrow or 
cause airway closure  
Emphysema Air trapped due to airway damage leading 
to difficult breathing. 
Acute bronchitis Viral or bacterial infection of the lungs 
resulting in shortness of breath 
Cystic fibrosis A genetic condition causing poor 
clearance of mucus from the bronchi; the 
accumulated mucus results in repeated 
lung infections  
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Figure 1.1 Representation diagram of the inhalation and exhalation process under 
normal breathing [7]. 
 
1.2. Mechanical Ventilation  
Mechanical ventilation intervention to substitute spontaneous breathing and 
maintain adequate gas exchange is mandatory for patient support during respiratory 
failure. The mechanics of inhalation in supported breathing fundamentally differs from 
normal breathing. The mechanical ventilator creates differential pressure by applying a 
positive pressure above atmospheric, either at the nasal/mouth opening (in the case of 
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noninvasive ventilation) or at the endotracheal tube opening (in the case of invasive 
ventilation); thereby driving air or a mixture of various gases into the lungs. This type is 
known as positive pressure ventilation  [1, 2, 8].  
1.2.1. Conventional Mechanical Ventilation 
Conventional mechanical ventilation (CMV) is used to replace the patient’s spontaneous 
breathing and delivers a tidal volume of 6-10 ml/kg [2, 9, 10] at a breathing rate 
(frequency) ranging from 12- 40 breaths/minutes (0.2 – 0.67 Hz). The tidal volume is 
defined as the total air volume inhaled during a single breath. It is greater than the 
anatomical dead space in the conducting airways and allows the gas to transport by a bulk 
convection mechanism. The use of CMV is, however, not always a safe intervention in 
many cases. 
1.2.2. Ventilator-Induced Lung Injury 
  CMV is associated with several risks that leads to complications in the patient. In 
many critical situations, it exacerbates the illness conditions and leads to lung injury, a 
condition referred to as ventilator induced lung injury (VILI). A common cause of VILI 
during CMV is the large tidal volume which results in lung over-distention (volutrauma) 
or lung damage due to excessive pressures (barotrauma) [1, 2, 11]. Airway and alveoli 
damages due to abnormal mechanical stress (i.e. shear stress) exerted at the airways walls 
is also a common cause of lung injury. The wall shear stress could be amplified due to 
phenomena variety of factors. The presence of intubation is seen to cause high-speed jet 
impingement at the trachea-carina ridge, which leads to high wall shear stress at the 
upper airways [12]. The airways obstructions and asymmetry in compliance between lung 
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units could produce higher velocity and velocity gradient along small airways, which is a 
mechanism that may increase the wall shear stress [13]. Lung injury and damage of the 
airways epithelium cells could be initiated as a consequence of the shear stress. Airway 
collapse and reopening applies additional stress at the alveoli, leading to an injury known 
as Atelectrauma  [14-16]. Table 1.2 summarizes the common VILI causes and their 
mechanisms. An alternate form of ventilation that involves high frequency oscillatory 
flow, commonly known as HFOV is used to avoid complications arising from CMV 
while maintaining adequate gas exchange [1, 2, 17] .  
 
Table 1.2 Forms of VILI and mechanism of occurrence. 
Type of VILI 
 
Mechanism 
 
Volutrauma  [1, 2] Lung over-distention associated with high tidal 
volume under CMV. 
Barotrauma  [1, 2] Lung injury due to excessive pressure under 
CMV. 
Atelectrauma  [14-16] Abnormal mechanical stress that is applied to 
the alveoli and small airways due to fluid 
occlusion during airways collapse and 
reopening. 
Biotrauma  [16, 18-20] Alveoli damage and inflammatory response to 
shear stress injuries secondary to atelectrauma.  
Shearing injury  [12, 13, 16, 20-22]  Airways epithelium cell rupture and 
inflammation due to high wall shear stress. 
Oxygen toxicity  [23, 24] Toxicity by oxygen overexposure leading to 
surfactant impairment.  
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1.2.3. High Frequency Oscillatory Ventilation 
Different mechanical ventilation modes were developed to reduce or avoid the 
lung injury associated with CMV. Lung ventilation by high frequency oscillation has 
become an alternative way to maintain adequate gas exchange while at the same time 
protecting against lung injury. This mode has been utilized for decades. It was first 
described in 1952 but not clinically used until early 1970s. Originally used only for 
infants and children, it was not approved for adults until recently (2001) [17]. The 
principles of ventilation strategy during high frequency oscillatory ventilation (HFOV) 
are different from CMV and normal breathing (Table 1.2). A very small tidal volume of 
~1-2 ml/kg is delivered at high operating frequencies of 1 - 30 Hz  [2, 17, 25, 26]. 
Furthermore, in CMV the lung is set to expire the air from the lung naturally, i.e. passive 
expiration; during HFOV, however, expiration is active.  
Table 1.3 Comparison between CVM and HFOV. 
characteristics  
 
CMV 
 
HFOV 
 
Frequency 
12- 40 bpm  
(0.2-0.67 Hz) 
60-3000 bpm  
(1- 50 Hz) 
Tidal volume  6-10 ml/kg 1-2 ml/kg 
Inspiration Active  Active  
Expiration Passive  Active  
 
To achieve gas exchange in the lung, the delivered tidal volume must exceed dead space 
volume [27]. The delivered tidal volume during HFOV is less than the anatomical dead 
space volume, which disputes the principal of gas exchange occurrence [27]. It is 
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therefore believed that gas transport under HFOV strategy cannot be achieved by only a 
bulk convention mechanism and there are other mechanisms contributing to the process. 
Previous studies [28-31] have identified several complex flow mechanisms that play a 
role in gas transport and mixing during HFOV. However, those complex mechanisms are 
not fully understood [28, 30]. A schematic diagram of the mechanisms of gas transport 
during HFOV is presented in Figure 1.2. These mechanisms have been classified and 
defined as follows:   
1) Bulk convection which contributes to the ventilation; however, unlike the CMV, 
it only impacts the proximal alveoli.  
2) Taylor-dispersion (or augmented diffusion) that is defined as the interaction 
between the axial velocity and radial concentration gradient.  
3) Pendelluft mechanism which is defined as the asynchrony of the time constant 
due to variation of respiratory units resistance (R) or compliance (C). This causes 
gas exchange between the adjacent lung units  [32].  
4) Coaxial counter flow which occurs when the flow switches between inspiration 
and expiration phases (and vice versa). The flow with higher momentum through 
the middle of the airways lags behind while the gas at the vicinity of the walls 
respond on time and flow in phase. Consequently, a net convective mixing 
occurs.   
5) Cardiogenic gas mixing that occurs due to the cyclic movement of the heart.  
6) Molecular diffusion that plays an important role in gas exchange at the alveolus. 
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Figure 1.2 Mechanisms of gas transport during HFOV management.  1) bulk convection, 
2) Taylor-dispersion, 3) pendelluft flow, 4) coaxial counter flow, 5) cardiogenic mixing, 
and 6) molecular diffusion  [2, 33]. 
 
1.3. Aerosolized Drug Delivery 
The respiratory tract has recently become an attractive route for drug delivery, as 
the lung has the capability for absorbing pharmaceuticals either for local or systemic 
delivery  [34]. Although mechanical ventilation is used to facilitate the patient’s 
breathing  [35], in many situations, especially in long-term administration, aerosol drug 
delivery is inevitable during the ventilation process  [36, 37]. The aerosolized form of the 
drug is delivered for local treatment, such as ephedrine for nasal decongestion, beta-2 
agonists for bronchodilation, and to combat inflammation in diseased airways such as 
from asthma and COPD [38]. It has also become a preferred route for systemic delivery: 
insulin for diabetes therapy, pain management, cancer therapy, and nano-therapeutics. 
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This preference is due to many advantages that the lung route offers for health care. It 
avoids the traditional invasive methods of delivering drugs into the bloodstream 
(injection), avoids gastrointestinal tract problems (oral delivery), and lessens side effects 
because there is no exposure to the drug for the rest of the body. One of the most 
attractive factors is that the lung has a large surface area ~ 70-140 m
2
, which allows for 
excellent absorption and exchange with the bloodstream  [38]. Pulmonary drug delivery, 
however, is still a challenging task  [34, 39]. For example, to achieve optimum drug 
delivery (i.e. result in efficient treatment, reduce side effects and be cost-effective), the 
drug should be directed from the release point to a predetermined site. This process of 
targeted drug delivery, however, needs to optimize many factors that affect aerosol 
transport, such as drug-particle characteristics (size), inhalation waveform, and particle 
release point [39]. Furthermore, drug delivery to a mechanically ventilated patient is very 
complex, and a very low amount of aerosols successfully reach the lower lung sites due 
to the many complications that arise during therapy management procedures [37, 40, 41]. 
This complexity increases during invasive HFOV because of very rapid ventilation and 
low tidal volume [42]. Efficacy of aerosol deposition relies on various parameters [37, 
41]: 
(a) Ventilator related: these include ventilation mode, tidal volume, respiratory rate, 
duty cycle, inspiration waveform, and the breath-triggering mechanism.  
(b) Circuit related: endotracheal tube size, humidity and density of inhaled gas. 
(c) Device related: the type of device (nebulizer, metered dose inhaler, or dry powder 
inhaler), fill-volume, gas flow, cycling (inspiration vs. continuous), duration, and timing 
of actuation. 
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(d) Drug related: dosage, formulations, particle size, targeted site for delivery, and 
duration. 
(e) Patient related: age, ethnicity, severity of airway obstruction, mechanism of 
obstruction, presence of dynamic hyperinflation, and patient ventilator synchrony. 
 Due to a lack of specific knowledge regarding the role of these factors, producers 
of ventilator machines currently recommend disconnecting the patient from a HFOV and 
applying manual ventilation during inhaled drug administration [42]. This, however, 
could possibly be harmful to the patient [42].  
1.4. Motivation and Objective 
1.4.1. Research Motivation 
The dissertation research was motivated by several unresolved issues associated 
with understanding pulmonary fluid dynamics and aerosol-drug delivery during HFOV. 
Although HFOV has become a common therapy, its outcomes are, however, still unclear 
and is the topic of much debate amongst clinicians [43, 44]. Pulmonary flow physics 
based on HFOV management strategy is very complex and is not yet fully understood. 
The variation in the frequency and shape of the HFOV waveform plays an important role 
in gas transport and exchange [21, 45]. Little attention is given to the shape of the HFOV 
waveform, as the majority of the earlier work used a sinusoidal approximation [21, 45]. 
This gap should be bridged to understand HFOV fluid dynamics for clinically relevant 
conditions. It is well documented in the literature that the shape of the HFOV waveform 
is machine/manufacturer-specific and is characterized by different acceleration 
/deceleration patterns [45]. Moreover, the presence of intubation has a strong effect on 
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the flow structure during HFOV and is critical for understanding flow conditions that can 
lead VILI.  
For CFD modeling of pulmonary gas dynamics, traditional boundary conditions 
are used at the domain outlets. It is classified as follows: Type-I boundary condition 
where a flow rate, or velocity at each outlet is specified, Type-II boundary condition 
where uniform pressure is used, and Type-III boundary condition where the mass fraction 
(MF) at each outlet of the statistical lung models is imposed. These boundary conditions, 
however, do not account for non-uniformity of the lung ventilation [46]. Furthermore, gas 
exchange between adjacent units cannot be captured due to the absence of consideration 
of asymmetry in compliance and resistance of these units. Various CFD studies have 
modeled HFOV with these types of outlets’ boundary conditions [47, 48]. However, the 
pendelluft flow was either not observed [47] or observed merely due to geometry 
asymmetry at the main bronchi [48]. Physiologically relevant boundary conditions will 
accurately predict lung lobar ventilation and are vital to fully capture all the dominant 
flow mechanisms that occur during HFOV. The pendelluft flow between lung units and 
the existence of asymmetric units compliance significantly contribute to wall shear stress 
in the small pathway, which could play a vital role in lung injuries.   
The feasibility of drug delivery during high frequency ventilation management 
has long been dubious due to the numerous challenges associated with this ventilation 
mode, and is not sufficiently understood. However, the potential of drug delivery during 
HFOV is a current topic of debate in the medical community [42, 49]. Due to insufficient 
knowledge regarding the role of the ventilator parameters and patient-related factors, 
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ventilator machines producers currently recommend disconnecting the patient from 
HFOV and applying manual ventilation during inhaled drug administration [42], a 
recombination that could potentially be harmful to the patient [42]. In addition, there are 
only limited in vitro and in vivo studies of flow and aerosol transport in the lung during 
HFOV [42, 50]. Despite the great contribution of these studies, they entail many flaws, 
such as the lack of predicting the regional deposition of aerosols. In addition, patient-
related parameters such as airway geometry, pulmonary disease, and exhaled aerosols 
were not considered. Further and extensive investigations are therefore required in order 
to understand and optimize aerosols transport during HFOV [37, 42]. Detailed and 
validated CFD could be an alternative route to study and understand drug delivery during 
HFOV. The realistic model and physiological boundary conditions would allow, for the 
first time, to quantify aerosolized drug delivery to the lungs under HFOV conditions, 
which could be efficient depending on the ventilation strategy. The developed drug 
delivery model under HFOV conditions will provide an opportunity to investigate the 
effect of different carrier gases on the particle transport during HFOV. The carrier gas 
properties will have a strong impact on the gas and particle transport, which may 
drastically change the flow field and particle motion allowing optimum HFOV therapy.  
1.4.2. Research Objectives 
The main objective of the dissertation is to develop an accurate computational 
fluid dynamic model using a high order turbulence model to investigate the following 
unresolved problems of gas and particle transport in the patient specific human lung 
under invasive HFOV therapy and various lung conditions:  
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i. Investigate various (ventilator) device-specific conditions that are vital to critical 
care clinicians.  
ii. Study the effects of the presence of intubation (ETT) on the gas transport and lung 
injury. 
iii. Test the efficacy of traditional boundary conditions on gas exchange and particle 
transport under HFOV and develop a physiologically relevant boundary condition 
that is capable to predict the lung lobar flow redistribution and capture the crucial 
gas transport mechanisms.   
iv. Analyze the potential of the aerosol-drug delivery under HFOV using 
physiologically relevant boundary conditions and demonstrate the important 
mechanisms that influence the particle dynamics under rapid ventilation process. 
In addition, enhance HFOV therapy by investigating the role of the carrier gas on 
the gas exchange and particle deposition.   
The dissertation aims to provide deeper insight into the fundamental mechanisms 
of gas transport and mixing in a transient turbulent flow that occurs in a branched 
complex system like the human respiratory tract. A systematic study would allow for: (i) 
advancement in the current understanding of the flow mechanisms during HFOV; (ii) 
enhance the accuracy of CFD modeling of gas and aerosol transport under HFOV; (iii) 
provide guidelines that may lead to optimizing ventilator management protocols and 
treatment under HFOV and assess particle deposition rates and patterns for clinically 
relevant conditions; and, (iv) provide a systematic pathway for diagnosing lung diseases 
and severity. 
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1.4.3. Procedures 
To achieve the objectives of the dissertation, the present study was conducted as 
follows:  
i. Reconstructed a large-scale patient-specific human lung model using medical 
computed tomography (CT) scans for a mechanically ventilated patient.  
ii. CFD simulations using a high order turbulent model to properly capture impotent 
flow physics were conducted. Large eddy simulation was implemented.  
iii. The equation of motion (pressure as a function of the flow rate and lung resistance 
and compliance) that governs the flow during mechanical ventilation was used to 
create various commonly used ventilator pressure-controlled waveform shapes 
and applied at the model inlet. Intubation was represented by invasive 
endotracheal tube (ETT).  
iv. Developed, validated and implemented boundary conditions based on 
physiological properties. Time-dependent pressure boundary conditions were 
developed and applied to the realistic lung model based on airways’ coupled 
resistance-compliance.   
v. FORTRAN subroutines were used to implement Lagrangian approach to model 
the aerosol-drug transport under HFOV parameters and different lung conditions. 
Detailed analysis and quantification of the global and local deposition fraction of 
the particles in a realistic large-scale lung model were presented. 
vi. Gas exchange and particle transport under various carrier gases with a wide range 
of density and kinematic viscosity under rapid ventilation process were tested.  
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1.5. DISSERTATION OVERVIEW  
The dissertation is divided into eight chapters. Following chapter 1, the 
respiratory tract descriptions and a literature review of the classical lung models are 
presented in chapter 2. Details of the procedures and methods for reconstructing the 
present patient specific lung model are discussed and demonstrated. In chapter 3, the 
procedures of meshing the obtained complex geometry are discussed. In addition, 
detailed descriptions of the numerical techniques along with the grid independence 
studies and validation exercises with available experimental data from the literature are 
provided. We review existing numerical and experimental studies of flow transport under 
HFOV in chapter 4. The specifics of ventilator waveform shapes and implementation as 
relates to our CFD study are presented. In addition, a convergence study—depending on 
the number of ventilation cycles—is conducted and discussed. It is followed by details of 
the outlet boundary conditions application based on the classical model of Horsfield et 
al  [51]. The results are presented and discussed in terms of the coaxial counter flow 
patterns, existence of the pendelluft mechanism, and flow structures. The lung injury due 
to wall shear stress and conclusion of the best and safest HFOV setting are discussed. 
Chapter 5 discusses the derivation, validation and employment of physiological outlet 
time-dependent pressure boundary conditions. In addition, a review of the traditional 
boundary conditions and their capability of resolving flow mechanisms under HFOV is 
presented. The role of airways coupled resistance-compliance during HFOV is discussed; 
the results are presented in terms of airflow redistribution in the lung lobes under 
different ventilator parameters and lung conditions. The captured pendelluft flow 
throughout the lung model is characterized. The use of coupled resistance-compliance 
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boundary conditions is also compared to the traditional boundary conditions. Chapter 6 is 
devoted to exploring the drug delivery during HFOV. A Lagrangian approach to model 
particle transport under HFOV conditions is validated and discussed. Detailed 
quantification of the total and regional particle deposition is demonstrated. The 
discussion of the potential of drug delivery during ventilation by high oscillation 
frequency is given. Last, the efficacy of HFOV therapy is investigated in light of the 
comparison with drug delivery under normal breathing and conventional mechanical 
ventilation. Chapter 7 addresses the role of carrier gas properties on the gas exchange and 
aerosol-drug delivery during HFOV management. The effects of gas density and 
kinematic viscosity on the turbulence, airways resistance, gas transport, and particle 
deposition are presented. The enhancement of HFOV therapy is discussed. Chapter 8 
presents conclusions and limitations of the current research and several future directions 
are discussed.  
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CHAPTER 2 
PATIENT-SPECIFIC MODEL 
RECONSTRUCTION  
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2.1. Pulmonary Anatomy and Physiology 
The human respiratory tract is a system of gas passages with complex and 
dynamic structures [1, 2, 34, 39, 52, 53]. It is divided into three regions based on 
anatomy: (a) the extrathoracic region, which includes the oral cavity, the nasal cavity, the 
pharynx, the larynx, and the upper part of the trachea; (b) the upper bronchial region,  
which includes the main bronchi; and (c) the lower bronchial region, comprised of the 
bronchioles and the alveolar region  [1, 2, 34, 39]. Figure 2.1 presents detailed 
information and illustrations for the respiratory tract anatomy [54].  
 
Figure 2.1 Schematic for human respiratory tract  [54]. 
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The present study focuses on invasive mechanical ventilation. In this type of ventilation, 
an endotracheal tube is inserted through either nose or mouth to a certain level in the 
trachea [55-58]. The extrathoracic region therefore has no role on the gas and aerosol 
transport under invasive ventilation strategy. For this reason, the segmentation processes 
and model configurations include only the upper tracheobronchial tree along with 
intubation.  
2.1.1 Tracheobronchial Tree 
The regions from the trachea and the bronchi, and bronchioles is termed the 
tracheobronchial tree (TB) [34, 39, 59], primarily due to the fact that at the end of the 
trachea, the tracheobronchial tree bifurcates or branches into right and left lungs 
constituting tree-like structures [39]. The two lungs are asymmetric and constitute a 
network of hollow tubes. Each tube, which is called a “mother” or “parent” branch, 
bifurcates into two branches called “daughter” branches. Figure 2.2 displays a single 
representative bifurcation tube and the most popular terminologies for the bifurcated  
 
Figure 2.2 Bifurcation terminologies. 
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airways segment. The branch angle is the angle between the two daughter branches of a 
bifurcation.  The ridge-like area that divides the flow between the daughter tubes is called 
a carina. The airways network are then progressively bifurcated into smaller airways 
without overlapping, which decreases in diameter and length at each branching [39, 53]. 
The airways after each bifurcation are considered to be in a new generation; and each 
bronchial generation is assigned a number starting—at the trachea—from zero (i.e. 
generation zero, G0), progressing to G1 at the main bronchi and so forth up to generation 
(G23) at the end of the TB, see Figure 2.3 [39, 53].  
 
Figure 2.3 Schematic diagram of the human tracheobronchial tree, its division and 
airways generations [39, 59, 60]. Adopted with permission from Elsevier publishing. 
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The number of airways in each generation is approximately double that of the previous 
generation. Since the  airways consist of 23 generations, the total tracheobronchial tree 
encompasses a total of 2
23
 airways in addition to millions of alveoli  [34, 61]. 
Cartilaginous rings exist around the upper airway segments. The main functions of the 
cartilages are to maintain stiffness and prevent all of these airways from collapsing. The 
trachea has about 16 – 20 cartilaginous C-shaped rings , which continue to the subsequent 
airways, the shape and size gradually changing and decreasing as the generation number 
increases [39].   
The tracheobronchial tree is functionally separated into different regions. With a 
focus on respiratory function, the respiratory tract is divided into a conducting zone and 
respiratory zone  [34]. The conducting zone extends from G0 at the trachea up to G16. 
The function of the conducting zone is to convect the gas from the larger airways to the 
small airways; therefore, the gas exchange does not occur in this zone. Between the 
conducting and respiratory zones, there is a transitional zone constituted by respiratory 
bronchioles, where the gas continues through, moving to lower airways while some gas 
exchange starts taking place. The respiratory zone consists of alveolar ducts and sacs 
where the primary function is gas exchange  [62]. Schematic diagrams for the 
tracheobronchial tree division based on function and generations are presented in Figure 
2.3.  
The lung is anatomically further subdivided into five major lobes (Figure 2.4).  
The left lung encompasses two major lobes: the left upper lobe (LUL) and left lower lobe 
(LLL). The right lung is divided into three major lobes: right upper lobe (RUL), right 
middle lobe (RML) and right lower lobe (RLL). The airways wall is lined with 
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epithelium cells  [63, 64]. The airway epithelium has a major role in heating and 
conditioning the inhaled gas  [39, 65]. Furthermore, it is a primary line of defense against 
pathogens and particulates inhaled from the environment  [66].  The epithelium contains 
several cell types: ciliated, goblet, brush, and basal cells  [67, 68]. In a diseased lung, the 
function of the airway epithelium is affected by local inflammation. This causes 
hypersecretion of mucus resulting in airway closure problems  [69-72].  
 
Figure 2.4 Lung major lobes and subdivisions. RMB: right main bronchus. LMB: left 
main bronchus. RUL: right upper lobe. RML: right middle lobe. RLL: right lower lobe. 
LUL: left upper lobe. LLL: left lower lobe. 
 
2.1.2. Lung Volume and Capacity 
The amount of the air in the lung can be subdivided into different volumes and 
capacities. Figure 2.5 explains the terms and divisions of the lung volumes  [2, 39, 73]. 
Approximately 1/10 of the total lung capacity is used during normal breathing at rest 
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whereas higher amounts are delivered when exercising  [2, 39]. The tidal volume is 
defined as the volume of gas that is inhaled and exhaled in a single normal inspiration or 
expiration. The volume of air existing in the lungs after a deep inhaled breath is called the  
 
Figure 2.5 Lung volume definitions and capacities [73]. 
 
total lung capacity (TLC). Even with maximum effort to fully expire all the air occupying 
the lung, a residual volume (RV) exists. The result of the difference between the residual 
volume and the total lung capacity constitutes the vital capacity (VC).  The inspiratory 
reserve volume (IRV) is the maximum volume of air that can be inspired above a normal 
tidal inspiration, and the expiratory reserve volume (ERV) is the maximum volume of air 
that can be exhaled after expiration of a normal tidal volume. The volume of maximum 
inhalation is the sum of the inspiratory reserve volume and the tidal volume, which is 
27 
 
known as the inspiratory capacity (IC).  The sum of the expiratory reserve volume and 
the residual volume results in the functional residual capacity (FRC), which constitutes 
the volume of air that remains in the lungs after a normal tidal expiration. Table 2.1 
summarizes all the lung volumes and capacities and the relationship to the total lung 
capacity and tidal volume  [2, 39].   
 
Table 2.1 Lung volumes and capacities. 
Volume and capacity Definition 
Volume
*
 
(mL) 
Total lung capacity (TLC) The maximum volume in the lung 6000 
Tidal volume (VT) Inspired and exhaled volume 500 
Inspiratory reserve volume (IRV) Max. volume can be inhaled above VT 3000 
Expiratory reserve volume (ERV) Max. volume can be exhaled above VT 1200 
Vital capacity (VC) IRV+ERV+VT 4700 
Inspiratory capacity (IC) IRV+ VT 3500 
Functional residual capacity (FRC) ERV+RV 2500 
Residual volume (RV) TLC-VC  or  FRC-ERV 1300 
*
 The values are for average volume in a 70-kg young adult based on Pierce [2]. 
 
2.2. Intubation 
Tracheal intubation is an unavoidable procedure in the intensive care unit during 
invasive mechanical ventilation  [57]. A compliant tube is connected to the ventilator 
circuit to serve as a gas passageway from the ventilator to the trachea inside the lung. 
There are several types of intubations  [74-77]. A flexible endotracheal tube can be 
inserted through the nasal or oral passages. The oral passage is the most frequently used 
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pathway for intubation  [2, 77]. In this type of intubation, the tube is inserted through the 
mouth passing through the pharynx to a distance above the carina inside the trachea. 
Tracheotomy is another type of intubation, in which the tube is inserted through a 
surgical incision that is made at the anterior portion of the neck [2]. Tracheotomy 
intubation is done when there is a need for prolonged mechanical ventilation or given the 
impracticality of using the nasal or oral passages for the tube—often in critical situations 
such as head and neck cancers, severe facial trauma, large congenital tumors of the head 
and neck, and inflammation of the head and neck [2]. The common endotracheal tube 
size for adult females is 7 or 7.5 mm (inner diameter) while for adult males it is 8 or 8.5 
mm [2, 55].  Figure 2.6 shows the different types of intubation. 
 
Figure 2.6 Illustration of different types of intubation. 
 
The presence of endotracheal tubes is seen to be one of the most crucial features in gas 
transport  [78, 79]. It is therefore important to be included in the model. Several past 
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studies have been devoted to studying the role of the endotracheal tube  [75, 80-83]. The 
emphasis of these studies, however, has merely been on assessing the influence of the 
ETT tube on airways resistance and work of breathing, or on hospital practices to prevent 
tracheal damage. Esteban et al [74] reported that an endotracheal tube or a tracheotomy is 
used for ~99 % of  the mechanically ventilated patients in America, which emphasizes 
that understanding the effects of the endotracheal tube is critical for clinical applications.   
2.3. Classical Lung Model 
The most important component of modeling the pulmonary fluid dynamic and 
particle transport is the human lung geometry. There are many computational and 
experimental studies that have been conducted to investigate the flow and particle 
deposition inside the respiratory tract [48, 84-91]. However, traditionally, all of these 
studies used classical models for the sake of simplicity. The most popular classical lung 
models are the Weibel model  [59] and Horsfield model  [51]. These are based on a 
statistical description of the lung, which are not realistic and physiologically non-
representative. These models do not represent a real effective diameter and length of each 
individual branch. Furthermore, they are composed of a network of cylindrical tubes with 
uniform cross-sectional and symmetric branches (the Horsfield model does have a slight 
virtue of accounting for asymmetry). Although there is much to be learnt from the study 
of a simplified bifurcation, a greater degree of detail is needed to gain more useful insight 
into the problems of airflow and particle transport throughout the respiratory system.  
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2.4. Patient Specific Model Reconstruction 
The recent advancements in medical imaging technology and image processing 
techniques have facilitated a way to reconstruct anatomically realistic lung models [39, 
53, 92]. Data-set images of a patient can be obtained using CT-scans or magnetic 
resonance imaging (MRI). These scans describe the anatomical shape of the lung and can 
be used to reconstruct the lung model, thus allowing the traditional use of simplified 
models to be replaced by more realistic ones in pursuit of patient-specific modeling. 
Several studies have begun to use realistic geometries based on CT scans of patients, 
including nasal, oral, and the tracheobronchial tree  [34, 39, 46, 47, 93-97].  The 
particular geometry features have shown to have a significant role in altering the flow 
fields and particle transport throughout the airways domain. It is therefore essential to use 
a model that resolves the important anatomical characteristics of the lung geometry  [34, 
39, 53, 98-100].    
In the current study, the tracheobronchial tree was reconstructed for a 
mechanically ventilated female patient using CT-scans. The reconstruction procedures 
involve several operations starting with CT-scans acquisition from our collaborator Dr. 
Gary Salzman at the university hospital and University of Missouri, Kansas City; 
converting 2D images of interested regions to 3D geometry; a segmentation process; and 
finally using a suitable modeling software to prepare the model for meshing and 
computational modeling. Figure 2.7 shows a flow chart of the reconstruction and 
segmentation process. Details of the process are discussed in the subsequent sections.  
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Figure 2.7 Illustration of geometry reconstruction and the segmentation process. 
 
2.4.1. CT-Scans  
Computed tomography is a medical imaging system that employs an x-ray emitter 
and detector to generate a series of planar cross-sectional images along an axis  [39, 101-
104]. During the imaging acquisition, the patient lies on a table that moves into the CT 
scanner. The x-ray tube emits a beam that rotates around the patient, taking multiple x-
rays in cross-sections along the desired region of the body. The x-ray details are collected 
by the detector and directed to the computer, which creates separate images of the organ 
in order to form slices. Figure 2.8 shows representative slices of the lung from the trachea 
entrance to the lobar bronchus. Unlike the conventional x-ray where a single 2D slice is 
obtained, CT-scans consist of a set of 2D images that can be grouped in a stack of images 
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(see Figure 2.9), which can be stored using a DICOM (Digital Imaging and 
Communications in Medicine) format. 
 
Figure 2.8 randomly selected 2D slices (in axial sections) from the trachea to lobar 
bronchus. A: inlet of trachea, B: the point where the trachea splits into the main bronchi. 
C: the entrances of right and left main bronchi, and D: the right and left bronchi 
segments. 
 
Thus, the CT-scans can be viewed in different planes via a DICOM viewer or converted 
to a 3D model using suitable image processing software by stacking the slices together, 
see Figure 2.9. The three planes of the CT-scans and the definitions of the positions are 
illustrated in Figure 2.10. Each structure of the organs (i.e. lung, in current study) has a 
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different degree of absorption or reduction of the x-ray beam  [39, 103-105], which 
subsequently attenuates the strength of the x-ray accordingly. Any slice is a set of a 
matrix of pixels and each pixel has a grayscale value corresponding to the degree of 
attenuation caused by each structure or tissue  [39, 103-105].  
 
 
Figure 2.9 Two-dimensional slice stack of CT-scans constituting a 3D lung geometry. 
 
 
Figure 2.10 Anatomical planes and positions definition. 
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The grayscale values are measured in Hounsfield units (HU) and are defined as  [39, 103-
105]: 
1000


w
wp
HU


                                             (2.1) 
where p is the mean x-ray attenuation coefficient of the pixel, and w   is the mean x-ray 
attenuation coefficient of water  [39, 103, 104]. Figure 2.11a presents the HU values for 
different structures (with air clearly having the minimum attenuation coefficient while 
bone has the highest). The distance between each slice is known as a slice thickness, 
which takes the 2D pixel into a 3D volume element called a voxel, see Figure 2.11b.   
 
Figure 2.11 (a) Grayscale and Hounsfield unit value for different material and (b) 
illustration of the pixel and voxel elements [39]. 
 
The voxel dimension is represented by pixel size × pixel size × slice increment. The CT-
scans for the current study were acquired for a 60-year-old female patient undergoing 
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mechanical ventilation treatment at the University of Missouri at Kansas City (UMKC) 
hospital. A Siemens SOMATOM Definition AS+ (140 KV and 74 mAs) CT scanner was 
used. A total of 260 slices were obtained and stored as a DICOM format file. The quality 
of a CT scan is determined by several metrics, such as: field of view, resolution, pixel 
size, slice increment, and pixel depth  [101].  The field of view was approximately 34 cm 
and covered the entire lung.  The resolution of each scan was 512×512 pixels, with a 
pixel size of about 0.602×0.602 mm and a slice increment of 3 mm. Images were taken at 
a pixel depth of 12-bit grayscale. Table 2 summarizes the important scan parameters. 
Table 2.2 Details of Computed Tomography scans. 
Metric Value 
Field of view 34.4 cm 
Slice thickness 3 mm 
Resolution ( Width × Length) 512 mm × 512 mm 
Pixel size 0.671 mm 
Total images 260 
 
 
2.4.2. Model Reconstitution  
The obtained CT-scans images were used to reconstruct the current 
tracheobronchial tree. The 3D reconstruction was performed using Mimics® software 
(Materialize Inc., Belgium) in which the imported DICOM file of the CT raw images 
(260 slices) was converted to appear in axial or transverse, sagittal and coronal planes, 
see Figure 2.12.  
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Figure 2.12 The tree views of the images as they appear in MIMICS interface. 
 
The reconstruction operations begin by performing a thresholding process [39, 106]. This 
is achieved by setting a range of HU values that represents the region of interest and then 
extracting the set of voxels with grayscale values in the selected range. The green mask in 
Figure 2.13a is the initial thresholding region. A region growing process was then 
executed on the set of voxels that was undergoing the threshold process to attain a 
continuous set of voxels, which eliminated all separated structures  [39, 106]. The created 
mask (yellow) after the region growing maneuver is presented in Figure 2.13b.  
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Figure 2.13 (a) The thresholding process and (b) The region growing process. 
 
To reconstruct the volumetric geometry of the lungs, the Calculate 3D operation in 
Mimics was implemented. Figure 2.14 shows the obtained 3D lung model. Segmentation 
process was subsequently performed on the reconstructed volumetric lung to remove 
under-resolved branches and extract the final upper trachea-bronchial geometry. The 
under-resolved regions were eliminated by removing voxels from the mask of the 3D 
volumetric model. The region growing process was performed again to extract the 
airways of the tracheobronchial area. The raw extracted 3D airways model is presented in 
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Figure 2.15. After the segmentation process, the set of voxels constitutes the upper 
airways of the respiratory system, and the volume represents space that gas would flow 
 
Figure 2.144 3D volumetric lung geometry. 
 
through in the lungs. The extracted airways should be later manipulated and cleaned up to 
create a smooth surface and to create inlets and outlets for air to flow through  [107, 108]. 
This is a necessary operation, which prepares the airways model for setting boundary 
conditions during computational fluid dynamics simulations. The model preparations 
were made using the open-source modeler software, Blender 2.5. The segmented airways 
were exported as STL (stereolithography) using available STL+ module command in 
Mimics. The STL file of the geometry was imported into Blender 2.5. Then the 
smoothing process was carefully performed. At each outlet of peripheral branches, a set 
of faces were grouped and were projected onto a plane (at the end of the branch) 
perpendicular to the branch the outlet belonged to. Extensions were added to each outlet 
to avoid any back flow and ensure fully developed flow [94, 109, 110]. To create the 
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extension, the projected faces parallel to the branch segment were extruded while 
gradually transitioning the outlet shape to a circle.  
 
 
Figure 2.155 Segmented airways. 
 
In the clinical practice, the patient is ventilated through a tube, which results in 
altering the inhaled gas conditions. Previous studies to predict flow phenomenon during 
HFOV have concluded that invasive devices like the endotracheal tube must be 
accounted for in order to capture the complicated flow physics  [111]. As a result, an 8 
mm interior diameter ETT was chosen and added to the model to complete the lung 
geometry  [2, 55]. For meshing purpose, the completed geometry was exported from 
40 
 
Blender in STL format file to be used by a mesh generator software. The prepared 
geometry in Blender is shown in Figure 2.16.   
 
 
Figure 2.166 Cleaned up model with extensions and ETT. 
 
2.5. Final Upper Tracheobronchial Tree Model 
The finial realistic human airways geometry under consideration is shown in 
Figure2.17. The upper tracheobronchial model consists of the endotracheal tube (ETT), 
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which was inserted into the trachea, and seven generations beyond the trachea, i.e. G0 to 
G7. The final model encompasses fifty-three small, peripheral airways. To identify the 
outlets in the left and right lung, each outlet was assigned a number from 1 to 53, 
consecutively. The model was identified by the major lung lobes as: main bronchi (MB),  
 
 
Figure 2.177 Final tracheobronchial tree with endotracheal tube.      Left upper lobe 
(LUL).      Left lower lobe (LLL).       Right upper lobe (RUL).      Right middle lobe 
(RML).       Right lower lobe (RLL). The outlets numbered consecutively from 1 up to 
53. The inset represents a magnified plot of point A for superior part of LLL and point B 
for RML, where outlet numbers are not evident in the original plot. 
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left upper lobe (LUL), left lower lobe (LLL), right upper lobe (RUL), right middle lobe 
(RLM), and right lower lobe (RLL). Detailed descriptions of the model outlets 
dimensions, generation, and the anatomical parts the outlet belongs to were present in 
appendix A.  
The current geometry major features were compared to the two most common 
statistical models (i.e. the Weibel  [59] and Horsfield  [51] models) and to selected 
realistic models existing in the literature in Table 2.3. It is not feasible to compare airway 
size directly with the statistical models or other realistic models because of human 
airways intra- and intersubject variabilities, which depend on many elements such as: 
height, weight, physical activity, age, gender and sundry physiological factors [93, 112]. 
Therefore, the major sizes of the current model were compared to other models in terms 
of a diameter ratio of the first two generations, i.e. the trachea and main bronchi 
bifurcations. The diameter ratio presented in Table 2.3 is defined as the daughter branch 
diameter (main bronchus) divided by the parent branch diameter (trachea). The minor 
diameter ratio is the smaller diameter ratio of the bifurcation while the larger ratio is the 
major diameter ratio. The current model exhibits a similar major diameter ratio as that of 
the asymmetric Horsfield  [51] and realistic large scale model of Choi  [47]. In addition, 
the minor diameter ratio was similar to the idealized model used by Heraty  [98]. In 
general, the current features of the model are consistent with those described in the 
literature for both classical and image-based models. The current realistic model has 
many important points of advantage concerning lung geometry over the classical models 
that have previously been used intensively. These points include the shape and 
orientation of the airways, which includes the realistic direction the branching occurs, the 
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branching angles, and airways’ curvature. Therefore, the modeling of gas and particle 
transport in the current model would capture more realistic physics of the fluid flow due 
to resolving the geometry crucial features. Moreover, the coupled computational fluid 
dynamics–image based geometry is a more accurate representation of a patient’s airway 
size, shape, position, curvature, and diameter variations. Image based modeling also 
provides patient-specific characteristics such as airway constrictions due to lung disease. 
Although some important features of the geometry through medical imaging techniques 
have been resolved, the current geometry still lacks some details such as cartilaginous 
rings and deeper airways generation (beyond G7). This is because of the limitations of 
the resolution and data acquisition techniques of current CT-scans  [34, 39].   
 
Table 2.3 Comparison of the major dimensions of the geometry of the current study to the 
statistical (idealized) and realistic models in the literature. 
Study 
Dd /Dp
* 
Minor Diameter 
Ratio 
Major Diameter 
Ratio 
Present study 0.64 0.75 
Horsfield model  [51] 0.69 0.75 
Weibel model  [59] 0.68 0.68 
Heraty - Realistic Model  [98] 0.64 0.68 
Heraty - Idealized Model  [98] 0.84 
Choi - Idealized Model  [47] 0.70 
Choi - Large-scale model  [47] 0.75 
*
Dp is the parent (G0) diameter; Dd is the daughters (G1) diameter of the main bronchi. 
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CHAPTER 3 
NUMERICAL METHODS AND 
VALIDATION  
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3.1. Mesh Generation 
The geometry mesh is one of the fundamental aspects in computational fluid 
dynamics as the mesh quality plays a major role in accurate modeling and in resolving 
real physics of the flow field [39]. The grid represents a discrete of the geometry domain 
where a discretized set of mathematical partial differential equations are solved.  
There are two categorizes of mesh type, structured and unstructured. Typically, a 
mesh is considered structured when the cells have a regular (uniform) pattern, which 
consists of hexahedral elements in 3D (quads in 2D). On the other hand, an unstructured 
mesh is defined as a mesh with cells of irregular pattern, usually comprised of triangles in 
2D or tetrahedral elements in 3D. Different mesh elements types can be seen in Figure 
3.1. The selection of mesh type and style is very crucial; however, the complexity of the 
 
 
Figure 3.1 2D and 3D mesh elements types. 
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computational model plays the pivotal role in determining suitable mesh [39, 113, 114]. 
Structured hexahedral elements are always preferred over other mesh types due to their 
alignment with the flow direction. However, in spite of this preference, the structured 
hexahedral meshes are prohibitively expensive in terms of time [1-3]. In addition, 
complex geometries like the realistic network of human airways do not fit exactly in the 
Cartesian coordinate, which is required for application of structured mesh [39]. Table 3.1 
summarizes the most used mesh styles in the literature for problems and geometries 
relevant to the current study. In general, image–based models and some of the simplified 
geometries have always employed pure tetrahedral mesh elements [47, 97, 107, 115-120]. 
The hexahedral or tetrahedral with prism layers were used only for simplified geometry 
with single or few generations, especially when performing RANS (Reynolds-averaged 
Navier–Stokes) turbulence model [95, 121, 122]. In the current study, the computational 
geometry was reconstructed based on a set of CT-scans, which led to a very complex 
tracheobronchial tree model as described in Chapter 2 and appendix A. The 
computational mesh used in this research was generated using unstructured tetrahedral 
elements, which is considered appropriate for complex geometries like present CT-scan 
based lung models [4-12]. To properly resolve the boundary layer, a very fine mesh was 
created near the wall. 
ANSYS ICEM 14 CFD
®
 was used to generate the computational mesh. Due to 
the large variation of the airways size from trachea to the peripheral segments (see Table 
A.1and A.2 in appendix A), the geometry was broken into different parts to enable mesh 
element size specifications locally. Figure 3.2 shows the flow chart for mesh creation 
procedures. The STL file of the broken geometry was then fed into ICEM and then a 
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“build topology operation” was applied to create the curves and points that define the 
geometry parts and to inspect the geometry walls for any holes. To increase the mesh 
quality, all points and  
Table 3.1 Literature review of geometries, mesh styles and turbulence models used in 
studies relevant to respiratory flow dynamic. 
Author (year) 
Flow 
Modeling 
Geometry Mesh type 
Isaacs et al (2006)  [123] Laminar Simplified: G0-G1 Hexa 
 
Lin et al (2007)  [124] DNS CT-scan: M -G7 Tetra   
 
Farkas et al (2007)  [116] Laminar  Simplified: G0 - G2 Tetra   
 
De Backer et al (2007)  [97] RANS CT-scan: G0 - ~G7 Tetra 
 
Xi et al (2008)  [121] k-ω  CT-scan: M-G0  
Simplified:G3-G4  
Tetra P 
Hexa 
 
Xi et al (2008)  [125] k-ω CT-scan: larynx - G5 Tetra P 
 
Zhang et al (2008)  [126] k-ω  Simplified: G0-G15 Hexa 
 
Gemci et al (2008)  [117] Laminar  Simplified: G0 - G17 Tetra   
 
De Backer et al (2010)  [107] k-ω CT-scan: M - ~G7 Tetra 
 
Xia et al (2010)  [118] LES CT-scan: M- G7 Tetra  
  
Choi et al (2010)  [127] LES CT-scan: M -G7 Tetra   
Lambert  et al (2011)  [119] LES  CT-scan: M -G7 Tetra   
 
Dehbi (2011)  [122] LES Simplified: M – G0 Tetra P 
 
Katz et al (2014) [120] Laminar  CT-scan: G0 ~ G6  Tetra   
Abbreviations: M: mouth. Hexa: Hexahedral. Tetra: pure tetrahedral. Tetra P: 
tetrahedral with prism layer. Simplified: idealized model based on Weibel [59] or 
Horsfield [51].  
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unnecessary curves were removed to avoid needless constraints for the mesh; and only 
those guide curves where the mesh should be split were kept (e.g. at inlet, outlets). The 
maximum size of each part of the geometry was set and Octree method mesh in the 
domain [128] was selected to create the domain of a primary mesh. After computing the 
mesh, the volume mesh was deleted and only the surface mesh was kept. This step was 
necessary to later improve mesh quality by creating the volume mesh with an operation 
that extrudes mesh inward from higher quality surface mesh. Meanwhile, the surface 
mesh was then smoothed using the Laplace smoothing method, which is an iterative 
process resulting in a more uniform spacing of nodes.  
 
Figure 3.2 Mesh generation procedures used in the current work. 
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The surface mesh was further smoothed using a normal smoothing algorithm available in 
ICEM, also an iterative method, which works by moving nodes to improve the quality of 
the surface elements. Subsequently, a surface mesh with higher quality was achieved. 
The quality of a surface element (triangle) is defined as the minimum ratio of the height 
of the triangle to its corresponding base length, normalized so that an equilateral triangle 
would have the highest quality of 1, while zero is the lowest and worst quality [16]. For 
the current surface mesh, after manual manipulation of poor elements by splitiing ediges 
or merging nodes, a minimum quality of 0.45 and average of ~0.85 was attained, which is 
considered high-quality mesh [16]. The smoothing process does not change the geometry 
features and size due to constriction of the nodes to the surface specified in the imported 
STL file. The front Delaunay method, which is the most common operation used in mesh 
generation [129, 130], was then applied to create the volume mesh [128]. In this 
operation, a Delaunay triangulation is used to create the tetrahedral elements. To refine 
the mesh near the wall, a value of 1.25 for the growth ratio was applied to control the 
expansion of the volume elements as the distance from the wall increased [16]. The 
smoothing process was later reapplied to the created volume mesh. The quality of a 
tetrahedral volume element is defined as the ratio of the radius of an inscribed sphere to 
the radius of a circumscribed sphere, normalized so that a regular tetrahedron would have 
a quality of unity [16]. The process employed in the present study led to a mesh with 
minimum mesh average quality of ~0.75, with a minimum quality of any volume element 
of 0.40. Figure 3.3 shows the adopted mesh for all simulations in the present study. The 
final mesh consisted of 2.42×10
6
 total elements. The justification of this choice is 
discussed in details in the section of the mesh convergence study of this chapter. 
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Figure 3.3 Final mesh. The expanded view displays the surface mesh. Slice a-a shows the 
volume mesh in a cut plane through the transition between parent and daughter branches 
in the first bifurcation.  Slice b-b show the volume mesh in a cut plane through the 
trachea and the endotracheal tube. Slice c-c show the volume mesh in a vertical cut plane 
through the endotracheal tube, trachea and main bronchi. 
 
3.2. Computational Method and Turbulence Modeling  
The set of governing equations were solved for the flow field variables CFD 
approach. CFD uses the discrete domain (i.e. discretized into a finite set of control 
volumes) to replace the continuous domain, where the transport equations for mass and 
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momentum are discretized into algebraic equations to solve for the flow variables at the 
grid points [39, 131-133]. The dimensionless Reynolds number is a criterion used to 
characterize the flow regimes pattern in internal flow [134]. It is defined as the ratio of 
the flow inertial force to the viscous force: 

UDRe , where U is the velocity, D is the 
tube diameter, and  is the kinematic viscosity,  /  where   is the fluid dynamic 
viscosity and   is the fluid density. For the flow in a perfect circular tube, the flow is 
characterized as laminar when Re < 2300, transient when 2300 < Re < 4000, and 
turbulent when Re > 4000  [134]. The jet caused by flow through the endotracheal tube 
and complex features of the geometry (like curvatures, asymmetry, successive branching 
angle and non-uniform cross-sections) contributes additional disturbances to the flow. 
Consequently, the critical values of Re , where the transition to turbulence is initiated, 
become lower in bifurcated tubes [135, 136]. Therefore, the turbulence was modeled in 
the current study using a high order turbulence model.  
 Traditionally, CFD modeling flow in the airways uses two equation RANS 
models like k-ε and k-ω (k: turbulence kinetic energy, ε: turbulence dissipation rate, ω: 
specific dissipation)  [34, 39]. A list of different models used can be found in Table 3.1. 
However, such low order models are not able to capture anisotropic turbulence, which is 
significant near the wall boundaries of the upper airway regions. Additionally, they 
involve model constants, which should be experimentally calibrated [39]. Furthermore, in 
the case of modeling particle transport while using RANS to model continuous phase, an 
additional model is needed to account for the influence of the velocity fluctuation on the 
particle transport, which could reduce the modeling accuracy [39, 53]. The flow field can 
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be fully resolved using direct numerical simulation (DNS); an approach where a solution 
of the discretized governing 
 
 
 
Figure 3.4 Comparison of the LES model to RANS and DNS. 
 
 equations is obtained using higher order methods and are completely independent of 
modeling application, though this entails application of a very fine mesh to resolve the 
smallest scales of the motion, i.e. the Kolmogorov length scale: 4/1)/3(   . DNS of 
three-dimensional problems therefore requires a computing mesh with a total number of 
grid points of order ~Re
9/4
 with overall computational cost related to ~Re
3 
 [132, 137, 
138]. For these reasons, DNS is limited to flows with a very low Reynolds number and 
simple computational domains. High order LES has recently become an alternative 
approach for modeling flow inside the lungs, see Table 3.1. In contrast to RANS, where 
all turbulence scales are modeled, LES has a unique feature that the large scale eddies are 
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resolved and the effect of small scales are modeled using a subgrid scale model [34, 39, 
137-140]. LES is therefore considered as a middle ground between RANS and DNS in 
terms of the accuracy and computational cost, see Figure 3.4. Moreover, Another distinct 
advantage of LES over RANS is its ability to resolve large scale turbulence eddies, 
specifically in regard to accurately modeling particle transport [141]. Since particle, 
motion is influenced more by the larger scales, the subgrid scales effect is diminished for 
particles with higher inertia [142]. Therefore, in the present study, LES was used to 
model the 3D transient oscillatory flow during HFOV. 
 
3.2.1. Filtering Operation  
The principle behind LES is the application of a spatial filtering to separate the 
large from small scale eddies instead of using time-averaging techniques. Subsequently, 
the larger scale eddies are directly resolved while the smaller scales are modeled  [132, 
139, 140]. The spatial filtering operation is applied using a filtered variable defined 
as  [132, 138, 140]:  
'
3
'
2
'
1
),(),,(),( dxdxdxtxfxxGtxf 

  (3.1) 
 
where   is the entire domain, ),( txf is the filtered variable, ),( txf  is the 
unfiltered variable, and ),,( xxG is the filter function.  is the filter cutoff width. The 
overbar indicates spatial filtering. There are three commonly used filter functions G [132, 
138, 140] are listed below in Table 3.2.    
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Table 3.2 Common filter functions. 
Filter type Filter function  
Box filter 



 


2/,3/1
2/,0
),,(
xx
xx
xxG  
Gaussian filter 


















2
22/3
2
6exp
6
),,(
xx
xxG

 
Spectral cutoff 
 


3
1
'
'
)(
]/)sin[(
),,(
i ii
ii
xx
xx
xxG  
 
Figure 3.5 illustrates the energy cascade decomposition during LES using the filter width
 to separate the energy-containing eddies and energy-dissipating eddies. The 
commonest filter width used for the filtering operation is the grid size, for 3D 
computations 3 zyx  , where x , y and z are the grid size in in x, y and z 
directions, respectively  [132, 140]. 
 
Figure 3.5 Energy cascade decomposition during LES.  Kc is the cutoff wavenumber 
computed using cutoff width ∆. 
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3.2.2. Filtered Navier-Stokes Equations 
Applying the spatial filtering operation to the Navier-Stokes equations, all eddies 
whose scales are smaller than the filter width are filtered out. The filtered conservation 
of mass equation for incompressible flow is:  
0


i
i
x
u
 (3.2) 
where iu is the filtered i
th
 velocity component with an overbar denoting filtering. The 
filtered momentum equation for incompressible flow is  [139, 140]: 
i
ij
i
j
j
i
ji
ji
j
i
xx
u
x
u
xx
p
uu
xt
u


































 


1
)(  (3.3) 
where xi is the i
th
 position component, ρ was set 1.185 kg/m3, and p is the pressure. The 
filtering process leads to the subgrid-scale stress τij , defined as  [139, 140] 
jijiij uuuu   (3.4) 
The total field velocity is defined as uuu  , where u is the resolved velocity and u  is 
unresolved velocity component. To account for the effect of the unresolved small scale 
eddies, the subgrid scale stress (SGS) must be modeled [132, 138, 140].  
3.2.3. Subgrid Scale Model 
Several subgrid scale models used for LES modeling. The most classical model is 
the Smagorinsky model  [143] where the eddy-viscosity is modeled in terms of strain rate 
tensor as: 
ijijssgs SSC 2)(
2 , where Cs is constant. However, it is well known that 
Smagorinsky’s model entails many defects [144, 145]: the model constant has to be 
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adjusted for each flow, the model has near wall limiting behavior of )(~ 0yO which is not 
correct, and for laminar flow the model does not diminish and is highly dissipative in 
transition region. The developed version of the Smagorinsky model was also introduced 
by Germano  [146], which is known as the dynamic model. While the dynamic model has 
a feature of adjusting the model constant automatically to the flow type, several other 
limitations have not been resolved [33, 34]. An advanced SGS model was developed and 
introduced by Nicoud and Ducros [147]. It is known as the wall-adopting local eddy 
viscosity (WALE) and is based on the square of the velocity gradient tensor. The WALE-
SGS model has the ability to reproduce laminar to turbulent transitions and to return the 
correct wall-asymptotic )(~ 3yO variation of the SGS viscosity [33, 34]. Furthermore, 
the WALE model is invariant to coordinate translation or rotation and only local 
information are needed, which makes the LES appropriate in complex geometry [33, 34]. 
In general, the SGS model should satisfy several flow properties for accurate modeling 
such as: correct wall-behavior and produce zero eddy viscosity in the case of a pure 
shear. Table 3.3 summarizes the capability of different well-known models in terms of 
several important properties.  
Table 3.3 Comparison of different well-known models in terms of several important 
properties [145] 
Property Smagorinsky [143] 
Cs 
Vreman [148] 
Cv 
WALE  [147] 
Cw 
Asymptotic 
 
)(~ 0yO  
(NS) 
)(~ yO  
(NS) 
 
)(~ 3yO  
(S) 
Pure shear 
 
1 
(NS) 
0 
(S) 
0 
(S) 
Isotropic 
 
2.45 
(NS) 
1 
(NS) 
0 
(S) 
Abbreviations: S: satisfy; NS: not satisfied 
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For its many advantages, the WALE model was adopted for the subgrid-scale eddy 
viscosity model. The relationship between the SGS and the large-scale strain rate tensor 
ijS  is expressed in Equation 3.5 [139, 140]: 
ijsgskk
ij
ij S

 2)
3
(   (3.5) 
The strain rate tensor, ijS  is defined as [139, 140]: 














i
j
j
i
ij
x
u
x
u
S
2
1
 (3.6) 
The subgrid scale viscosity νsgs for the LES WALE model is modeled as  [140, 147] 
4/32/5
2/3
2
)()(
)(
)(
d
ij
d
ijijij
d
ij
d
ij
wsgs
SSSS
SS
c

  (3.7) 
In Equation 3.7 
d
ijS  is the traceless symmetric part of the square of the velocity gradient 
tensor [139, 140]: 
222
3
1
)(
2
1
kkijjiij
d
ij gggS   (3.8) 
where ijg  is the velocity gradient tensor [139, 140]:  
j
i
ij
x
u
g


  (3.9) 
3.2.4. Numerical procedures  
The computational investigations were carried out using an implicit finite volume 
based solver, ANSYS® CFX14. The advection term was solved using a second order 
central differencing scheme. For LES, a central differencing scheme is necessary for 
accurate modeling. The artificial numerical diffusion, arising due to discretization that 
58 
 
presents itself in different schemes such as upwind, is eliminated [16]. A second order 
backwards Euler scheme was used for the transient term. Convergence criteria was set 
such that the root mean square (RMS) residual for mass and momentum equations was 
less than 10
-4
  [48, 117]. The time step was set such that the low Courant–Friedrichs–
Lewy (CFL) was satisfied. More details of numerical procedures, time step specification, 
particle-tracking modeling, and user-enhanced programs are presented in the subsequent 
chapters. The transient simulation was run on an 8-processor (2.4 GHz) Dell precision 
workstation T7500 with 24 GB of RAM. 
3.3. Mesh Independence study 
The predicted solution must be independent of the grid resolution [39, 131-133]. 
Prior to CFD modeling, the mesh independence can be achieved by examining the 
important flow variables on different mesh sizes at equivalent flow conditions.  In the 
present study, a grid convergence analysis was performed over eight different meshes 
with the total number of mesh elements ranging from 1.182×10
5
 to 6.535×10
6
. Average 
velocity and turbulent kinetic energy )5.0(
''
iiuuTKE  , where 
'
iu is the fluctuation velocity, 
were used as the convergence criteria. The average velocity and TKE were evaluated for 
slices at the left (L-L) and right (R-R) main bronchi. The percentage difference of the 
results from each of the two successive meshes is presented in Table 3.4. The inset plot 
shows the locations of the slices L-L and R-R where the variables were evaluated. 
Clearly, for all variables at all locations, the solution is converged for mesh size > 
8.47×10
5
 elements with maximum difference of ~4.4%. Therefore, a mesh of size 
2.42×10
6
 elements was used for all simulations.  
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Table 3.4 Details of grid independence study.  
Mesh 
size 
Percent Difference%
*  
 Uave 
 L-L 
Uave 
 R-R 
TKE 
 L-L 
TKE 
 R-R 
 
1.18105 -   -  - -  
4.6105 14.73 6.02 17.82 18.92 
8.5105 10.19 6.77 23.46 13.54 
1.6106 4.03 3.33 4.44 1.85 
2.4106 3.13 1.09 3.48 2.12 
3.5106 3.59 2.92 4.22 1.04 
4.1106 3.21 3.69 2.55 1.31 
6.5106 2.21 3.93 2.00 2.86 
*
Percent Difference% is define as 100
1
21


M
MM
 
Abbreviations: M1 is U or TKE value of mesh 1, M2 is U or TKE of mesh 2,  
Mesh1 and mesh2 are each two successive meshes.  
 
3.4. LES VALIDATION 
LES modeling was validated against available experimental data of the oscillatory flow 
inside a bifurcation model by Lieber and Zhao [87]. This experimental study is usually 
used to validate the numerical modeling procedures of oscillatory flow in bifurcated 
tubes  [47, 85, 149-151]. A single idealized model was used in the experimental study. A 
glycerin-water solution (ν = 6103.6  m
2
/s) was used as a working fluid and was pumped 
through the test section by a reciprocating pump, see Figure 3.6. Velocity measurements 
were taken at key points in the domain using laser Doppler anemometry (LDA). The 
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Reynolds number based on the peak flow rates was 2077. The Womersley number α =4.2 
(  /a , where a is the tube radius and the angular frequency ω = 2πf, where f is 
the frequency). The computational model was created following the description provided 
by Zhao and Lieber [88]. It was a single idealized bifurcation based on the Weibel 
model [59], see Figure 3.7a. The numerical simulation was set to match the experimental 
procedures. Similar working fluid properties were used. To mimic the experiment outlet 
conditions setup, mass flow rate in left and right branches were employed as a fraction of 
the instantaneous inlet mass flow rate. The measured flow rates in the left and right 
branches were 48% and 52% of the inlet flow rate, respectively. The walls were assumed 
rigid, with a no slip condition. The Womersley velocity profile along with a sinusoidal 
flow waveform were imposed at the inlet of the parent tube [47].  
 
 
Figure 3.6 Experimental apparatus from [152]. Adopted with permission from (ASME). 
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where i is 1 ,  r is the non-dimensional radial distance such that r =0 in the center of 
the tube and r =1 at the wall, and,  Jo is the zeroth Bessel function of the first kind. The 
pressure gradient driving the flow is represented by the real part of
* i tA e  . The peak flow 
rate of 4/Remax DQ  is used to determine the parameter A
*
. A user-enhanced 
FORTRAN subroutine was used to implement the Womersley velocity profile in CFX 
solver. The LES–WALE turbulence model, along with the numerical solver procedures 
described in the previous sections, was implemented to simulate transient oscillatory flow 
matching the experimental investigation. Figure 3.7b compares the velocity profile results 
from the CFD simulation to experimental measurements at different locations along the 
bifurcation. The axial velocity obtained by the current numerical code, at both inspiration 
and expiration phases, agreed with the LDA measurements. These concordances indicate 
that the present code and LES model are sufficiently accurate to model oscillatory flow in 
the human tracheobronchial tree model. 
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Figure 3.7 (a) The replicated bifurcation model matches the experimental model. (b) 
Results from experimental validation. Circles represent LDA measurements of velocity 
from Lieber and Zhao [152]; lines represent velocity profiles obtained by simulation. 
Data are for two different cycle times 0.7T (inspiration phase) and 0.2T (expiration 
phase). 
 
 
 
  
63 
 
CHAPTER 4
1
 
FLOW TRANSPORT AND GAS 
MIXING DURING INVASIVE 
HIGH FREQUENCY 
OSCILLATORY VENTILATION 
 
 
 
 
 
 
 
 
  
                                                 
1
 This chapter was based on the following published paper with permission from Elsevier 
publishing: 
Alzahrany M., Banerjee A., Salzman G. Flow Transport and Gas Mixing During Invasive 
High Frequency Oscillatory Ventilation. Medical Engineering and Physics. 36 (6), 
P647–658 
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4.1. Introduction 
A mechanical ventilator is commonly used in intensive care units to facilitate and 
support patient breathing during acute respiratory failure  [1, 2, 25]. As reviewed in 
Chapter 1, in many critical situations, as in acute lung injury and acute respiratory 
distress syndrome, usage of CMV based therapy could lead to lung injury due to high 
tidal volumes of 6-10 ml/kg  [2, 9, 10]. High Frequency Oscillatory Ventilation is then 
considered a useful ventilation mode as it allows for adequate gas exchange and prevents 
lung injury due to the usage of small tidal volumes of ~1-2 ml/kg  [9], albeit at higher 
frequencies of 1 - 30 Hz [2, 25, 153]. Unlike CMV where the primary mechanism of flow 
transport is bulk convection, flow transport during HFOV is complicated and not fully 
understood [28, 30]. Previous work  [28-31] has identified several physical mechanisms 
that play a role in gas transport and mixing during HFOV: (a) bulk convection; (b) gas 
exchange between respiratory units or pendelluft; (c) counter flow; (d) longitudinal 
mixing; and, (e) gas exchange by molecular diffusion. A detailed understanding of these 
mechanisms is essential for optimizing ventilation management strategies during HFOV 
and is the focus of this work. 
Oscillatory flow and convective mixing through human lungs have been 
numerically investigated by Choi et al [47] in a computed tomography (CT) based human 
airway model. The inlet condition was imposed at the mouthpiece of the model. There 
different flow conditions were modeled. Normal breathing case (NORM, VT = 500 mL 
and f = 0.2 Hz), a high frequency- normal-Re case (HFNR, VT = 16.58 mL and f = 6.28 
Hz), HFOV (VT = 47 mL and f = 6.28 Hz). While the coaxial counter flow was totally 
absent in case of NORM, it was found more evident in case of HFNR. The contribution 
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of the counter flow to the mixing was ~20% during HFOV. Nagels and Cater  [48] 
carried out a numerical simulation of HFOV in a simplified double bifurcation model. 
Sinusoidal velocity was impost at the trachea inlet with operating frequency of 25 Hz. 
Large eddy simulation along with Smagorinsky SGS was implemented. They observed 
flow reversal near the wall due to residual motion of the fluid at different times of the 
ventilation cycle. Flow transport between main bronchus was by pendelluft mechanism 
due to geometry asymmetry, a feature also reported by Adler and Brucker in their 
experimental study [111]. Bauer and Brucker [78] studied, in vitro, airway reopening and 
observed that the collapsed airway can be recruited at a high Womersley number. 
Oscillatory flow of HFV in a symmetric 3-generation Weibel model was numerical 
investigated under by Zhang and Kleinstreuer [150]. Differences between the oscillatory 
flow and the equivalent steady state was found even at peak flow. Tanaka et al [154] used 
laser Doppler anemometer to study the fluid dynamic in side idealized 3 generation 
Horsfield [51] based model. The spatial and temporal secondary flow intensities and its 
influence on gas mixing in HFOV was examined. Secondary velocity was found to be 
highly dependent on geometry features like the branching angle and curvature ratio of 
each bifurcation. Heraty et al. [98] conducted in vitro investigation of gas exchange 
during HFOV in a single idealized and realistic bifurcation geometry and reported that 
bifurcated geometry features influence the flow leading to secondary flow structures. 
Hatcher et al. [45] studied mechanical performance of five clinically available neonate 
HFOVs and reported that ventilator performance varied widely for the models chosen 
even though the devices had similar operating parameters (the difference attributed to 
different waveform shapes). The presence of intubation during ventilation therapy causes 
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a high speed-jet, which is released at the carina-trachea environment and induces shear 
stress at the airways walls. The wall shear stress (WSS) is seen to cause airways 
inflammation and epithelial erosion [12, 22]. Green [22] studied WSS in an idealized 
model and found that the high flow rate at the peak expiration due to coughing caused a 
high wall shear stress, which subsequently leads to airways inflammation. Muller et 
al [12] investigated experimentally the wall shear stress in a neonatal tracheal scaled 
model under high frequency jet ventilation (HFJV) by varying the location of the jets 
inside the ETT. High values of WSS were measured and it was observed that it doubled 
itself when the jet was moved closer to the wall from the center of the ETT. 
The majority of in vitro and computational studies have looked at the effect of 
ventilation frequency or ventilation mode during HFOV. It is well-known that the HFOV 
waveform varies between clinically available models, and it is hypothesized that this 
variation in the shape of ventilator waveform coupled with the frequency of the device 
and presence of intubation plays an important role in gas transport and mixing and lung 
injury. The current work is motivated by the need to study the effect of frequency (15, 10 
and 6 Hz) and waveform shapes (sinusoidal, exponential, and square) for three 
commercially available high frequency ventilators. The following problems have been 
addressed: 
o The ventilator-related parameters effects on gas transport during HFOV: 
ventilation waveform shapes and operating frequency 
o Effects of presence of intubation on the flow structure and ventilator-induced 
lung injury.   
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o  Influence of waveform shape and the rapid change in 
acceleration/deceleration of flow and pressure on lung injury during HFOV.  
4.2. Method 
4.2.1. Numerical Method  
Transient three-dimensional high frequency oscillatory flow was solved using an 
implicit finite volume CFD solver (ANSYS
® 
CFX13). Turbulence is modeled using the 
LES based WALE model described in Chapter 3 [147]. The advection term was solved 
using a second order central differencing scheme while a second order backwards Euler 
scheme was used for the transient term. Convergence criteria was set such that the RMS 
residual for mass and momentum equations was less than 10
-4
 [48, 117]. Courant–
Friedrichs–Lewy was constrained to unity during the whole breathing cycle by using 
adaptive time step with upper and lower limit of 10
-3
 s and 10
-6
 s respectively. Figure 1 
shows the geometry with the locations of all slices used in this chapter to compute 
different variables.  
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Figure 4.1 Illustration of the slices locations on the tracheobronchial tree model. 
Inlet boundary condition: A blunt turbulent velocity profile  [95] was imposed at the 
inlet of ETT; the mean velocity )(tum  was based on the corresponding pressure-
controlled ventilator waveform and its creation is discussed in the subsequent section of 
breathing conditions and waveforms. The velocity profile was defined as: 
7
1
1)(224.1),( 






ETT
m
R
r
tutru  (4.1) 
where
ETTR is radius of the endotracheal tube. A similar blunt velocity profile was reported 
by Martonen et al  [90] based on velocity measurements near the bifurcation site for Re = 
1225. Xi and Longest  [95] found a similar velocity profile just upstream of the larynx for 
Re range of 1211 to 2421. For current study, Reynolds number (
ETT
D
t
fV
ETT
/4Re  , where ETTD  is the ETT diameter) ranges from 6960 to 24694 
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for all cases based on the ETT inlet, and it was considered appropriate to choose a blunt 
profile.  
Outlet boundary condition: The mass flow rate at each outlet was calculated and set as a 
partial percentage of instantaneous mass flow rate at the inlet and defined as: 
)()( tqPtq inletkk  , where 
it
k
A
A
iHk PP ,
,
,  (4.2) 
In equation (3), k denotes outlet number; )(tqk and )(tqinlet are the instantaneous flow rate 
at both k
th
 outlet and ETT inlet, respectively;  kP   is the mass flow rate fraction at outlet 
k; iHP ,  is the mass fraction obtained from Horsfield et al  [51] for branch i; kA  is the 
equivalent area of outlet k; and, it
A
,  is the total of the equivalent areas of the outlets that 
are supplied by the branch corresponding to the i
th
 branch. Similar mass flow rate 
specifications have been used in past studies [95, 96, 100, 155, 156]. Tables 4.1and 4.2 
present the mass flow rate fraction used at each outlet in left and right lung respectively.  
Walls condition: The airway walls were considered to be rigid, dry and smooth and a no-
slip boundary condition was imposed [34, 39, 53].  
4.2.2. Breathing Conditions and Waveforms 
The boundary condition at the ETT inlet was specified in terms of a transient 
velocity  )(t
m
u  associated the blunt profile (i.e. Eqn. 4.1). The equation of motion that 
governs the flow during mechanical ventilations (Eqn. 4.3) was used to obtain the flow 
rate curve from a given pressure waveform shape [1, 2]. The flow rate was then used to 
compute the transient velocity at the inlet. Therefore, the pressure function was not 
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applied directly to the CFD simulations and was achieved in two separate steps, see 
Figure 4.2. Prior to the CFD runs, a MATLAB code was used to generate the transient 
velocity )(t
m
u . For a defined pressure function (waveform shapes: sinusoidal, 
exponential and square), 
 
 
Figure 4.2 Flow chart of the transient velocity generation using the ventilator input 
pressure waveform. 
 
Eqn. (4.3) was numerically solved using the MATLAB code for the volume and flow 
rate [1, 2]. Figure 4.3a plots the shape of three given pressure functions. Figs. 4.3b and 
4.3c are the computed volume and flow rate curves respectively. From the flow rate curve 
(Figure4.3c), the transient velocity )(tmu was obtained as ETTAQtmu /)(  , where ETTA  is the 
area of the ETT inlet. This transient velocity field was imported to the CFD runs as the 
inlet velocity profile. The equations of motion states that the pressure applied to the 
respiratory system for ventilated patient equal to the sum of pressure loss due to the total 
airways resistance, pressure drop due to the total lung compliance and the positive end-
expiratory pressure (PEEP). The pressure applied to the respiratory system is the sum of 
the pressure applied by the ventilator (P) and the pressure due to the respiratory muscles 
(Pmus). Thus, the equation of motion is described as [1, 157, 158]: 
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PEEP
C
V
RQPP mus  ;  
dt
dV
Q   (4.3) 
where Q is flow rate and V is volume. The lung compliance and airway resistance are 
defined as: 
V
C
P



; PR
Q



 (4.4) 
R and C  were taken as 4.33cm H2O/(L/s) and 0.127 L/cm H2O respectively, and were 
based on averaged values for different patients from Grimby [159] and were considered 
constant in evaluating waveform pattern [160]. The PEEP was assumed zero and for 
totally supported patient, the contribution of the muscles is zero (Pmus is zero) [1, 157, 
158].  Consequently, Eqn. (4.3) collapses to:   
C
V
RQP   (4.5) 
HFOV is characterized by a tidal volume that is less than or equal to the dead space  
volume of the conducting airways [1]. For current geometry, the dead space volume was 
60 mL. A tidal volume of 50 mL was chosen such that it satisfies the above constraint 
and allows us to compare present work with previous studies  [47, 79, 98].  The inverse 
of the active inspiration phase was used to impose the active expiration phase such that 
inspiration to expiration ratio (I:E) was 1:1. Table 4.3 presents flow parameters for all 
cases considered in the current study. 
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Figure 4.3 Pressure-controlled waveforms and flow rates’ curves at f = 15Hz. 
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Table 4.1 Mass flow rate fraction for each outlet used for boundary conditions in left 
lung. 
Anatomical part 
Outlet 
No. 
Generation 
Diameter 
(mm) 
Mass flow 
rate% 
Trachea - G0 14.82 100% 
LUL: Anterior 
 
1 G5 2.01 1.11% 
2 G5 2.3 1.46% 
3 G5 2.2 1.33% 
4 G5 2.98 2.45% 
LUL: Posterior 
 
5 G6 2.65 2.64% 
6 G6 1.96 1.44% 
7 G6 1.52 0.87% 
8 G6 2.74 2.82% 
LUL: Lingula-
Superior 
9 G4 1.68 1.10% 
10 G4 2.05 1.64% 
LUL: Lingula-Inferior 
11 G4 2.42 1.93% 
12 G4 2.27 1.70% 
LLL: Superior 
13 G4 1.27 0.90% 
14 G4 1.16 0.75% 
15 G4 2.34 3.05% 
LLL: Posterior basal 
16 G6 2.85 2.16% 
17 G6 2.37 1.50% 
18 G6 2.28 1.38% 
19 G6 3.2 2.73% 
LLL: Anterior Basal 
20 G7 2.36 1.66% 
21 G7 2.07 1.28% 
22 G7 2.35 1.65% 
23 G7 2.35 1.65% 
24 G7 1.59 0.76% 
25 G7 1.61 0.77% 
LLL: Lateral basal 
26 G6 2.56 2.41% 
27 G6 2.5 2.29% 
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Table 4.2 Mass flow rate fraction for each outlet used for boundary conditions in right 
lung. 
Anatomical part 
Outlet 
No. 
Generation 
Diameter 
(mm) 
Mass flow 
rate% 
RUL: anterior 
 
28 G5 2.35 2.33% 
29 G5 1.44 0.88% 
RUL: Posterior 
 
30 G6 3.88 2.53% 
31 G6 3.02 1.53% 
32 G5 4.7 3.71% 
RUL: Apical 
 
33 G5 2.59 1.25% 
34 G5 5.01 4.68% 
35 G4 3.77 2.65% 
36 G5 2.02 0.76% 
37 G5 2.72 1.38% 
RML: Lateral 38 G4 1.75 0.90% 
RML: Medial 
 
39 G5 0.97 0.28% 
40 G5 1.86 1.02% 
RLL: Meddle basal 
 
41 G6 3.09 2.81% 
42 G7 2.72 2.17% 
43 G7 2.75 2.22% 
44 G6 3 2.65% 
45 G6 1.78 0.93% 
RLL: Posterior basal 
46 G6 3.92 4.52% 
47 G7 2.89 2.46% 
48 G7 3.25 3.11% 
RLL: Anterior basal 
 
49 G6 2.79 2.29% 
50 G6 1.85 1.01% 
51 G6 3.01 2.66% 
RLL: Superior 
 
52 G6 3.12 2.86% 
53 G6 1.81 0.96% 
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4.2.3. Solution Independent of Cycle’s Number   
To evaluate the required number of cycles to reach a statistically independent 
solution, a transient simulation was run up to ten HFOV cycles.  Average velocity and 
turbulent kinetic energy were used as the convergence metric. The average velocity and 
TKE were evaluated at slices at left L and right R main bronchi; see Figure 4.1 for the 
locations of the slices. The percent difference of the results from each two successive 
cycles are presented in Table 4.4. It was observed that flow parameters converged after 
approximately two cycles with a maximum difference of ~2.5% in TKE and ~4.9% in the 
average velocity. An oscillatory difference in the root-mean-square velocity of 4% 
persists during multi-cycles of HFOV was observed by Nagels and Cater [48]. Four 
HFOV cycles were considered adequate and values reported in this study are for the 
fourth cycle. 
 
Table 4.4 Solution independent of the cycle number study. 
Cycle 
No. 
Percent Difference%
*
 
𝑈𝑎𝑣𝑒  
 L 
𝑈𝑎𝑣𝑒  
R 
TKE 
L 
TKE 
 R 
1 - -  - - 
2 1.39 0.79 57.11 33.73 
3 1.05 1.85 0.66 16.21 
4 2.47 4.90 1.86 2.45 
5 2.02 3.46 1.89 0.67 
6 0.58 0.32 0.02 1.01 
7 4.47 3.08 0.01 0.57 
8 4.41 0.97 0.22 0.58 
9 4.46 4.75 0.02 0.02 
10 2.08 4.06 0.07 0.13 
*
Percent Difference% is define as 100*
1
21
M
MM 
 
Abbreviation: M1 is U or TKE value of Cycle 1, M2 is U or TKE of Cycle 2  
Cycle1 and Cycle2 are each two successive cycles. 
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4.3. Results 
Results from the computations of oscillatory flow in a patient specific lung model 
under HFOV conditions are described next. Simulations were performed with and 
without ETT to understand the effect of invasive medical devices. The flow field for all 
cases was characterized by high turbulence and strong secondary motions due to 
waveform shapes, complexity of the geometry, presence of invasive devices, and a high 
Reynolds number due to high frequency.  
4.3.1. Effect of Waveform Shape  
4.3.1.1. Coaxial Counter Flow 
Figure (4.4) plots velocity vectors for the three-waveform shapes at f = 15 Hz on a 
vertical slice made by a plane which cut through the ETT, trachea, and main bronchi; the 
inspiratory and expiratory flow is denoted by red and blue arrows, respectively. For 
clarity, a close-up picture of the near bifurcation site is provided as an inset. The flow 
structures at end expiration (EnEx) qualitatively resembled that at early inspiration 
(EaIn); similarly, the flow at end inspiration (EnIn) resembled that at early expiration 
(EaEx). Variations in coaxial counter flow were observed between the cycle phases (see 
Figure 4.4) and varied with waveform shape. For example, during the EnEx phase, the 
flow at the vicinity of the right trachea and outer wall of the right main bronchus was in-
phase for sinusoidal and exponential waveforms (zones 1 and 2) but out-of phase for the 
square waveform (zone 3). These differences were also present during the EnIn phase. 
The exponential and square waveforms (zones 4 and 5) exhibited a uniform coaxial 
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counter flow compared to the sinusoidal case (zone 6). For the sinusoidal wave, the flow 
was mostly in-phase except at the outer wall of right bronchus. For the exponential and 
square waveforms, the flow had lower momentum at the vicinity of outer walls of the 
main bronchi and the walls of the trachea and flows ahead of phase.  
 
Figure 4.4 Co-axial counter flow for (a) sinusoidal, (b) exponential, and (c) square 
waveforms at end expiration (EnEx) and end inspiration (EnIn) phases for f =15 Hz and 
Q =18.2 L/min. Red arrows represent inflow vectors (inspiration) and blue arrows 
represent outflow (expiration) vectors 
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4.3.1.2. Pendelluft Flow 
Gas exchange between left and right main bronchi was observed for the sinusoidal 
waveform in EnEx phase (Figure 4.4a) and was found to persist up to the EaIn phase (see 
Figure 4.5a). The flow at the left bronchus reversed its motion, moved over the carina 
ridge to the right bronchus and demonstrated a pendelluft-like gas transport. In the case 
of the square waveform, pendelluft was observed during the EaIn phase (see Figure 4.5b) 
but was absent for the other phases. Pendelluft-like features were completely absent at all 
phases for the exponential waveform.  
 
Figure 4.5 Pendelluft-like flow at end inspiration (EaIn) at the main bronchi bifurcation 
site, and vector plots for 15 Hz HFOV frequency using (a) sinusoidal-waveform, and, (b) 
square-waveform. Red arrows denote inspiratory flow and blue arrows denote expiratory 
flow. 
4.3.1.3. Secondary Flow 
Figure 4.6 presents secondary flow strength (SFS) contours and instantaneous 
streamlines that are used to analyze secondary flow features at a vertical slice (made by a 
plane which cuts through the ETT, trachea and main bronchi) and two different cross-
sectional planes (TI and T2). Secondary flow strength is defined as the ratio of the radial 
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(
rV ) component of velocity to the mean velocity component at a given location  [161]. 
SFS was characterized as strong when the ratio is greater than 0.6, moderate when 0.3 ≤ 
SFS ≤ 0.6, and weak when SFS < 0.3. Contour plots for En-Ex and En-In phases were 
plotted for three waveform shapes at f = 15 Hz. Flow transport, under current conditions, 
as characterized by strong secondary flow (i.e. SFS > 0.6) due to the high Reynolds 
number and presence geometrical complexity such as ETT, successive branching tubes, 
curvatures and non-uniform cross-sections. The secondary flow behavior differed based 
on waveform shape and phase. Different vortical structures were associated with the flow 
field near flow reversal. Small vortical structures existed due to presence of shear layers 
between coaxial counter flows. Complex, distorted, asymmetric and unstructured vortices 
formed at the transverse planes at all locations and during all phases. However, the shape 
and strength of these vortices differed from one station to another. For example, at the 
EnEx phase of the sinusoidal wave (see Figure 4.6a) a large counter-clockwise swirl 
motion existed at slice T1 while a pair of asymmetric counter-rotating vortices developed 
at T2 due to the effects of asymmetric merging of the flow from the main bronchi and 
effects of curvatures. Additionally, the secondary motion, at any given location, changed 
appreciably depending on ventilator phase. As illustrated in Figure 4.6a, a single vortex 
occurred at T1 in the EnEx phase, whereas two counter-rotating vortices formed at the 
dorsal side of the trachea and a large clockwise vortex at the ventral side at the same 
location during EnIn phase.   
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Figure 4.6 Secondary Flow Strength (SFS) contour and streamlines at different planes 
(vertical slice and two different transverse slices T1&T2) for f = 15 Hz for (a) sinusoidal, 
(b) exponential, and, (c) square waveforms. Plots presented for end expiration (EnEx) 
and end inspiration (EnIn) phases. 
 
The secondary flow pattern changed with variation in the waveform shape. A 
stronger secondary flow with a higher radial velocity occurred at the main bronchi during 
the EnIn phase of the non-sinusoidal waveforms (Figure 4.6a). This enhancement was 
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also evident by counting the total number of counter-rotating vortical structures that 
existed on the transverse slice T2 at the same phase. Upon comparing the streamlines on 
T2, it was observed that three counter-rotating vortices exist for a sinusoidal waveform 
(Figure 4.6a). However, upon changing to a non-sinusoidal waveform (exponential or 
square), the number of vortices increased, depicting a further strengthening of secondary 
flow which would subsequently lead to enhanced gas mixing at the same plane.   
Figure 4.7 plots the averaged SFS for the sinusoidal and square waveforms at 
different times during the ventilation cycle. SFS was averaged at different locations, 
cross-sectional planes were considered in the trachea (T1) and main bronchi (L1 and R1, 
see Figure 4.1). High SFS values were observed over the cycle time for both cases with 
four distinct peaks that indicates the start and end of inspiration and expiration. The peak 
value during EaIn occurred approximately ~6% quicker for the square waveform and was 
followed by a rapid deceleration that led to the occurrence of the second peak for En-In. 
It was observed, however, that the occurrence of the second peak was delayed for the 
square waveform due to lower deceleration compared to the sinusoidal case. Similar 
observations were made for the expiration phase. The square waveform is characterized 
by a relatively steep gradient of pressure and flow rate and this leads to stronger 
disturbance, which was characterized by an intermediate peak during the inspiration 
phase (see L1 and R1 in Figure 4.7b); such a peak was not present for the sinusoidal case. 
Additionally, at T1, a noticeable difference in SFS magnitude was observed during the 
EnEx phase. Towards the end of the cycle, the SFS decreased for the case of a sinusoidal 
waveform as opposed to increasing that of the square waveform. This was attributed to 
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the flow history along with the presence of a strong merging of the flow from the left and 
right airways main bronchi. 
 
Figure 4.7 Temporal variation of averaged-SFS for f= 15 Hz at different locations (cross-
sectional slices, T1 at the trachea and L1-R1 at the main bronchi).  (a) Sinusoidal 
waveform. (b) Square waveform. 
4.3.1.4. Turbulence 
 Figure 4.8 displays spatial distribution of normalized TKE from the ETT 
entrance down to the lower branches (G6-G7) for both the left and right lungs; 
normalized values are reported at the peak inspiration phase (i.e. maximum TKE) for the 
sinusoidal and square waveform. TKE increased from the entrance to the end of the ETT 
before gradually decreasing (~ 40% in value) in the lower regions of the trachea. TKE 
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dropped abruptly to ~ 44% as the flow passed on to the main bronchi (G1). Downstream 
of the main bronchi, an increase in TKE was observed at the entrance regions of G2 and 
G3 in the left and right lungs due to geometrical complexity of successive branching 
tubes and non-uniform cross sections. A relatively higher magnitude in the left side 
occurred due to the sharper transition in the geometry. TKE decayed gradually further 
downstream until it reached the lower region of G5, where the TKE value dropped to < 
5% and the flow was deemed to be laminar. During the process of decay in the lower 
generations, the right lung had a slightly higher TKE compared to the left lung, which 
was attributed to the asymmetry and local geometrical differences between the left and 
right airways.     
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Figure 4.8 Plot of Turbulence Kinetic Energy (TKE) from ETT inlet to lower generations 
(G7) in both left and right lungs at the peak inspiration phase (f = 15 Hz)  and two 
waveforms and model without ETT.  TKE normalized by TKEmax =806 m2/s2. 
 
To quantify the variations in turbulence with changes in HFOV waveforms, 
temporal variation of normalized TKE was plotted (see Figure 4.9). TKE was averaged at 
a vertical slice that cuts through the ETT, trachea and main bronchi. Gas transport with 
the square wave resulted in higher turbulence than the sinusoidal and exponential cases as 
the square waveform is distinguished by higher deceleration period (i.e. 93% of the 
inspiration phase) resulting in higher flow disturbance  [135] and a resulting high TKE. 
In contrast, the flow deceleration occupied 50% of the inspiration phase for the sinusoidal 
waveform and the associated TKE values were lower. 
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Figure 4.9 Temporal variation of TKE for f = 15 Hz at vertical made by a plane which cut 
through the ETT, trachea and main bronchi for cases of sinusoidal waveform, exponential 
waveform, square waveform and sinusoidal waveform for the case without ETT. TKE 
normalized by the maximum time-averaged TKE =212.73 m
2
/s
2
. 
 
 
4.3.1.5. Wall Shear Stress 
 Figure 4.10a-c compares WSS contours at peak inspiration for the three 
waveforms at the first bifurcation site; an enlarged back view of the site is presented for 
the benefit of the reader. Due to the impingement of the ETT-jet at the first carina, high 
values of wall shear stress were observed and mostly concentrated at the bifurcation site 
of the main bronchi (see Figure 4.10a) for the sinusoidal waveform. The high shear stress 
region extended from the lower region of the trachea to the branches that led to the upper 
and lower lobes of the left lung (see back view) and to first carina ridge of the right lung. 
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The shear stress was minimal along the top surface of the main bronchi due to a large 
swirling motion along the outer walls. Beyond these locations, the WSS appeared merely 
around the carina’s ridge in lower generations. However, the magnitude of WSS varied 
depending on the location of the carina and was ~20% of the value at the main bronchi. A 
change in the waveform shape to exponential led to more localized patches of the WSS 
(see Figure 4.10b). Even more reduction of the WSS patches were observed while using 
square waveform. In the latter case, the patches of local maximum shear stress appeared 
solely at the inner wall very close to the flow divider of the first bifurcation (see Figure 
4.10c). The distribution of WSS was inversely proportional to the level of TKE in the 
flow. The square form, which had the maximum TKE resulted in more localized patches 
when compared to the sine waveform where the WSS was more distributed.  
The time variation of WSS was also calculated at the carina (denoted by point P) 
and is shown in figure 4.10d. The point P is located on the inner wall at the entrance to 
the right main bronchus (see Figure 4.10d); it was susceptible to local maximum shear 
stress in all cases. It was observed that WSS increased during flow acceleration and 
decreased during flow deceleration following a pattern similar to the flow rate curve. In 
addition, a large increase in WSS occurred during inspiration compared to expiration due 
to the influence of ETT-jet.   
 
88 
 
 
Figure 4.10 (a)-(c) Wall shear stress (WSS) contour at peak inspiration (f = 15 Hz) for the 
three waveforms. Plots show the back view of the first bifurcation. (d) Temporal 
variation of the WSS at point P for the three waveforms and f=15 Hz. 
 
4.4. Effect of Frequency 
To understand the effect of HFOV frequency, simulations were run at frequencies 
of 10 Hz and 6 Hz [Womersley number (α) of 14.85 and 11.50 respectively]. Counter-
flow patterns for the sinusoidal and square waveforms at EaIn phase are plotted in Figure 
10a. Changing oscillatory frequency had a pronounced effect in counter flow pattern. For 
example, for the sinusoidal case, flow at the right side of trachea was still in phase (zone 
1), whereas, at the same location (zone 3) the flow was out of phase. The differences in 
89 
 
the counter flow pattern when using different waveform shape still existed even when 
changing the frequency. This was clearly observed by comparing the flow at zones 2-4 in 
the case of 10 Hz and zones 3-5 for the 6 Hz frequency (Figure 4.11a). The pendelluft-
like motion was observed at EaIn phases when using a sinusoidal waveform with 
frequency of 6 Hz (see Figure 4.11a). For non-sinusoidal shapes, pendelluft was not 
present when HFOV frequency was decreased. 
The variation of the wall shear stress along the cycle time had similar profiles for 
all frequencies. Its magnitude, however, dropped with a decrease in the frequency (see 
Figure 4.11b). For further illustration, Table 4.4 presents the maximum wall shear stress 
WSS (at point P in Figure 9d) for the inspiration and expiration phase for all three 
waveform and frequencies. It was found that the WSS value dropped by ~ 72% when the 
frequency was reduced from 15 Hz to 6 Hz, indicating a reduction in the risk of alveolar 
damage and barotrauma at lower frequencies. 
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Figure 4.11 (a) Coaxial counter flow at the bifurcation site for the sinusoidal and square 
waveforms. Data are for HFOV frequencies of 10 and 6 Hz and EaIn. Red arrows denote 
inspiratory flow and blue arrows denote expiratory flow. (b) WSS versus normalized 
cycle time (
cyclenormalized TtT  ) at point P (see Figure 9d) for frequencies of 6, 10 and 15 
Hz and the case of the sinusoidal waveform. 
 
4.3.1. Effect of Endotracheal Tube 
To check the influence of ETT on fluid transport and mixing, simulations were 
performed without the ETT for the sinusoidal waveform at a frequency of 15 Hz. The 
results show that the presence of ETT had a significant effect on the flow structure. 
Figure 4.12a shows the coaxial counter flow at En-In for the cases with and without ETT. 
The coaxial counter flow had zones of reversal flow in the case of ETT (Figure 4.12a). In 
the case without ETT, the inspiratory flow moved uniformly in the core region of the 
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trachea and inner wall of the main bronchi and the expiratory flow transported along the 
outer wall of the main bronchi and trachea.  
Figure 4.12b shows the wall shear stress distribution at the first bifurcation site 
(back-view) for the case without ETT. The local maximum WSS moved downstream 
(lower generation) and was present at the carina site between generation G2 and G3 in 
the left lung (see Figure 4.12b). This was in sharp contrast to the case where the ETT jet 
was present and resulted in patches of maximum WSS at the bifurcation of the main 
bronchi.  
 
Figure 4.12 Coaxial counter flow at Ea-In for sinusoidal waveform (f=15 Hz) for  cases 
with and without ETT; (b) Wall Shear Stress (WSS) contours at the first bifurcation site 
(back view) for the case without ETT (sinusoidal wave,  f =15 Hz). 
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To further elaborate the effects of ETT, the maximum WSS at the point P (see 
Figure 4.10d) during inspiration and expiration, for the cases with and without ETT, are 
listed in Table 4.4. The maximum WSS during inspiration phase decreased ~87% when 
the ETT was absent. The absence of ETT was seen to drastically reduce the overall 
turbulence in the geometry. In the trachea, when ETT was present, the TKE observed to 
be ~ 20 times higher (see Figure 4.8). Furthermore, the averaged TKE was ~ 94% and ~ 
83% lower during inspiration and expiration respectively when intubation was absent.  
 
Table 4.5 Maximum wall shear stress (WSS) at point P for all cases at inspiration and 
expiration phases. 
Waveform Sinusoidal  Exponential Square 
Frequency, Hz 15 10 6 
No 
ETT
* 15 10 6 15 10 6 
Wall 
Shear 
stress  
Pa 
In 
 
19.72 9.96 5.66 2.61 19.61 7.21 5.18 19.24 8.98 4.48 
Ex 
 
1.04 0.68 0.28 2.00 1.27 0.44 0.24 2.38 0.41 0.40 
*
At f=15 HZ 
 
4.4. Discussion 
The effectiveness of the convective mixing (non-diffusive component due to 
stretching and folding of material region of fluid) depends on the interaction and activity 
of the flow structures [47, 162]. The gas mixing occurs in the case of irreversible 
oscillatory flow and diminishes when the flow is reversible (i.e. the fluid particle returns 
to its initial location at the end of cycle). Therefore, the radial and axial mixing rate 
increases when the coaxial counter flow is associated with higher secondary flow and 
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turbulence  [47, 98, 162-164]. On the contrary, even with existence of counter flow, the 
absence of secondary flow leads to zero net convective mixing [47]. The qualitative 
results from the present study demonstrated that the coaxial counter flow occurs near 
flow reversal for all three waveforms with different features. These differences of the 
flow pattern could lead to a significant impact on the gas mixing. The counter flow was 
associated with higher turbulence intensity and slightly stronger secondary flow when 
using square waveform than the other cases. Furthermore, using square waveform led to a 
high reduction on the WSS distribution due to lower flow rate and the flow structures 
activity at the vicinity of the lung walls. This implies that using square waveform could 
be more efficient for gas mixing and less dangerous to the lung epithelium layer, due to 
the reduction of the WSS  [12].  
The present results were also compared to existing studies in the literature to 
examine the effect of the geometry morphology. Heraty et al  [98] experimentally studied 
the oscillatory flow in both single idealized and realistic bifurcation models. Choi et 
al  [47] numerically studied HFOV in idealized single bifurcations and a large scale 
realistic lung model. The following differences were observed: for a sinusoidal 
waveform, the irregular counter flow had a different pattern (highly disturbed) to that in 
Choi et al  [47] (idealized model) and Heraty et al  [98] for all frequencies. It resembled 
the patchy appearance of the counter flow in case of HFNR (high frequency normal 
Reynolds number) in the large-scale model  [47]. In addition, at the EnIn/EaEx phase, 
using non-sinusoidal waveform exhibited entirely different patterns of the counter flow to 
that in Choi et al  [47] (large-scale model). The counter flow pattern was relatively 
uniform and resembled that in Heraty et al  [98]. It was also observed that the pendelluft 
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flow was absent when using exponential waveform shape. This mechanism was also not 
reported in previous studies  [47, 98]. These variations suggest that the geometry features 
along with the waveform shape play a major role in the coaxial counter flow pattern and 
the pendelluft flow. Furthermore, both studies  [47, 98] used an idealized geometry and 
reported existence of Dean-type vortices  [165], whereas highly complex and asymmetric 
vortices were observed in the current geometry. The variation in the geometry 
morphology and the presence of the ETT-jet had a major role in this difference. The 
comparison of the major dimensions of the current geometry, Heraty et al  [98]  and Choi 
at al  [47] are listed in Table 4.5. 
Table 4.6 Comparison of the major dimensions of the geometries of the current  study, 
Heraty et al  [98] and Choi et al  [47].  
Study 
Dd /Dp 
βo 
Right Left 
Present study 0.64 0.75 74.33
o 
Heraty - Realistic Model 0.64 0.68 44
o 
Heraty - Idealized Model 0.84 63
o
 
Choi - Idealized Model 0.70 70
o 
Choi - Large-scale model 0.75 70
o 
Note: Dp is the parent (G0) diameter, Dd is the daughter (G1) diameter, and, β is the angle 
between the main bronchi. 
 
4.5. Conclusion 
A LES-WALE model was used to investigate gas transport and mixing in HFOV 
for three different waveform shapes and frequencies. The primary focus of this study was 
to understand how different flow mechanisms were altered as a result of changes to 
waveform and frequencies. It is concluded from the study that: 
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1- The coaxial counter flow existed near flow reversal for all three waveforms with 
different features. The non-sinusoidal waveforms exhibited a uniform coaxial 
counter flow compared to the sinusoidal case at End-Inspiration/Early Expiration 
phase.  
2- Pendelluft flow was present for the sinusoidal waveform at all frequencies but 
occurred only at early inspiration for the square waveform at highest frequency, 
whereas this was absent in the case of using exponential waveform. 
3- A square waveform shape resulted in higher secondary flow strength (SFS>0.6) 
and higher turbulence intensity, which could lead to more efficient mixing.  
4- A reduction of ~87% in the wall shear stress occurred during inspiration phase 
when the intubation was absent. The turbulence kinetic energy in the case of using 
ETT was found to be 20 times greater than when the ETT was absent. 
5- The square waveform resulted in the least wall shear stress on the lung epithelium 
layer and may be used in patients without the risk of barotrauma to both airways 
and the alveoli.  
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CHAPTER 5
2
 
THE ROLE OF COUPLED 
RESISTANCE-COMPLIANCE IN 
UPPER TRACHEOBRONCHIAL 
AIRWAYS UNDER HIGH 
FREQUENCY OSCILLATORY 
VENTILATION  
 
 
 
 
 
  
                                                 
2
 This chapter was based on the following published paper with permission from Elsevier 
publishing: 
Alzahrany M., Banerjee A., Salzman G. The Role of Coupled Resistance-Compliance in 
Upper Tracheobronchial Airways under High Frequency Oscillatory Ventilation. 
Medical Engineering and Physics. Published online. September 2014. 
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5.1. Introduction 
  The Pulmonary flow based on HFOV is notably complex [32], and several 
physical mechanisms are thought to play a role in gas transport and mixing. See chapters 
1 and 4 for more details. A better understanding of gas transport associated with these 
mechanisms is vital for the improvement of HFOV management [32]. Detailed CFD 
studies provide valuable information on flow physics that can be used to formulate the 
ventilation technique, and boundary conditions are of paramount importance to 
accurately modeling the flow physics during HFOV. For instance, gas exchange between 
respiratory units (i.e. pendelluft mechanism) is time constant dependent. The time 
constant () is the product of the resistance and the compliance of the airways; the 
asynchrony of the time constant due to variation of the respiratory units resistance or 
compliance causes the gas exchange between the units [32]. It is therefore essential to 
model resistance and compliance at the domain outlets properly to capture this movement 
correctly and to characterize the flow redistributions that occur during HFOV. 
Traditionally, different types of (flow) outlet BCs are utilized in pulmonary CFD, 
including: (a) Type-I BCs where uniform flow rate or velocity is prescribed [47]; (b) 
Type-II BCs where uniform pressure is used  [48, 117]; and (c) Type-III where the mass 
flow rate at each outlet is set as the mass fraction of the instantaneous inlet mass flow 
rate [96, 166] and is based on statistical model data [51]. However, these BCs do not 
account for non-uniformities of lung ventilation [46], and gas exchange between adjacent 
units cannot be captured due to inability of modeling the asymmetry in R&C between 
adjacent units. Hirahara et al [109] have studied air flow in an idealized lower airways 
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model (G18-20) using the lumped and CFD method. They implemented Type-II BCs 
based on R&C of the airways and determined that pressure had a phase-delay due to 
compliance asymmetry, which caused flow transport by pendelluft mechanism.  
In the present study, time-dependent pressure BCs as a function of instantaneous 
flow rate and coupled R&C was imposed at the exits of the image-based lung geometry 
model. The primary objective is to perform LES modeling to investigate the effect of 
coupled resistance-compliance BCs on the lung lobar ventilation and gas transport, 
particularly mass exchange by asynchronous ventilation, under invasive HFOV. To 
account for healthy and diseased lungs, several scenarios were considered by varying 
lung compliance either between lungs or locally between units.  
 5.2. Methods 
Figure 5.1a shows the lung model with an endotracheal tube and the units 
locations. LES is used to model the transient three-dimensional oscillatory flow using a 
finite volume solver (ANSYS® CFX14). Wall Adapting Local Eddy viscosity sub-grid 
scale model is adopted to model small-scale eddy effects [167]. The details of the 
numerical techniques and computational mesh of the current complex lung geometry 
were described in chapter 3. The time step was set to be 10
-5
 s to ensure a low CFL 
number [46].  
    5.2.1. Breathing Cycle and BCs 
Inlet boundary condition: A sinusoidal waveform was considered as follows: 
)2sin()( max ftQtQ  , where the maximum flow rate tVfQ max  and t is the 
cycle time. HFOV frequencies of 6, 10 and 15 Hz were selected. A tidal volume of 50 
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mL was chosen and was appropriate, as it was less than the dead space volume [1, 47]. A 
blunt velocity profile was imposed at the inlet of ETT as [90, 95]:  
7
1
1)(224.1),( 






ETTR
r
tUtru                                                      (5.1) 
 ( ) sin(2 )ampU t u ft  is obtained velocity from the HFOV waveform; and 
2/ ETTtamp RfVu   is the amplitude velocity.  
 
Figure 5.1 (a) Model with descriptions of the locations of all selected units and lung main 
lobes [RB:  right bronchus, LB: left Bronchus. RUL: right upper lobe, RML: right middle 
lobe, RLL: right lower lobe; LUL: left upper lobe, LLL: left lower lobe]. The letters A to 
D represent the following:  A represents the main bronchi bifurcation (LB and RB), B 
represents the bifurcation between the RUL and the branch that leads to both RML and 
RLL, C represents the bifurcation between the RML and RLL, and D represents 
bifurcation between the LUL and LLL. (b) The dimensions of a symmetric Weibel’s 
Model are used to calculate the pressure at each resolved outlet branch in the CT-scan 
model. 
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Outlet boundary conditions: The equation of motion [eqn. (5.2)] was used to compute 
pressure at each outlet in the CT model as a function of instantaneous flow rate ( )
joutk
q t at 
outlet number k (generation j) of CT model and the R&C of the airways as  [109, 166, 
168, 169]: 
( )
V
p t PEEP Rq
C
   , 
dt
dV
q                                                          (5.2) 
where PEEP is the positive end-expiratory pressure (assumed zero). To estimate R and C, 
a symmetric Weibel network [59] is chosen beyond each CT model outlet (see Fig. 1b), 
and resistance was calculated based on steady flow through the Weibel model. The total 
compliance value was taken from the literature. Because the Weibel model bifurcates into 
two symmetric branches, beyond generation Gj of our CT model, the flow rate (
ib
tq )( ) 
at each subsequent generation i (=j+1) was evaluated as: 
( )
( )
2
joutk
b i ji
q t
q t

                                                          (5.3) 
The total pressure loss from the outlet of the CT model to the alveoli due to resistance in 
all airway segments was then calculated as (see Fig. 5.1): 
23
1
( )
( ) ( )
2
i
joutk outk i jp resist
i j
R t
p t q t

 
 
                                             (5.4a) 
Additionally, the pressure loss due to compliance was computed as  
  
j
j
j
outk
T
outk
compp
outk
C
dttq
tp



0
)(
)(                                             (5.4b) 
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where dttq
T
outkj
0
)( is the delivered volume V during a period from t = 0 to t = T. Using 
equation (5.2), the total pressure at the k
th
 CT-Model’s outlet is calculated as a sum of the 
total pressure loss at each time step due to R&C in all airways segments: 



















j
j
i
jj
outk
T
outk
ji
jioutkoutk C
dttq
tR
tqPEEPtp 0
23
1
)(
2
)(
)()(                               (5.4c) 
A time-dependent resistance [R(t)] at each branch is computed using the formula 
introduced by Barbini et al [170]:  
,( ) [1 ]i L i bi biR t R k q                                                            (5.5) 
where 
4128 dLRL   is the Poiseuille (laminar) resistance, L and d are the length 
and diameter of each Weibel segment,   is the fluid viscosity, biq is the volume flow rate 
at each branch of generation i, and, bik  is a constant estimated based on the inlet flow 
rate. For the current study, the inlet flow rate ranged from 56.5 L/min to 141 L/min and a 
range of values of 6.4285 s/l to 0.047 s/l, representing G5 to G10, were chosen for bik . For 
generations G11- G23, the value was taken as zero [170]. The second term in eqn. (5.5) 
accounts for a high flow rate, where turbulence effects may be present   [170]. However, 
this term was found to have no significant effect on the solutions under the present 
HFOV conditions as the low flow rate at the terminal units leads to a very small 
contribution from this term (0.013<Re< 1823). Additionally, the compliance in eqn. 
(5.4c) dominated the pressure level at each outlet for the current HFOV and geometry 
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conditions. Our findings are consistent with High et al [171], who reported that lung-
compliance dominates the pendelluft flow. The compliance for each generation is 
calculated by adopting the formula introduced by Barbini et al [170]: 
j
ooutk CC j 2/                                                         (5.6) 
where oC  is the total compliance and j is generation number of outlet number k
th
. Grimby 
et al [172] measured the total compliance for a group of patients suffering from COPD, 
bronchial asthma, and cysts; the compliance ranged from 0.15 to 0.55 l/cm H2O. A value 
of 0.2 l/cm H2O for C0 was adopted in the present study.  
 
Wall boundary condition: No-slip wall BCs were used [34] and the number of cycles 
required to reach statistical convergence was investigated. The solution statistically 
converged after two-three cycles for the range of frequency reported in this work. Four 
cycles were considered adequate, and the values reported are from the fourth cycle [166]
.
 
Table 5.1 presents all cases considered in the current study.  
 
Table 5.1 HFOV and lung conditions used for the current study (VT = 50 mL). 
Case No. Frequency (Hz) Compliance ratio (CR) 
1-3 10 1, 4, 10 
4* 10 10 (local variation) 
5-6 15 1, 10 
7-8 6 1, 10 
 
The compliance ratio (
LR CCCR / , where RC and LC  is the compliance of the right and 
left lung respectively) was varied by keeping the compliance in each generation in the left 
lung fixed and the corresponding generation in the right lung is multiplied by a different 
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factor. For case 4 (see Table 5.1), the compliance ratio of the selected local lung adjacent 
units was varied by multiplying the compliance of outlets in one unit by 10, while the 
compliance at the outlets of the neighbor unit were kept fixed. For more illustration, 
Figure 5.2 shows an example of the local compliance ratio variation (CRLocal) between 
two units. The local CR variation is made, while the global CR in both the left and right 
lungs was kept 1. The selected adjacent units are (unit1 and unit2), (unit3 and unit4), 
(unit11 and unit 12), and (unit 25 and unit 26); see Fig. 5.1a. 
 
Figure 5.2 An example of local variation of the lung compliance ratio, CRLocal. 
Considering two adjacent units (1 and 2), the compliance ratio CR of unit 1 to unit 2 was 
set 10, [CRLocal=Cunit1/Cunit2=10], as follows: CRLocal=Cunit1/Cunit2, CRLocal=10, 
 Cunit1=10Cunit2, (C1 or C2)=10  (C3 or C4) 
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5.3. Experimental Validation 
The computational results with coupled resistance-compliance BCs were 
validated with the experimental data of Lee et al [173] who investigated the flow 
transport in a symmetric single Y-shaped bifurcation representing G18- G19 based on the 
Weibel description  [59]. Two cases with highest and lowest air volume ratio (VR) were 
considered at HFOV frequency of 15 Hz, i.e., VR = 8 and 1. The air volume ratios is 
defined as the ratio of volume in left branch to volume in right branch al [173]; and it was 
calculated by integrating the flow rate over one ventilation cycle. The time-dependent 
pressure BCs were used at the outlets [eqn. (5.4)] and resistance was computed using eqn. 
(5.5). The compliance at outlets of G19 was computed using the technique described in 
the previous section and the CR was varied until reaching the volume ratio. A very small 
time step was used (i.e., ∆t=10-5 s) to properly resolve the pendelluft movements. The 
coupled R&C BCs successfully replicated the experimental data (VR 8:1 and 1:1), which 
demonstrated the maximum and minimum pendelluft flow in the experiment. The 
simulation results show the flow swings between the two branches at EnIn and EnEx 
phases (Fig. 5.3a), mimicking the experimental observations (Fig. 5.3b).  
For further comparison between the experimental and computational results, the 
elapsed time during the pendelluft (TP) was quantified and compared in Table 2 for both 
cases. TP signifies the period from the beginning to the end of the pendelluft flow; and it 
was calculated as the total time-period between instances when the flow-rate curves for 
the mother and daughter branches crosses the zero flow phase. TP was in close agreement 
with experimental measurements at the EnIn phase. A maximum difference of 10% in TP 
was found at the EnEx phase in case of VR=8; and was attributed to approximations in 
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model geometry, especially at the transition region of the bifurcation. In general, 
modeling results were in good agreement with the experimental data, validating that 
R&C BCs are important to modeling lung ventilation and gas transport under HFOV 
conditions. 
 
Figure 5.3 (a) Results from the validation study and comparison with (b) experimental 
data of Lee et al, 2006 [173]. Data were taken at time of t/T=0.5, where T=1/f is the total 
cycle time, f=15 Hz. In (a), the red vectors move upward, indicating the expiratory flow 
and blue vectors move downward, indicating inspiratory flow. Images in (b) were taken 
(with permission from Institute of Physics Publishing) from Lee et al, 2006 [173]. 
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Table 5.2 Comparison of predicted and measured elapsed time during Pendelluft flow 
(TP) for different cases. 
Case 
No. 
Volume 
ratio 
(VR) 
 
Compliance 
ratio 
(CR) 
Phase 
TP (µs) 
Percent 
Difference 
Experimental 
measurement 
Lee et al [24] 
Predicted 
values 
(Present 
study) 
1 8 9.35 
EnIn 1000 µs 1000 µs 0% 
EnEx 1000 µs 1100 µs 10% 
2 1 1.04 
EnIn 100 µs
 
95.9 µs 4.1% 
EnEx 100 µs 101.92 µs 1.92% 
 
 
5.4. Results and Discussion 
   5.4.1. Flow Distribution 
The flow distribution throughout the major lung divisions (left and right lung) was 
computed as a fraction of the total inlet mass flow rate and compared with different 
computational and experimental (both in vitro and in vivo) studies. The flow distribution 
under coupled R&C BCs demonstrated a significant change in the cases when traditional 
BCs were employed. To illustrate the difference in the BCs, a flow distribution ratio (FR) 
was defined as the ratio of the flow rates between the left and right lungs. Table 3 
presents the percentage of the total flow defined as the flow distribution in the left and 
right lung as a percentage of the total flow in the trachea and compares the FR values for 
various pulmonary CFD studies reported in the literature using different types of BCs. 
The values of FR based on utilizing coupled R&C in the present work ranged from 0.62 
to 0.69 for a healthy lung (i.e., CR=1) and 0.45 to 0.49 for a diseased lung (i.e., CR>1). 
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For brevity, only four cases are presented in Table 3. De Backer et al [97] conducted in 
vivo flow measurements (for a COPD patient) using clinical scintigraphy imaging 
techniques and reported a FR value of 0.41. This value is in good agreement with our 
computational results utilizing coupled R&C BCs with diseased lung scenario (CR>1).  
However, previous CFD studies using traditional BCs predicted a value of FR that was 
twice as large. A value of 0.79 was reported by De Backer et al [97] with the type-II BCs. 
A value of 0.83 was obtained in our previous work [166]
 
 with Type III BCs based on MF 
values prescribed by Horsfield et al [51].  Moreover, in vitro experiments by Cohen et 
al [174] reported a FR of 0.67; this value is in agreement with the cases of the healthy 
scenario (CR=1). Therefore, it is clear that the lung CR plays an important role in flow 
distribution between the two lung lobes and physiological BCs based R&C must be used 
to capture relevant HFOV flow mechanism. 
To investigate the effects of lung compliance on flow distribution, the CR was 
varied from 1 to 10. When the compliance is higher in one lung or unit, a higher volume 
is delivered due to the decrease in pressure in that region. To study the influence of the 
frequency on the flow ratio, simulations with three values of frequency (6, 10 and 15Hz) 
were run, while the CR was held constant. Additionally, a parametric study was also 
performed by varying the CR from 1 to 10 for each frequency.  
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Table 5.3 Comparison of the flow distribution between the left and right lungs with the 
available published data. 
 Percent total flow (the flow distribution in the left and right lung as a percent of 
the total flow in the trachea) 
10 Hz, 
CR=10 
 
15 Hz, 
CR=10 
6 Hz, 
CR=10 
 
6 Hz, 
CR=1 
 
Cohen
a 
De Backer
b
 Alzahrany
c 
BCs 
Type 
R&C BCs P=const. 
In 
vivo 
Type-
II 
Type-III 
Left 
Lung 
32.29 33.02 30.83 40.88 40 29 44 45.4 
Right 
Lung 
67.71 67.98 69.17 59.12 60 71 56 54.6 
FR 0.48 0.49 0.45 0.69 0.67 0.41 0.79 0.83 
a
Experimental study on the human tracheobronchial cast under cyclic inspiratory (up to 
G10) with constant pressure at the outlets (P=const.). The values are reported for the 
mean of range of inlet flow rate conditions  [174] and Q = 7.5 – 60 L/min. 
b
Clinical gamma scintigraphy measurements (Q = 23 L/min) (left column) and CFD with 
Type-II BCs (Right column) uniform pressure at all outlets. The geometry consists of ~ 
6-7 generations  [97]. 
c
CFD study on the same considered geometry in the current study using pre-specified 
mass flow rate fraction at outlets based on the Horsfield  [51] Model (Type-III 
BCs) [166]. 
 
The flow distributions demonstrated strong dependency on the HFOV frequency with a 
variation in lung CR. Upon changing CR from 1 to 10, the FR decreases by 
approximately 21%, 24%, and 35% for the HFOV frequencies of 6, 10, and 15 Hz, 
respectively. This is attributed to the higher pressure at the inlet associated with the 
increased operating frequency and to the change in the time constants of the system [78, 
169]. 
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  5.4.2. Pendelluft Mechanism 
To demonstrate the presence of pendelluft flow, vectors and streamlines at EnIn 
in a selected lung unit (# 26, see Fig. 5.1) are plotted in Fig. 5.4. The red vectors denote 
inspiratory flow and blue denotes expiratory flow. As observed in Fig. 5.4a, the flow in 
branch 45 began expiring and filled into branch 44, which was still inspiring (see 
delineated regions 1 and a close-up). However, simulations with Type-III BCs failed to 
predict pendelluft behavior (see delineated regions 2 and close-up view in Fig. 5.4b) as 
both branches respired in the same phase.  
Table 4.4 briefly summarizes previous CFD studies with different outlet BCs for 
the occurrence of pendelluft flow. Choi et al [47] studied the airflow during HFOV in a 
large-scale realistic model (up to G7) using  type-II BCs. A HFOV frequency of 6.28 Hz 
was used for which the authors report the absence of any pendelluft flow. Nagels and 
Cater [48] studied HFOV at 25 Hz frequency in an idealized double bifurcation model 
with type-II BCs employed at the outlets. Pendelluft flow was captured between the main 
bronchi. Similar observations have been reported by Alzahrany et al [166] where Type-
III-based BCs were imposed. In both studies [48, 166], the existence of pendelluft flow 
was merely geometry (asymmetry) dependent and was only captured at the main bronchi. 
In contrast, in the present study, coupled R&C BCs successfully captured the pendelluft 
flow in different lung regions due to asymmetry in the R&C of the lung units.  
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Figure 5.4 Comparison of the flow field vectors and stream-trace at the EnIn phase for 
frequency of 10 Hz at unit 26 using: (a) coupled R&C BCs; and (b) MF (Type-III) BCs. 
The red vectors denote the inspiratory flow and blue vectors denote the expiratory flow. 
The Pendelluft flow occurs in the case of using coupled R&C, while it is absent in case of 
using Type-III BCs. Data are shown for t/T=0.49 and f=10 Hz. 
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5.4.2.1. Pendelluft Time and Volume  
The pendelluft intensity was characterized based on the pendelluft time percent 
(fP) and Pendelluft volume percent (Vp). Figure 5.5 shows a representation of the 
pendelluft characteristics and the definitions of the relevant parameters. For any unit, Qu, 
Q1 and Q2 are the flow rates in the mother and daughter tubes (branches 1 and 2). TP is the 
Pendelluft time defined as the total time-period between instances when the flow-rate 
curves for the mother and daughter branches crosses the zero flow phase. The pendelluft 
time percent (fP) is defined as the percent of the total cycle time that pendelluft occurs. 
The pendelluft volume percent (Vp) is defined as the ratio of the volume exchanged 
between the daughter branches [VT1 branch 1 at EnIn or VT2 branch 2 at EnEx] to the total 
volume delivered to the unit (Vu) and is calculated by integrating the flow rate over one 
cycle [175]. 
 
Figure 5.5 Representation of the pendelluft characteristics and relevant parameters. Qu is 
the flow rate in the mother tube of the unit.  Q1 and Q2 are the flow rates in the daughter 
tubes (branches 1 and 2), respectively. TP is the Pendelluft time. Vu the total volume 
delivered to the unit. Shaded area, the gas volume exchanged between the daughter tubes 
(VT1 branch 1 and VT2 branch 2) during the pendelluft time  [175]. 
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5.4.2.2. Varying the Compliance Ratio 
Figure 5.6 presents fP and VP for the case of f = 10 Hz and different CR (1, 4 and 
10 between the right and left lung; CRlocal= 10 between selected regional units). To 
facilitate a comparison between the different cases, a few specific examples are listed in 
Table 5.5. Pendelluft was observed at different lung units with varying intensity. For 
example, at the EnIn phase and CR=10 (see Fig. 5a),  fP (VP) in unit 1 was approximately 
less than 0.3% (1.5%), but these values were five-fold higher in unit 26, which was 
located in the more compliant lung. Various scenarios were observed by varying the CR. 
In units that were located in the less compliant lung, only small changes occurred in (fP 
and VP) by changing CR, while a significant change occurred in the units located in the 
higher compliant lung (see Example 1, Table 5.5). However, this feature was location 
(geometry) dependent (see example 2); an increase in CR (from 4 to 10) resulted in a 
decrease in fP (33.9%) and VP (42.44%) in the LLL lobe (less compliant). 
Both the parameters were also compared across different HFOV phases (EnIn and 
EnEx). It was observed that both fP and VP were higher at EnIn phase compared to EnEx 
when both lungs were equally compliant (Fig. 5.6b). However, upon increasing the CR, 
the scenario was reversed in some units, depending on the locations and CR value (see 
Example 3). The largest increase (> 500%) in both parameters was obtained for case 4 
when CR was varied between selected local units while keeping the global CR at unity 
between right and left lungs (see example 4). This mimics a scenario in which a patient 
may have local blockage in the lungs due to presence of a tumor that would change CR 
locally in an otherwise healthy lung. Two conclusions can be made based on these 
observations. First, fP and VP were weakly dependent on global lung compliance in the 
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less compliant airways with only a slight increase or decrease (±5%) in both parameters. 
Second, both parameters were strongly dependent on local lung compliance, as both fP 
and VP were drastically changed in those units. Furthermore, these observations were 
independent of the phase of HFOV and were similar in both EnIn and EnEx phases. The 
dependency of the pendelluft intensity on the locations was observed by Andrey et 
al [176] in their in vivo study and was attributed to the differences in the distribution of 
the volume between lungs and major lobes and the effect of the regional features, such as 
diameter, length, asymmetry and sharp transitions in geometry. 
 
Figure 5.6 Pendelluft time percent (fP) and Pendelluft volume percent (VP) between the 
selected lung units for f=10 Hz. The data are for cases 1 to 4 (CR=1-10) at (a) at EnIn, 
and (b) EnEx. 
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Table 5.5 Illustration of the effects of a varying CR on the pendelluft intensity for 
 f=10 Hz. 
Example 
No. 
CR  
Lung 
Anatomy 
Terminal 
Unit 
Generation 
(lung unit) 
fP   VP Status 
1 1,10 
LUL: 
Anterior 
Less 
compliant 
Unit2 G5 (L) 12% 13% 
Increase 
as CR 
 
Increases 
RUL: 
Apical 
Higher 
compliant 
Unit20 G5 (R) 95.56% 100.3% 
2 4,10 
LLL: 
Anterior 
Basal 
Unit12 G7 (L) -33.9% 
-
42.44% 
Decrease 
as CR 
Increases 
3 
1 
RLL: 
Medial 
basal 
 
Unit26 G6 (R) 
81.3% 81% 
Increase 
at EnIn 
10 6.19% 18.33% 
Increase 
at EnEx 
4 
10 
(local) 
LUL: 
Posterior 
 
Unit3 G6 (L) 533.6% 897% 
Increase 
from 
CR=1 
 
 
5.4.2.3. Effect of HFOV Frequency 
To examine the effect of the frequency on the pendelluft flow, simulations were 
run at HFOV frequencies of 6, 10 and 15 Hz (CR =1). It was found that the oscillating 
frequency had a significant impact on the pendelluft intensity; the general trend that was 
observed was fP and VP tended to increase as the frequency increased. This is attributed to 
the elevation of the inlet pressure due to the frequency increase, which leads to a higher 
pressure gradient and changes the system’s time constants, leading to more pronounced 
phase-shift that enhances the pendelluft flow [78, 169]. It was also dependent on the 
location. For example, in unit 2 (located in LUL), both values increased substantially (fP 
by 199.78% and VP by 190.3%) when changing the frequency from 6 to 15 Hz. However, 
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an increase of 43.8% in fP and 37.6% in VP was observed in unit 28 located in RLL lobe. 
This is most likely due to the proximity of unit 2 to the branch that feeds LUL lobe. Unit 
2 receives 23.3% of the total volume that enters that lobe. On the other hand, unit 28 is 
located in the distal end of RLL lobe and it receives 12.9% of the total volume feeds that 
lobe. Similar observations of increasing pendelluft intensity with increasing frequency 
were also reported by Elad et al [169]. In their study, however, a lumped method was 
used to analyze flow in single bifurcation. At the EnEx phase, similar observations to 
those of the EnIn phase were found.  
5.4.2.4. Pendelluft Intensity between the Lung’s Major Lobes 
The pendelluft intensity (fP and VP) was computed for all frequencies between 
major lobes for CRs of 1 and 10, respectively (see Figure 5.7). For the case of CR = 1 at 
EnIn phase, (Fig. 5.7a), both the pendelluft parameters increased with an increase in 
HFOV frequency. The Pendelluft intensity was strongest at location B (i.e., between RUL 
and the branch leading to RML and RLL). During EnEx phase, a drastic decrease in fP 
and VP was observed compared to that at EnIn phase, particularly at locations B and C. In 
contrast to the inspiration phase, where the flow diverged at the bifurcation site, a strong 
merging of the flow occurred during the expiration phase, which caused a reduction in 
the pendelluft intensity. Simulations with CR of 10 (Fig. 5.7b) exhibited slightly different 
features of pendelluft flow. The pendelluft intensity increased at locations in the right 
lung (more compliant) and decreased at locations in the left lung when increasing the CR 
(see Fig. 5.7) and is attributed to the increase/decrease of the flow in the higher/lower 
compliant lung. At the EnIn phase, different behavior of the pendelluft at location C 
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(right lung) was observed when the CR increased to 10. A further increase in the 
frequency (to 15 Hz) decreased the intensity of pendelluft (Fig. 5.7b).  This was most 
likely due to a combination of changes in the flow features when increasing the frequency 
and CR along with the effect of the irregular structures of this branch. The right lung 
(more compliant) received the majority of the flow. Additionally, this branch had 
irregular structures with sudden contractions, followed by an expansion at the junction 
that fed all successive branches. At the EnEx phase (Fig. 5.7b), similar trends were 
observed for a CR value of 10, as both fP and VP were consistently higher than the case of 
using CR=1.  
 
Figure 5.7 Pendelluft time percent (fP) and Pendelluft volume percent (VP) between the 
lung major divisions (lobes) at different HFOV frequencies (6, 10 and 15 Hz) for (a) CR 
= 1; and, (b) for CR = 10. The solid lines are at the EnIn phase, while the dashed lines are 
at the EnEx phase. 
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5.4.2.5. Physiological Relevance of Pendelluft Flow 
Ultman et al  [175] reported challenges in assessing the physiological relevance of 
Pendelluft flow in an idealized single bifurcation model mostly due to the lack of a direct 
measurement of the pendelluft in the lungs. A study by Andrey et al [176], using the 
method of sounds mapping to detect the lead and lag time of the pendelluft in the lung (at 
14 sites), was therefore used as a guide to discuss the physiological relevance of our 
simulations. Andrey et al [176] reported mean and standard deviation (s.d.) values of the 
lead time (Tp at EnEx) and lag time (Tp at EnIn) for groups with subjects classified into a 
control group and those suffering from COPD. The measured values in all 14 sites were 
averaged, and then the mean and s.d. values of each group were reported as a percent of 
the lead and lag time to the inspiratory time,  fPI = (Tp)/ (inspiration time) 100. Values of 
fPI were reported as 4%±5% (mean ± s.d.) for the control group, while a value of 
14%±13% was reported for the COPD group. The values of reported lag time were 
13%±12% and 28%±25% for the control and COPD groups, respectively. In the present 
CFD study, the values of fPI varied based on the different factors (e.g., units and lobes’ 
locations, CR and frequency). The mean values of fPI for the selected 13 units (see Fig. 
5.1) were 1.94% and 1.51%, for the case of f=15 Hz and CR=10, at EnIn (lag time) and 
EnEx (lead time), respectively. These values fit into reported ranges of the in vivo 
study  [176].  
 
 5.4.3. Coaxial Counter Flow 
The bidirectional flow that exists at the beginning/end of the inspiration and 
expiration phases was compared for different BCs. Figure 5.8 presents the counter flow at 
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the vertical slice (made by a plane that cuts through trachea and the main bronchi) at the 
EnIn phase for f = 10 Hz. The red vectors represent the inspiratory flow and blue vectors 
represent the expiratory flow. In addition to the existence of the pendelluft flow in the 
case of using coupled R&C BCs (Fig. 5.8a), the expiratory flow moved uniformly at the 
vicinity of the outer wall of the right bronchus and continued along the right side of the 
trachea. This is in agreement with observed coaxial counter flow in the experimental 
study of Heraty et al. [98], a feature that is not replicated with traditional MF BCs. In the 
case of MF BCs, the released flow from ETT (inspiratory flow) deviated toward the right 
bronchus instead of impinging on the carina ridge. Subsequently, the upcoming 
expiratory flow was forced to swirl inside this airway segment and is highlighted in 
close-up regions 1 and 2 in Figure 5.8. 
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Figure 5.8 Comparison of the coaxial counter flow during the EnIn phase (t/T=0.49, f=10 
Hz) at the vertical slice (made by a plane that cuts through the trachea and the main 
bronchi) using the following: (a) coupled R&C BCs and (b) Type-III BCs. Red vectors 
denote the inspiratory flow and blue vectors denote the expiratory flow. 
 
5.4.4. Effect of Coupled R&C on the Flow Field 
To examine the effect of using coupled R&C BCs on the flow field, the contour of 
the instantaneous velocity (Figs. 5.9a - b) and time-averaged velocity (Figs. 5.9c - d) for 
both coupled R&C and Type-III BCs were compared at a slice in unit 26. Contours were 
plotted at the peak expiration phase (t/T = 0.75). The differences in flow structure and 
velocity magnitude in Fig. 5.9 indicated transient features of the flow field  [177]. 
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Furthermore, comparing Figs. 5.9a and c (Type-III BCs) to Figs. 5.9b and d (coupled 
R&C BCs), a significant change in the flow structure and velocity magnitude (in both 
instantaneous and mean flow) was observed. This is due to the deviation in the pressure 
drop magnitudes throughout the domain between the two cases. 
 
 
Figure 5.9 Comparison of the effect of BCs on the flow structures. (a) and (b) are the 
instantaneous velocity and (c) and (d) are time-averaged velocity. The velocity contour is 
for unit 26 during peak expiration (t/T=0.75, f=10 Hz). 
 
Figure 5.10 shows the pressure gradient distribution at the line extending from G2 
to the lower regions of both left and right lungs at peak inspiration for the cases of using 
R&C and MF BCs. Relatively, similar trend of distribution in both cases was observed. 
The differences in the pressure gradient magnitudes, however, were very significant 
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throughout the domain. This is because when forcing mass fraction at the outlets, the 
pressure inside the domain adjusts accordingly to achieve that specified fraction and will 
not account for the geometry morphology [97] as the present time-dependent pressure 
boundary conditions. This indicates that using traditional boundary conditions could lead 
to unrealistic prediction of the flow distribution.  
 
 
Figure 5.10 Comparison of the pressure gradient distributions throughout the 
lungs between cases of using coupled resistance-compliance R&C (CR=1) and using 
mass fraction MR boundary conditions. The pressure gradient was computed along line 
extends from G2 to G7 at peak inspiration in both Left and Right lungs. 
 
The difference and fluctuation in the pressure gradient between the right and left lung 
were due to the highly asymmetric lung geometry and the variation of the airways 
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dimensions. This was also observed and reported by Comerford et al [178] in their study 
of structured tree outflow boundary conditions for modeling the airflow in patient specific human 
lungs. These observations are different from that inside classical simplified models where the 
pressure uniformly drops throughout the domain as results of the symmetric and uniform 
geometries [178].  Figure 5.11 shows the wall shear stress (WSS) distribution along unit 26 
for the cases of using MF and R&C BCs. The data presented correspond to the EnIn 
phase. Regions of high WSS occurred around the daughter tubes while using MF BCs 
(see Fig. 5.11a). 
 
 
Figure 5.11 Comparison of the wall shear stress (WSS) distributions at unit 26 between 
the cases of using coupled R&C (f=10 Hz, CR=1) and using MF BCs. The WSS was 
computed at EnIn (t/T=0.49, f=10 Hz). (a) The mass flow rate fraction BCs (MF) and (b) 
coupled R&C BCs. 
 
While using R&C BCs, a drastic change in the WSS distribution was observed. A high 
WSS was noticed in the region surrounding the flow divider (carina ridge, see 
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demarcated region in Fig. 5.11b) as opposed to the case of MF BCs, where a minimal 
WSS occurred at the same site (Fig. 5.11a). This is a consequence of the pendelluft flow, 
which occurred during this period (i.e., EnIn) while using R&C BCs. The gas flows from 
branch 45 to branch 44, moving over the carina ridge; consequently, a high velocity 
gradient is created near the wall, which causes the higher WSS.  
 
5.5. Conclusions 
A LES model was used to study the flow transport under HFOV conditions with 
physiologically relevant outlet BCs. A time-dependent pressure was employed as a 
function of the instantaneous flow rate and coupled airways resistance-compliance. A 
significant change in the regional flow distribution was observed when using coupled 
R&C BCs for healthy and diseased lungs. In addition, the pressure drop throughout the 
lung domain demonstrated a significant deviation from the case of MF BCs due to the 
ability of the applied physiological resistance-compliance BCs to account for the 
geometry morphology. Unlike traditional BCs, the coupled R&C BCs successfully 
captured pendelluft flow in all of the lungs’ major lobes and terminal units, which 
enables accurate HFOV modeling. Varying compliance between the right and left lungs 
demonstrated a significant effect on the flow distribution, and it was more pronounced for 
the highest HFOV frequency. Increasing the CR locally between lung units induced 
maximum pendelluft flow with a five-fold increase in some units. The coaxial counter 
flow and flow structures were significantly influenced by the modified BCs. The 
pendelluft flow significantly induced a WSS surrounding carina due to gas exchange 
between the units’ branches. The pendelluft intensity in different regions may be used as 
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an important indication of the respiratory diseases and the severity of lung pathway 
diseases. The intensity of the pendelluft flow associated with the ventilator setting (e.g., 
frequency, tidal volume, and waveform shape) could help in improving treatment 
protocols for patients undergoing HFOV treatment.  
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3
 
AEROSOLIZED DRUG 
DELIVERY IN SPECIFIC-
PATIENT LUNG MODEL 
DURING INVASIVE HIGH 
FREQUENCY OSCILLATORY 
VENTILATION 
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during Invasive High Frequency Oscillatory Ventilation. Journal of Aerosol Science. 
Under review September 2014. 
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6.1. Introduction 
Invasive mechanical ventilation is typically used to substitute spontaneous 
breathing of patients admitted to the intensive care unit [1]. In many situations, aerosol 
drug therapy using bronchodilators, antibiotics, and surfactants becomes inevitable 
during the ventilation process to stabilize the patient [36, 37]. Aerosolized drug delivery 
to a mechanically ventilated patient is complex and very low amount of aerosols 
successfully reach the lower lung leading to complications during ventilation therapy [37, 
41, 179]. This complexity increases significantly during invasive HFOV because of high 
frequency and low tidal volumes [42]. Efficacy of aerosol deposition relies on various 
parameters that are: (1) ventilator related, e.g. ventilation mode or tidal volume 
inspiration waveform; (2) circuit related, e.g. endotracheal tube size or density of inhaled 
gas; and, (3) device related, e.g. type of device and its positions [37, 41]. Due to the 
absence of the knowledge of the role of the these factors on drug aerosol delivery, the 
current practice is to remove the patient from HFOV and perform manual ventilation 
during inhaled drug administration [42]. The advantages of HFOV therapy is a current 
topic of discussion in the medical community [180, 181]. However, there are only limited 
in vivo and in vitro studies investigating drug delivery under HFOV.  
Computational fluid dynamics (CFD) studies have been carried out to understand 
and optimize flow and drug delivery to human lungs under normal breathing conditions, a 
comprehensive review can be found elsewhere [34, 53, 182]. However, particle transport 
and deposition during HFOV has been overlooked and thus not sufficiently understood. 
Amongst a few reported in the literature include an in vitro study by Garner et al [42] to 
investigate drug (albuterol) delivery by a metered-dose inhaler in a pediatric lung model 
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under HFOV. A lung simulator with 4.5-mm endotracheal tube was used and operating 
frequencies of 5 and 15 Hz were used to administrate albuterol repeatedly. It was found 
that only <1% of the administered dose was delivered to the lung simulator regardless of 
the HFOV operating conditions (i.e., frequency and inspiratory time). In contrast, a more 
recent study by Sood et al [50] found that pulmonary aerosol delivery during HFOV was 
effective and was at least as efficient as conventional mechanical ventilation (CMV). 
Aerosolized drug were administered to piglets using the HFOV circuit and MRI was used 
to visualize contrast before and after delivery; the effectiveness of the drug delivery was 
assessed by signal intensity (SI) changes. None of the reported studies perform 
exhaustive parametric analysis to quantify the actual percent of aerosol delivered to the 
lungs and characterize the local deposition properties.  
The main objective of this study is to investigate the aerosol-drug transport in a 
patient subjected to HFOV management. CFD based methods is used to estimate global 
and local deposition characteristics of various aerosol particles in a realistic large-scale 
lung model. Primary flow mechanisms that govern gas transport and mixing during 
HFOV can be classified as : (a) bulk convection; (b) gas exchange between respiratory 
units or pendelluft, where the gas exchange between adjacent units at the end/beginning 
of the respiratory phases due to the regional asymmetric resistance and compliance; (c) 
coaxial counter flow; (d) longitudinal mixing; and (e) gas exchange by molecular 
diffusion [32, 166]. Physiologically relevant boundary conditions that are capable of 
capturing those crucial flow mechanisms are required for accurate computational 
modeling of HFOV. Traditionally, flow rate, or velocity at each outlet is specified (Type-
I boundary condition). Alternately, several studies use uniform pressure (Type-II 
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boundary condition), while others use the mass fraction (MF) at each outlet of the 
statistical lung models (Type-III boundary condition). These boundary conditions entail 
several limitations; for example, utilizing them forces the solver to adjust the pressure 
inside the domain to attain the specified velocity, pressure or flow, which ignores the 
non-uniformities in lung ventilation [46]. It is also deemed essential to model pendelluft 
between adjacent units during HFOV and traditional boundary conditions discussed 
above cannot capture this mechanism due to inability of modeling the asymmetry in 
airways resistance and compliance between adjacent units. A recent study by Makris et 
al [183] that investigated particle transport and deposition under HFOV and normal 
breathing conditions at 16 Hz and 0.25 Hz frequencies concluded that HFOV resulted in 
higher particle deposition than normal breathing due to stronger secondary and counter 
flows. However, the deposition was only characterized inside a single bifurcation 
representing generations G3 to G4 using one of the aforementioned traditional boundary 
conditions that are unable to recreate the pendelluft mechanism. In chapter 5, it has been 
demonstrated that the use of a coupled airways resistance-compliance (R&C) boundary 
condition that successfully captured important gas mechanisms in HFOV, especially 
pendelluft flow [184]. These physiologically relevant time-dependent pressure boundary 
conditions based on a coupled resistance-compliance of the airways were used along with 
a large eddy simulation (LES) coupled to a Lagrangian particle transport model to 
investigate a gas-solid two-phase flow under HFOV   
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6.2. Method 
6.2.1. Continuous Phase Model 
 Figure 6.1 displays the model, which was identified by the major lung lobes as: 
main bronchi left upper lobe left lower lobe, right upper lobe, and right middle and lower 
lobes. The continuous phase (airflow) was modeled using LES with the numerical 
techniques described in the previous chapters.  
 
Figure 6.1 tracheobronchial tree model with an endotracheal tube (ETT) inserted into the 
trachea. MB: main bronchi, LUL: left upper lobe, LLL: left lower lobe, RUL: right upper 
lobe and RML&RLL: right middle and right lower lobes. 
 
 
131 
 
  6.2.2. Particle Transport Modeling 
The Lagrangian tracking approach was implemented to model the particle 
transport during HFOV simulation. The Newton’s second law of motion is used in 
Lagrangian method to track each individual particle. The force balance leads to the first 
order differential equation for the particle momentum as follows [185]: 
        
P
p
p F
dt
du
m   (6.1) 
 where mp is the mass of the particle, which is calculated as the particle density ( p ) 
times the particle volume density ( pV ), pu is the particle velocity, and PF  is the 
summation of the forces acting on the particle. There are many forces affect that particle 
motion and trajectory in a fluid, such as drag, gravitational, lift, diffusion, virtual mass, 
pressure gradient, and basset force. However, the inclusion of any force depends on the 
flow conditions, computational model features, and particle properties. Monodispersed 
spherical solid particles with diameters ( pd ) ranging from 0.5 to 5 µm and density ( p ) 
of 1000 kg/m
3
 were considered [186], which led to very high particle to fluid density ratio
1/  p . Therefore, all the forces that depend on the  /p , such as virtual mass, 
pressure, and basset forces, were neglected. Furthermore, the effect of gravity were not 
considered. Since the study was conducted for a patient under invasive mechanical 
ventilation, the orientation of the patient was assumed in lying position (horizontal 
position) during drug delivery. Mark Brouns  [187] studied the particle deposition in an 
extrathoracic model including trachea with different orientation positions. He concluded 
that due to dominant drag force, the gravity force has no effect in case of the horizontal 
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position of the model. Furthermore, in current study, the particles transport under very 
rapid ventilation, which does not allow enough time for the particle to settle down [188]. 
The ignorance of the gravity force has also been assumed in many past studies [189-194]. 
The important forces that considered in present study include the drag force, the Saffman 
lift force, and the Brownian motion force [125]. User-defined FORTRAN was used to 
implement these forces in ANSYS® CFX®. The final particle momentum equation was 
considered as follows  [125]: 
        BrownianliftcipippD
p
p ffCuuuudC
dt
du
m  8/)(2  (6.2) 
  
u is the fluid velocity. The first term on the right side of the equation represents the drag 
force. DC is the drag coefficient and is defined based on the expression of Morsi and 
Alexander [195]: 
Re/24CD  1.0Re   
(6.3) 
69.3Re/0903.0Re/73.22 2CD  1Re1.0   
222.1Re/8889.3Re/1662.29 2CD  10Re1   
6267.0Re/67.116Re/5.46 2CD  100Re10   
3644.0Re/2778Re/33.98 2CD  1000Re100   
357.0Re/1057.4Re/62.148 24 CD  5000Re1000   
46.0Re/1087.57Re/546.490 24 CD  10000Re5000   
5191.0Re/104167.5Re/5.1662 26 CD  Re10000   
 
Cunningham correction factor cC  is used based on Crowe [196] to account for Non-
continuum slip effects on the drag of nanoparticles. It is defined as:  
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where λ is the mean free path and  was taken to be 65 nm. The Cunningham correction 
factor increases as the particle diameter decreases. The cC  behavior for the considered 
particle size range in the current study can be seen in Figure 6.2. 
 
Figure 6.2 Cunningham correction factor for the particle size ranging from 0.5 to 5 µm. 
 
The shear-induced Saffman lift force liftf  is expected to play a large role in the 
micrometer particles with significant inertia in areas with rapidly changing geometry or 
significant turbulence [39]. It is perpendicular to the direction of the flow due to velocity 
shear. It is defined as [197]: 
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where nˆ  is the unit wall normal vector pointing out of the domain. us is the wall-tangent 
slip velocity is defined by [197]: 
ˆ ˆ
su v t u n             (6.6) 
where tˆ  is the unit wall-tangent vector in the direction of the particle velocity described 
as: 
    ˆ ˆ( )ˆ
ˆ ˆ| ( ) |
n v n
t
n v n
 

 
       (6.7) 
 
The function g is used from Cherukat and McLaughlin as [198]: 
 
2 3
2
2 3 2
( , ) 1.7631 0.3561 1.1837 0.845163
3.24139
2.6760 0.8248 0.4616
1.8081 0.8796 1.9009 0.98149
g    
 

  
      
 
     
 
      
          (6.8) 
 
The parameters κ and Λ are defined as  [198]:  
          
2 p
p
h
d
   (6.9) 
where hp is the distance from the wall to the particle, and  
       
2
p
s
d
u

      (6.10) 
where   is the shear rate and is approximated for particles near the wall by  [198]:  
  
ˆ
p
u t
h


          (6.11) 
Brownianf  is the Brownian force  [39]. The effects of this force are most noticeable on 
particles that have very low inertia, i.e. particles with a diameter less than 1μm. The 
submicron particle is subjected to the collision of the gas molecules, particularly in very 
small airways [39]. It is modeled using the approach by Li and Ahmadi  [199]:  
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where kB is the Boltzman constant, Tf is the absolute temperature of the fluid, Δt is the 
particle integration time step, and ζ is a vector of 3 randomly generated numbers each 
taken from a Gaussian distribution with zero mean and unit variance.  The Brownian 
diffusivity D  is defined as [199]: 
  
p
cfB
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~
           (6.13) 
The obtained particle velocity (
Pu ) from Equation (6.2) is used to calculate the particle 
displacement as follows: 
        p
p
u
dt
dx
 , (6.14) 
where, xp is the particle position. Forward Euler was used to solve Equation (6.14) as 
follows:  
        tuxx
n
p
n
p
n
p 
1
 (6.15) 
Δt is the particle tracking time step size.  The subscript n in Equation (6.15) indicates the 
particle tracking step number.  
The  one-way coupling of particle-fluid interaction was employed  [39]. In this 
approach, the continuous phase (flow field) affects the dispersed phase (particles 
trajectories) but the particles do not influence the fluid. Furthermore, the particle –particle 
interaction was not considered. A user-defined FORTRAN subroutine was compiled with 
a CFX solver to track each individual particle at each time step. The particle was allowed 
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to deposit at the wall (when the distance between the wall and particle center was less 
than the particle radius [39]), exit the domain, or stay active inside the model. Another 
FORTRAN subroutine was also used so that the rate of particles injected scaled with the 
inlet mass flow rate such that gives the desired number of injected particles. The particles 
were injected uniformly over the ETT inlet cross-section area over the inspiration phase 
of the fourth HFOV cycle to avoid start-up effect [94, 200]. At the site of injection, the 
velocity of the particles was set to match the velocity of the fluid.  
 6.2.3. Breathing and Boundary Conditions 
Inlet condition: A blunt velocity profile was imposed at the inlet of the ETT as [90, 95]:  
        
7/1
1)(224.1),( 






ETTR
r
tUtru  (6.16) 
 
( ) sin(2 )ampU t u ft  is the obtained velocity from the sinusoidal HFOV waveform; 
2/ ETTtamp RfVu   is the amplitude velocity. 
Outlet condition: The developed time-dependent pressure outlet boundary conditions in 
chapter 5 have proven effective way to capture the crucial gas transport by high 
frequency oscillatory ventilation allowing accurate modeling. It was therefore utilized to 
investigate the particle transport and deposition during HFOV. 
Walls: No-slip wall BCs were used [34]. Table 6.1 presents HFOV conditions, flow and 
particle parameters under consideration.  
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6.2.4. Validation 
   To examine the particle modeling technique, the present numerical code was 
validated against available experimental data of Kim and Garcia [201] and Kim and 
Iglesias [202]. These experiments are considered appropriate for the purpose of particle 
modeling validations  [34] and have widely been used in the past studies  [151, 194, 200]. 
A single bifurcation geometry was reconstructed to match the experimental model. Cyclic 
inlet flow with Re= 1500 and 4000 and particles with kSt number ranging from 0.01 to 
.25 were simulated and compared to experimental data from Kim and Garcia [201] for 
frequencies of 16 to 50 cycles/min, and the in vitro study of Kim and Iglesias [202] for 
constant flow. Figure 2a shows that the predicted deposition efficiency fits well with 
experimental data, which validates the present numerical code. To determine the global 
and local deposition fraction independence of the total number of injected particles, 
different groups of particles were examined. Group 1 that consist of a total of 4000 
particles was first studied, the number of particles was then increased by a factor of two 
to 8000 and 16000 particles (groups 2 and 3 respectively).  The global and local 
deposition fractions are defined as  [203, 204]: 
G
L
Total particles deposited in whole domain
DF
Total particles at ETT inlet
Total particles deposited in region of interest
DF
Total particles at ETT inlet


                                (13) 
The difference in DFG was found to be <1% between the three groups. Furthermore, the 
DFL in the five major lung subdivisions was depicted in Fig. 2b during both inspiration 
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and expiration phases. It was found that the local deposition factor was converged for all 
groups of particles. Due to the low tidal volume, a total of 8000 particles was selected for 
the all simulations in this study to keep the volume fraction very low (i.e. dilute flow) 
such that a one-way coupling approach is valid [39]. The current validation is restricted 
to low Re <4000 due to unavailability of experimental data at large values of Re used in 
the work. We believe that the high values of Re (due to high HFOV frequency) will 
increase the impaction role, which is represented by the drag terms in eq. 6; the other 
terms are not sensitive to change in Re.    
 
 
Figure 6.3 (a) comparison of the particle deposition efficiency between numerical results 
and different experimental data of Kim and Garcia [201] and Kim and Iglesias [202]. (b) 
Local deposition fraction for different particles count. 
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6.3. Results and Discussion 
The airflow characteristics based on the non-dimensional numbers, Reynolds 
number and Womersley number are presented in Table 1. Reynolds number based on the 
ETT diameter ranged from 9458 to 23644. Reynolds number ranged from 26914 to 
64791 based on the trachea diameter. The higher values of Re in the trachea was due to 
the high-speed ETT-jet that was released in the trachea environment. Likewise, 
Womersley number ranged from 6.17 to 9.75 and 11.5 to 18.18 based on the ETT 
diameter and the trachea average diameter, respectively. The spatial and temporal particle 
deposition inside the 7-generations tracheobronchial tree model was quantitatively and 
qualitatively analyzed in terms of global deposition DFG, local deposition, DFL and 
deposition patterns under various HFOV parameters and lung conditions.   
6.3.1. Global Deposition  
Detailed quantifications of the particle deposition, i.e. global deposition during 
inspiration phase, expiration phase, total deposition during the whole cycle period, and 
global deposition in the left lung and right lung for the cases of CR=1 and 10 at HFOV 
operating frequency of 10 Hz are presented in Table 6.2. The deposition of the 
transported particles throughout the domain occurs during the inspiration phase as well as 
the expiration phase. However, the global deposition fraction during inspiration phase 
was 5 times greater than during the expiration phase when CR=1. Similar observation 
was reported by Zhang et al  [200] for the particle deposition in a triple bifurcation 
model. This is due to domination of the inertial impaction mechanism, which is also 
strongly enhanced by the presence and impingement of the high speed ETT-jet during the 
inspiration phase. A ten-fold increase of CR enhanced and doubled the deposition during 
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expiration phase due to the enhancement of the pendelluft [184], which enhanced gas 
mixing and particle dispersion. Consequently, the global deposition during the whole 
cycle increased from 45.94% when CR=1 to 54.2% when CR=10. The right lung was 
found to have relatively more deposited particles compared to the left lung, which was 
due to asymmetric airflow distribution. The majority of the airflow is always directed to 
the right lung due to the orientation of the right bronchus and its large diameter. 
Furthermore, increasing CR to 10 decreased the left lung compliance, which allowed the 
more compliant lung (i.e. right) to receive additional airflow [184] that  resulted in right 
to left lung deposition ratios of 1.29 and 1.34 for cases of CR=1 and 10, respectively.  
 
Table 6.2 Details of global particle deposition during different HFOV and lung 
conditions. 
Case  
DFG% 
In Ex Left Lung 
Right 
Lung 
Total
a 
10 Hz - CR=1 38.65 7.30 12.18 15.71 45.94 
  10 Hz - CR=10 38.94 15.26 15.03 20.13 54.20 
MF 36.38 10.85 16.39 14.90 47.23 
In: inspiration phase. 
Ex: expiration phase. 
a
The total deposition = deposition during In + deposition during Ex. 
 
Fig. 6.4 plots the particle deposition as a function of Stokes number during 
inspiratory and expiratory phase. The Stokes number is defined as LudSt pp  18/
2 , 
where u  is the velocity and L is a characteristic length, which is assumed to be the 
diameter of the ETT diameter. In the present study, St number ranged from 0.002 to 0.51 
for all cases, see Table 6.1. During inspiration phase (Fig. 6.4a), the deposition increases 
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with an increase in the Stokes number up to a value of 0.1 . For Stokes number values 
greater than 0.1, the deposition fraction undergoes a steep rise upon increase in the 
particle diameter due to the strong effect of the impaction mechanism and ETT-jet on the 
particles. The deposition fraction for the case of CR=1 was relatively higher than the case 
of asymmetric lung compliance (CR=10). This behavior reversed itself during expiration 
phase (Fig.6.4b). Additionally, the deposition rate decreased for the particles with 1.0St  
in the case of CR=1 during expiration phase and could be attributed to two factors; 
Firstly, the majority of the particles with a higher Stokes number were filtered during 
inspiration phase for the case of CR=1, noticeably for the 1.0St ( see Fig. 6.4a). 
Secondly, asymmetric lung compliance increases pendelluft flow intensity, which could 
enhance diffusion process of the particles. Consequently, more particles have the 
potential to deposit during the expiration phase for the case of CR=10.  
 
Figure 6.4 the particle deposition as a function of Stokes number kSt  for HFOV 
operating frequency of 10 Hz and CR=1 and 10. (a) Deposition during the inspiration 
phase and (b) deposition during the expiration phase. 
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6.3.2. Temporal Deposition  
   The particle deposition factor DFt was plotted as a function of the cycle time 
(t/T) (see Figure 6.5) for a HFOV frequency of 10 Hz with CR=1. Various particle size 
ranges were investigated. DFt is defined as the total amount of particles deposited at time 
t relative to the total particles injected during the cycle. The particle deposition rate 
demonstrated strong dependency on the cycle time, and is considered to be of vital 
importance for the particle release strategy over the ventilation cycle. In general, DFt 
demonstrated a similar pattern to the airflow, and the highest deposition occurred during 
peak inspiration. Li et al [192] observed similar particle deposition characteristics in an 
idealized lung model during cyclic inspiratory flow. In the present case, a predominant 
impaction mechanism coupled with the ETT-jet impingent resulted in higher the 
deposition rate for the larger particles. However, when the ventilation phase turned to 
expiration, different events were observed. Although the deposition shared similar 
patterns between the two phases, the deposition rate increased inversely with the diameter 
size during expiration. This is because high population of smaller particles stayed active 
until the cycle changed to expiration phase while majority of the larger diameter particles 
were filtered during inspiration phase. In addition, the effect of impaction that mostly 
influences the large particles was mitigated due to absence of the ETT-jet during 
expiration phase. This occurred while the small particles were still heavily influenced by 
the turbulence dispersion, secondary motion, and pendelluft flow, all of which enhanced 
the particle dispersion.  
 Particles with dp < 1 µm had remarkably different deposition pattern (see Fig. 
6.5a), the deposition rate increased at the end of the inspiration phase which may be 
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attributed to the presence of the pendelluft and coaxial counter flow in addition to strong 
secondary flow during this period. These flow features in turn enhances mixing and 
diffusion of the submicron particles. For further illustration, the Pathlines travelled by 
randomly selected particles with different diameters throughout the lung as a function of 
total time (i.e. the time it takes the particle to move from the released point to the current 
location) is shown in figure 6.5b. The data reported is based on the trachea, main bronchi, 
and the right lower lobe (see inset in Fig. 6.5b). For visualization purposes, the particle 
size was magnified 500 times. The larger particles do not follow the flow streamlines due 
to inertia and tends to stay in a straight path; taking a very short time to reach the main 
bronchi. Consequently, these large particles had a higher probability to deposit in the 
upper generations resulting in a high deposition rate during the inspiration phase. In 
contrast, the smaller particles tends to follow the flow streamlines and are influenced by 
the secondary motion and turbulent eddies. As a result, the trapped particles in a complex 
flow structure stayed active for longer time, causing part of the particles to deposit at the 
airways walls due to enhancement of the diffusion and random motion (marked regions 1 
and 2 in Fig. 6.5b). Meanwhile, the remaining particles remain active and continues to the 
next phase. Region 3 shows an interesting behavior of the complex particle motion, the 
particle at the end of the inspiration 
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Figure 6.5 (a) particle deposition as a function of the cycle time for HFOV operating 
frequency of 10 Hz and CR= 10; the time was normalized by the total cycle time T=1/f. 
(b) The travel of selected particles throughout the domain during the inspiration phase, 
colored by the traveled time. 
 
phase, instead of moving through right branch of RLL lobe, changes its path and 
penetrates the left branch. This is most likely due to the pendelluft flow between the right 
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branch and the left branch. The pendelluft intensity is strong enough to force upstream 
particles to change their paths.  
Figure 6.6 presents snapshots of three-dimensional particle dynamic at different 
times from the beginning of the inspiratory flow of the fourth cycle. The labeled distance 
in Fig. 6.6 is the vertical distance (Z) from the ETT outlet to the location indicated by an 
arrow. The ETT tube releases the particles in the trachea, which rapidly impacts the first 
carina ridge due to the proximity of the ETT to this bifurcation site. At t/T=0.15 (where 
T=1/f is the total cycle time), the cloud of the particles bifurcated and penetrated into the 
main bronchi, with particles of higher momentum penetrating deeper into the right 
bronchus to the beginning of G2, where  Z=4.7 cm. Upon completion of 25% of the 
cycle, the ETT-jet was developed and more particles were injected, resulting in deeper 
penetration inside all of the five major lobes (Z=12.2 cm). The dispersion of smaller 
particles was evident, due to their response to developments of the flow structures and 
reverse flow along the ETT-jet. At t/T=0.35, the particles reached and left throughout the 
majority of the domain outlets from all lung major lobes (see Fig. 6.6).    
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Figure 6.6 a snapshot of the particle dynamic at different times of the inspiration phase. 
The labeled distance is the vertical distance (Z) from the ETT outlet to the site indicated 
by the arrow. 
  
6.3.3. Local Deposition 
The local particle deposition assessment is a crucial measure of aerosolized drugs 
for therapeutic purposes. It could be of great importance for targeted delivery as well as 
an indication of localized deposition concentrations, which is deemed vital for assessment 
of administering a bolus dosage of the drug aerosols. The local deposition fraction in 
ETT, trachea, main bronchi, and in the five major lung lobes (i.e. LUL, LLL, RUL, and 
RML and RLL) is presented in Figure 7.7. For deeper insight, local deposition was 
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quantified and plotted for both inspiratory/expiratory flow and total deposition during the 
whole cycle for different ranges of particle sizes. The results are presented for the 
operating 10 Hz HFOV frequency for cases of both symmetric and asymmetric lung 
compliance (CR=1 and CR=10). During inspiration phase, the particles with dp< 3 µm 
demonstrated largest local deposition DFL in the ETT. In addition, more particles 
penetrated deeper in the lower lobes of the lung, which led to a high-localized deposition 
in the RML, RLL and LLL lobes while the upper lobes (i.e., RUL and LLL) received the 
lowest amount of the aerosol-drug, see Fig 7.7a. During expiration phase, the magnitude 
of the DFL significantly decreased compared to the deposition rate during inspiration 
phase. Additionally, in different regions, i.e. MB, LUL and LLL (in the case of 
asymmetric lung compliance), DFL was 8 times greater than symmetric lung compliance. 
This was due to the change in airflow distribution and increasing pendelluft intensity for 
the larger compliance ratio. For particles with dp>3 µm (Fig. 7.7b), the effects of the 
impaction and ETT-jet impingement were more pronounced and the peak localized 
deposition was shifted to the main bronchi. The deposition at the main bronchi was 
drastically amplified for asymmetric lung compliance (CR=10) during the expiration 
phase as result of the variations in the flow distribution and strong flow structure events 
at the main bronchi. The total local deposition trends (for each individual particle 
diameter range) followed the pattern of deposition rate during inspiration phase. This was 
because the deposition during the inspiration phase was much greater than during the 
expiration phase. For the range of particle size investigated in this work, the main bronchi 
received the greatest amount of the aerosol-drug compared to other sites. As an example, 
the local deposition fraction in the main bronchi was 3-fold and 16-fold greater than 
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deposition in the LLL and RUL lobes, respectively. This arose from the impingement of 
the high speed of the ETT-jet at main bronchi during the inspiration phase. The 
observation of the lowest deposition in the RUL and LUL lobes has been previously 
reported in different studies [39, 119]. 
 
Figure 6.7  The local particle deposition of various particle size ranges in different lung 
lobes for HFOV frequency of 10 Hz and cases of CR=1 and 10.   
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Figure 7.8 shows the regional deposition pattern when the local compliance ratio 
between adjacent units was changed. The local compliance ratio CRLocal of selected units 
(i.e. unit25 and unit26, see Fig. 7.1 for the location of the selected units) was varied by 
multiplying the compliance of outlets in unit 25 by 10 while the compliance at the outlets 
of the neighbor unit 26 were kept fixed. This variation was made while the global CR in 
both left and right lungs was unchanged (CR=1). Changing the compliance ratio locally 
allows the more compliant unit (i.e. unit 25) to receive more airflow and increases the 
pendelluft intensity. Consequently, more particles were convected through unit 25 (the 
more compliant unit) and the dispersion, as well as secondary motion, were enhanced, 
which resulted in more particles being deposited in this region. Furthermore, the 
enactment of the deposition was observed in the less compliant unit (unit 26) as well, 
though to a lesser degree than unit 25. This can be seen by comparing the right branch of 
unit 26 in the case of CR=1 and CRLocal=10 in Fig. 7.8. While there were no particles 
observed at that branch when CR=1, a few particles were observed to penetrate and 
deposit in the right branch of unit 26, see Fig.7.8. This is attributed to the pendelluft 
effect. The pendelluft flow exchange between adjacent units was found to increase as the 
asymmetric compliance increased and as a result, the regional particle depositions were 
enhanced.  
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Figure 6.8 the regional deposition pattern under an asymmetric local compliance ratio 
between unit 25 and unit 26. For clarity, the particle sizes were magnified. 
 
6.3.4. Effect of Boundary Conditions on the Particle Deposition 
The specification of the outlet boundary condition at the truncated levels of the 
tracheobronchial tree is of paramount importance for accurate gas and particle transport 
modeling [205]. The global deposition factor was estimated based on MF (Type II) 
boundary conditions and compared to the simulation run using R&C boundary 
conditions. Results are listed in Table 6.2. Data are shown for HFOV frequency of 10 Hz, 
CR=1 &10 for R&C boundary conditions and compared to the case of MF. Minimal 
differences were observed in the global deposition as both cases share the same flow rate, 
Reynolds number and Womersley number, spanning the same range of St number. As a 
result, the effects of the ETT-jet and impaction mechanism are similar and predominant, 
regardless of the boundary condition type. The local deposition, however, was drastically 
changed between the two cases. The trends and quantities of the local deposition fraction 
significantly changed in different lung regions based on the sensitivity of the boundary 
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condition to the local compliance (see Fig 6.7a-e). For example, Type II boundary 
conditions resulted in the local deposition fraction being 35-fold greater than the case of 
CR=10 at RML and RLL lobes during the expiration phase for dp<3 µm. Similarly, 
during expiratory flow, the local deposition fraction at the main bronchi was 40-fold 
greater when using R&C boundary condition for dp>3 µm, see Figs. 6.7c-e. This is 
attributed to the variation in the airflow distributions between lung lobes and the presence 
of pendelluft flow when considering airways resistance and compliance, which could 
significantly change the particle activity and dynamics. For further illustration, the 
variation in the deposition pattern in different lung regions between the cases of using 
different boundary conditions is presented in Figure 6.9. The influences of the airflow 
redistribution and pendelluft gas exchange on the deposition patterns are evident. When 
using MF based boundary conditions, the particles deposition were more localized at the 
carina ridge and branches. However when using the R&C boundary conditions, besides 
the dense deposition surrounding the carina ridge, a greater particle deposition was 
observed in the regions surrounding the airways segment walls (compare Fig. 6.9a and b).  
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Figure 6.9 the deposition pattern in different lung regions. (a) When using R&C 
boundary conditions and (b) when using MF boundary condition. 
 
6.3.5. Drug Delivery under Various HFOV Operating Frequency  
To examine the influence of different HFOV settings on the particle deposition, 
the particle transport under various HFOV frequencies was modeled. The results were 
analyzed and quantified in terms of global deposition, local deposition in the different 
major lung lobes, and deposition pattern. 
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6.3.5.1. Global Deposition 
Figure 6.10 compares the global deposition fraction for HFOV frequency of 6, 10 
and 15 Hz, for cases of symmetric (CR=1) and asymmetric (CR=10) lung compliance. It 
was found that the particle deposition increased almost linearly as the operating 
frequency increased. Changing the frequency from 6 Hz to 10 Hz resulted in 57% 
increase in the global deposition fraction (relative difference). Further increase of the 
frequency to 15 Hz enhanced the deposition fraction by 109%.  Three mechanisms are 
seen to strongly affect the deposition process as the frequency increased. First, the flow 
rate increases as the frequency increases, which enhances the role of impaction, 
turbulence dispersion, and secondary motion  [34, 206]. Secondly, the pendelluft flow 
intensity is found to increase significantly with the HFOV frequency [169, 184] which 
results in enhancement of the diffusion process and the random motion of the particle in 
the flow which in turn enhances the particle deposition. Thirdly, the boundary layer 
thickness ( ) in an oscillatory flow is inversely proportional to the dimensionless 
Womersley number, i.e.  /L , where L is a characteristic length [207]. Thus, 
elevating oscillating frequency reduces the boundary layer thickness, which enhances the 
convective diffusion and allows more particles to pass through toward the airways wall. 
The deposition rate trend in the case of CR=1 and 10 showed similar behaviors as the 
frequency changed; however, the deposition fraction was consistently higher when 
CR=10.  
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Figure 6.10 global deposition during different HFOV operating frequencies and 
CR=10. 
6.3.5.2. Local Deposition 
The local deposition fraction in different lung lobes was also quantified during 
inspiratory/expiratory flow for three different HFOV frequencies of 6, 10 and 15 Hz. The 
results are plotted in Fig. 6.11 for asymmetric compliance ratio (CR=10). During the 
inspiration phase, the local deposition rate trend was similar for all frequencies. The 
magnitude of DFL, however, was significantly different depending on the lobe location. 
For example, at the main bronchi, the location that showed the greatest deposition, DFL 
was 3.88-fold greater for a flow with frequency of 15 Hz as compared to the case of 6 Hz. 
However at lower generation, the effect of frequency variation was diminished, e.g. at 
RUL lobe, the deposition was lowest with no difference between all frequencies. During 
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the expiration phase, the deposition at all locations for the three frequencies was 
significantly lower than the inspiration phase. Furthermore, the frequency of 6 Hz had a 
consistently lower deposition rate compared to other cases, indicating more particles 
delivered to the deeper regions of the pulmonary tract. Interesting behaviors were 
observed during expiratory flow when using 10 and 15 Hz frequency. The local 
deposition rate peaked most significantly at RML and RLL and was 14-fold higher when 
using a HFOV frequency of  
 
Figure 6.11 a comparison of the local deposition fraction for various HFOV operating 
frequencies. 
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15 Hz. The local deposition at the main bronchi was 5-fold higher when reducing the 
frequency from 15 Hz to 10 Hz. This is probably due to the airflow redistribution and 
flow feature changes as consequences of the frequency and CR changes, along with the 
effect caused by the irregular structures of the branch that feeds the RML and RLL 
regions Although these observation during the expiration phase contributed a nontrivial 
amount to the total local deposition, the total deposition behavior always followed the 
deposition rate during the inspiration phase, see Fig. 6.11.   
6.3.5.3. Deposition Pattern 
The visualization of the deposition pattern provides a profound insight into the role 
of the geometry and flow features on the particle deposition hot-spots. Figure 6.12 
presents and compares the deposition pattern in the tracheobronchial tree for different 
HFOV frequencies. We illustrate the anterior lung side for clarity. Similar to the 
observation under normal breathing in many past studies [95, 96, 119, 191, 194], the 
enhancement of the particle deposition at the carinas was evident throughout the domain 
as a consequence of the flow diverging at the bifurcation sites, leaving particles to impact 
at the  flow divider (carina). In addition, notable enhancement of the deposition occurred 
at the sites of sharp transition. A unique deposition characteristic was identified under 
invasive HFOV. Besides the normal hot-spots that have been previously identified, high 
particle deposition concentrated along the inner and side walls of the main bronchi 
tubular segments due to the effects associated with the presence of the ETT-jet. The ETT 
releases a high-speed jet at the lower region of the trachea that impinges at the first carina 
and creates a large recirculation zone extending from the outer walls of the main bronchi 
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to the jet sides. These flow structures reduce the area available for the flow to pass 
through, and, as a result, higher velocities are created at the inner walls of the 
bronchi [166]. Thus, the role of the inertial impaction is greatly enhanced at these 
locations resulting in a highly localized and concentrated deposition inside the main 
bronchi segments. The ETT jet effects resembled the effects of the laryngeal jet reported 
by  [95] undertaken to quantify particle deposition inside the tracheobronchial tree. The 
influence of the ETT-jet on the deposition concentration at the main bronchi was more 
significant and maybe attributed to the strength  
 
159 
 
 
Figure 6.12 the pattern of aerosol-drug deposition under different HFOV 
conditions. 
and proximity of the ETT-jet at the first bifurcation site. It is evident that the localized 
deposition concentration increased as the HFOV frequency increased due to the effect of 
the flow rate. Furthermore, the particles with larger diameter tended to deposit at the 
carinas, sharp transition locations and inner walls of the main bronchi, due to 
predominant impaction and jet impingement. The smaller particles had a tendency to 
deposit at the sidewalls, such as at the trachea, as a consequence of the turbulent 
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dispersion, secondary flow, and pendelluft mechanism. For further illustration, the 
deposition patterns of small particles, mainly dp < 1µm and larger particle dp > 4 µm, are 
depicted in Figure 6.13. Clearly, the particles with dp > 4 µm concentrated at the carinas 
and the inner walls of the main bronchi due to the high inertial impaction effect, which 
was strongly enhanced by ETT-jet. The small particles dp < 1µm, however, more 
uniformly deposited throughout the domain. This was because the smaller particle was 
principally influenced by the turbulence dispersion and secondary flow as it complied to 
the flow streamline. As a result, the diffusion of the particles was enhanced resulting in 
the deposition at the airway walls throughout the domain. 
 
Figure 6.13 the deposition pattern of particles with a dp < 1µm and > 4 µm. 
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6.3.6. Potential of Drug Delivery to a Patient under HFOV Management 
The feasibility of drug delivery during HFOV has long been debated due to the 
numerous challenges that arise due to the high frequency associated with this mode [42, 
208]. Fink et al [208] studied drug delivery to the lung using different aerosol nebulizers 
that were compatible with HFOV, including a novel nebulizer (Aeroneb Pro) and jet 
nebulizers [MistyNeb (Allegiance) and Vix One (Westmed)]. They concluded that the 
drug delivery during HFOV management is possible and the Aeroneb Pro delivered 2.9 
times greater Albuterol to the end of ETT than the other two devices. Recently, Longest 
et al  [209] demonstrated a 50% improvement in drug dosage delivery through the 
mechanical ventilator circuits by redesigning the circuit components using a streamlining 
approach. Our simulations suggest that the global aerosol-drug delivery (relative to the 
total particles injected at the ETT entrance) under HFOV parameters was equivalent to 
cases of normal breathing and CMV. Upon comparing the current particle deposition 
fractions to values reported in the literature for different flow rates and particle sizes (dp 
=1 and 5 µm) using CFD  [210] and experiments [211], the deposition fraction values 
under HFOV were found to be comparable to the particle deposition during normal 
breathing for the same range of flow rates, see Table 4 and Fig. 6.14. However, the 
reported value of the deposition in realistic 6-generation model by Inthavong et al  [94] 
for the case of (Q=66 L/min) was relatively lower than the present prediction for the 
similar case (Q=54 L/min), see Table 4. This is because, unlike the geometry in Jin et al 
[210] and Zhang and Finlay [211] , the model in Inthavong et al [94] lacks the effects of 
the extrathoracic geometry (mouth to larynx). This emphasizes the importance of the 
effect of the geometry features on the aerosol transport throughout the human lung. The 
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total particle deposition during HFOV, for different frequencies, ranged from 29% to 
69%, which could be equivalent to the CMV.  This is consistent with the in vitro 
findings [212] which compared the albuterol delivery under HFOV and CMV and 
concluded that albuterol deposition during HFOV was two-fold higher than CMV. These 
findings are supported by the other in vivo studies [50] of pulmonary aerosol delivery 
during HFOV in piglets. They concluded that the aerosol-drug delivery was effective and 
was at least as efficient as conventional mechanical ventilation.  
 
 
Figure 6.14 a comparison of the particle deposition fraction of the present study of HFOV 
with the experimental measurements for normal breathing by Zhang and  
Finlay [211] for a particle diameter range of 3 to 5 µm in a model extends from mouth to 
G3. 
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The local deposition under HFOV, however, were significantly different form the 
normal breathing. High deposition concentrations at the main bronchi and the subsequent 
generations (lobar-to-segmental bifurcations) resulted from the great inertial impaction 
and ETT-jet impingement. This observation along with strong deposition dependency on 
the operating frequency could be beneficial for the aerosol-drug drug delivery under 
HFOV management. The lobar and segmental airways are highly susceptible to lung 
cancer [95, 213]; a patient suffering from lung cancer could receive HFOV support and 
possibly benefit from the peak localized aerosol-drug deposition at the upper airways 
generations. In addition, the upper generations, including large airways (G0 to G5), are 
most vulnerable to many diseases e.g. asthma and chronic inflammation [214]. Medicines 
administered, such as bronchodilators and anti-inflammatory agents to treat such disease, 
would then require upper tracheobronchial targeting  [95, 214], which could be achieved 
under HFOV management due to the high deposition concentration at those locations. 
More importantly, the dependency of the localized deposition on the ventilator frequency 
could be used to effectively control the regional deposition. For example, using a lower 
HFOV frequency (6 Hz) was found to reduce the local deposition of the aerosol at the 
main bronchi while the deposition in the lower lobes was comparable for all frequencies 
and high chance to deliver more particles to deeper region of the lung. Thus, when 
considering the risk of side effects at the sites of highly concentrated deposition, reducing 
the ventilator frequency could prevent drug overdose side effects while bringing a 
considerable portion to the lower lobes.  
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Table 6.3 Comparison of the present prediction of total particle deposition under HFOV 
conditions to the existing results in the literature for normal breathing. 
Study Geometry dp (µm) 
Flow rate 
(L/min) 
Total 
deposition% 
Jin et al 
 [210] 
CFD 
Mouth – G3 
idealized 
 
1 
60 
10.4 
5 45 
1 
90 
17.6 
5 71 
Zhang and Finlay 
 [211] 
Experiment 
 
Mouth – G3 
idealized 
 
5 90 71 
Inthavong et al 
 [94] 
CFD 
Trachea –G6 
realistic 
5 66 30.1 
Present  
CFD 
ETT- G7 
realistic  
1 
56.55 
14.74 
5 42.78 
1 
94.25 
23.32 
5 90.96 
1 
141.37 
36.67 
5 97.20 
 
 
6.4. Conclusion 
The aerosol-drug delivery under high frequency oscillatory ventilation was 
carried out under various ventilator settings and lung conditions. Large eddy simulation 
was performed to model the continuous phase and the Lagrangian tracking method was 
implemented to model the dispersed phase. User-enhanced FORTRAN subroutines were 
compiled with the solver to implement the Lagrangian model. A physiological time-
dependent pressure boundary condition was employed as a function of the coupled 
airways resistance-compliance and compared to the traditional boundary condition. The 
main observations can be summarized as the follows: 
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 The particle deposition during the inspiration phase was five-fold greater than 
expiration phase, and the asymmetric lung compliance was found to significantly 
affect the deposition, especially during expiration phase. Furthermore, the 
deposition fraction was strongly influenced by the release time of the particles’ 
injection.  
 The existence of the pendelluft flow and airflow redistribution due to resistance-
compliance BCs application demonstrated a significant influence on the local 
deposition magnitude and pattern compared to the traditional mass fraction BCs. 
 The ETT-jet was observed to have a major impact in enhancing the inertial 
impaction, resulting in highly localized deposition at the main bronchi and the 
few subsequent generations. The lower lung lobes significantly received more 
aerosol-drug compared to the upper lobes, which was consistent with existing 
results in the literature for normal breathing.  
 The asymmetric compliance ratio between adjacent regional units was found to 
enhance the regional deposition as a consequence of the flow redistribution and 
effect of the pendelluft flow.    
 A 2.5-fold increase of the operating frequency resulted in a 2.1-fold increase in 
the global deposition fraction in the upper tracheobronchial tree. Meanwhile, a 
2.5-fold reduction in the frequency resulted in 3.88-fold reduction of the local 
deposition at the main bronchi allowing more particles to penetrate deeply in the 
lung and reduce the drug side effect risk associated with sites of high deposition 
concentrations. This indicates that the operating frequency has strongly influence 
the global and local particle deposition fractions and the deposition magnitude 
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could be controlled by changing the frequency, which could be beneficial for 
targeted drug delivery.  
 Considering the particle deposition relative to the injected particle at the ETT 
inlet, aerosol drug delivery during HFOV could be equivalent to and as efficient 
as normal breathing and conventional mechanical ventilation, despite rapid 
ventilation cycles.   
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CHAPTER 7 
EFFECT OF CARRIER GASES 
ON TRANSPORT AND 
AEROSOL DRUG DELIVERY BY 
INVASIVE HIGH FREQUENCY 
OSCILLATORY VENTILATION  
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7.1. Introduction 
Various inert gases and gas mixtures can be used during the mechanical 
ventilation process to enhance gas exchange and mixing during mechanical ventilation 
management  [27, 215]. Carrier gas properties like density and viscosity plays an 
important role and can be tuned to enhance aerosol deposition for patients under therapy 
management [216]. Changing carrier gas density will alter the fluid dynamics in the 
airways; the resistance of the airways will vary depending on the gas properties. In 
addition, the flow regimes (i.e., laminar, transitional, turbulence) will also be altered with 
a variation in properties. Using a carrier gas with lower density and higher kinematic 
viscosity (e.g., Heliox, which is a mixture of helium and oxygen) reduces the flow inertia 
and also increases the viscous force [217]. As a result, the Reynolds number (ratio of 
inertial force to viscous force) could be drastically reduced. This reduction is a 
mechanism that effectively diminishes or suppresses the turbulence and is dependent on 
the Re number. Particle transport throughout the pulmonary domain is directly influenced 
by various flow transport mechanisms [34]; the trajectory of the particles is therefore 
strongly affected by utilizing different gas mixtures, which in turn alters the deposition 
rate and sites.  
Heliox has long been used for inhalation therapy [215] as the density of the gas 
mixture can be altered depending on the helium concentration. This feature is exploited to 
facilitate gas transport and to maximize aerosol-drug delivery in a diseased lung. Thus, 
density change could be used to offset increased flow resistance due to narrowing of the 
airways. The therapeutic outcomes are, however, still a subject of much debate in clinical 
practice. A comprehensive review of the outcomes of using different gas mixtures under 
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different ventilation modes and strategies can be found in [215, 218, 219]. Aerosol 
transport under different carrier gases has attracted the attention of many researchers  [27, 
120, 177, 220, 221] in their attempts to understand and optimize the inhalation therapy 
process. Sandeau et al [220] conducted a CFD study of aerosol transport with an 
extrathoracic (ET) model using Heliox as a carrier gas. A reduction of the respiratory 
effort and particle deposition in the ET model was observed indicating a positive 
outcome of the Heliox inhalation therapy. Similar conclusion was drawn by I. Katz et al 
[122] in their recent study of the regional particle deposition in the human lung model 
utilizing a helium-oxygen gas mixture. In vitro study of albuterol delivery using Heliox 
and air was carried out by Ari et al [221] through a pediatric high-flow nasal cannula. 
They concluded that using a lower density gas (Heliox) at a high flow rate (6 L/min) 
increased the delivered aerosol by >2-fold; however, the benefits of Heliox diminishes 
with decreasing inspiratory flow rate (3 L/min).  
High frequency oscillatory ventilation has become a commonly used ventilation 
method in the intensive care unit. The gas transport mechanisms is more complicated 
than during CMV as a tidal volume less than the dead space volume is delivered at high 
operating frequencies. Thus additional mechanisms that include coaxial counter flow, 
pendelluft flow, Taylor-dispersion, and molecular diffusion [32, 166] become relevant for 
HFOV in addition to bulk convection which is present for both cases. Understanding the 
gas transport and mixing during this mode of ventilation is therefore essential for 
optimize ventilation management. A recent study by the authors derived and used 
physiological time-dependent pressure outlet boundary conditions based on coupled 
airways resistance-compliance at the truncated level of the tracheobronchial tree has 
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successfully captured the important gas transport mechanisms under HFOV 
parameters [184]. In particular, the pendelluft flow mechanism was captured in different 
lung regions, and the pendelluft intensity was successfully quantified. The robustness of 
the developed resistance-compliance boundary condition led to more accurate modeling 
of the particle transport under the HFOV management mode [222]. It was found that the 
particle deposition, relative to the injected particles at the endotracheal tube inlet, under 
the HFOV conditions, could be as efficient as normal breathing and conventional 
mechanical ventilations, despite the very rapid ventilation cycle. Furthermore, the 
deposition rate was highly frequency dependent. The usage of a Heliox gas mixture is 
seen to enhance the gas exchange during HFOV, and it is postulated that the 
enhancement occurs via different flow transport mechanisms, particularly pendelluft 
flow [223, 224]. It is, however, not fully understood how gas mixtures affect transport 
mechanisms and how the particles respond to changes of constituent gas properties 
during HFOV [223].  
 In the current study, various carrier gases and gas mixtures that include He, He-
O2 (Heliox), Xe-O2 and SF6-O2 were utilized as the working fluid under HFOV; the main 
objective was to investigate the influence of the carrier gas on the flow transport and 
particle deposition, which may allow for optimum drug delivery and ventilation strategy. 
The study was conducted using a high-order turbulent model LES along with user-
defined subroutines to implement a Lagrangian particle tracking model. To account for 
the complex airways morphology, the realistic tracheobronchial model was reconstructed 
using computed tomography scans. An 8 mm interior diameter ETT was inserted into the 
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trachea to account for the invasive device and a portion of the ventilator circuit. A 
comprehensive list of parameters is provided in Table 7.1.     
7.2. Method 
The gas and particle modeling methods, boundary conditions and validations have 
been discussed in previous chapters. Figure 7.1 presents the model, the lung divisions and 
considered units for the analysis.  
 
Figure 7.1 Tracheobronchial tree model with an endotracheal tube (ETT) inserted into the 
trachea. RB: right main bronchus, LB: left main bronchus, LUL: left upper lobe, LLL: 
left lower lobe, RUL: right upper lobe, and RML&RLL: right middle and right lower 
lobes. 
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Table 7.1 presents the carrier gases under consideration, the HFOV conditions, and the 
flow and particle parameters. The compliance ratio was kept at 1. To investigate the role 
of the carrier gas density, four different gas mixtures were considered. The density of the 
heavier gas (sulfur hexafluoride-oxygen, SF6-O2) was 29-fold higher than the lighter gas 
(He); the He was considered to investigate the lower end of the gas density. Reynolds 
number (  /Re meanaveUD ) based on the mean velocity ( meanU ) and trachea-averaged 
diameter ranged from 1305 to 27100 for the lowest gas density (He) and highest gas 
density (SF6-O2), respectively. Likewise, the Womersley number ranged from 5.43 to 
25.28 based on the trachea average diameter, as seen in Table 7.1. 
Table 7.1 Properties of the considered carrier gases and flow parameters; 
HFOV f= 10 Hz. 
Gas 
mixture G
  (kg/m3) G (m
2
/s) 
Reynolds 
number 
tracheaRe  
Womersley 
number 
trachea  
He 0.166 
5109.11   1305 5.43 
He-O2
a 
0.4 
51095.4   3039 8.35 
air 1.185 
510511.1   5843 14.83 
Xe-O2
b 
2.597 
51081.0   18280 20.64 
SF6-O2
c 
4.8 
51054.0   27100 25.28 
Gas composition: 
a
80%He-20%O2, 
b
40%Xe-60%O2  [177], 
c
71% SF6-21%O2  [27] 
 
7.3. Results and Discussion 
The results of the gas transport and particle deposition in the ETT and 
tracheobronchial tree under different carrier gases were obtained in terms of flow 
regimes, turbulence, pendelluft intensity ratio, and global and local deposition. The 
findings are reported and discussed next. 
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 7.3.1. Flow Regimes Characteristics 
          The typical flow regimes under HFOV parameters are characterized into three 
regimes  [225].  Regime I consists of unsteady flow where a well-known Womersley 
linear solution can be approximated. Regime II covers viscous flow where the convective 
inertia and secondary flow effects are negligible (Poiseuille solution). Finally, regime III 
encompasses convective flow, which is distinguished by complex flow structures and can 
be further sub-divided into two zones, IIIa-convective and IIIb-convective depending on 
its location from the unsteady and viscous regimes. This characterization based on Jan et 
al [225] depend on two non-dimensional parameters; the Womersley number, and stroke 
length (L/a) where L is the stroke volume per average area of the cross-section airway 
segment, VT /A, and VT is the local tidal volume of the airway segment. These defined 
flow regimes were used in many past studies  [47, 154, 226, 227] as a guidance to 
anticipate the flow key features in different regions of the conducting airways model. 
Figure 7.2 shows the delineations of these three regimes and the flow characteristics 
through our lung geometry for different carrier gases that were considered in the present 
study. The boundary lines between different regimes are according to the constant 
Reynolds number values at 30 and 1500. The flow regime in the trachea was presented 
for all five-carrier gases. The characteristics of the flow regimes in selected airways 
segments from trachea to G7 are presented for He and SF6-02 mixture, which have the 
lowest and highest gas density, respectively. The results were compared to simulation 
with air as the carrier gas. The flow at the trachea (for all combinations tested) was 
located in the turbulent regime signifying very complex flow  [225]. Since all cases had 
similar values of the dimensionless local tidal volume (L/a), the distance from the 
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Re=1500 line was governed by α2. This is due to the dependency of the Womersley 
number on the gas kinematic viscosity. Consequently, as the gas density (kinematic 
viscosity) increased (decreased), the flow was located far away from the Re=1500 line 
(convective regime), see Fig. 7.2. The range of the dimensionless parameters for the three 
carrier gases compared in Fig. 7.2 are presented in Table 7.2. For SF6-O2, all airways 
segments were characterized by turbulent flow regimes and was located far away from 
the convective regime. When using air, the curve evidently shifted to the left; however 
the turbulent regime was predominant in all airways segments. Thus, the combination of 
higher density and lower kinematic viscosity of carrier gases when used in the presence 
of an ETT caused turbulent flow to exist at location that were deeper into the 
tracheobronchial tree. However, when using air, the peripheral segments (e.g., G7) were 
located near the convective regime indicating less turbulence. The lowest density gas 
(i.e., helium) noticeably mitigated the flow complexity. The curve was shifted towards 
the convective regime as some airway segments collapsed into this regime indicating 
diminished turbulence.  
 Based on these observations, the linear solutions of Womersley or Poiseuille 
cannot be approximated in any airways segments for HFOV. It was therefore evident that 
the flow complexity existed for all cases and increased as the gas density increased. 
However, according to the curves behavior in Fig. 7.2, using a carrier gas with lower 
density could significantly enhance gas transport and aerosol-drug delivery during HFOV 
management. 
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Figure 7.2 Flow regime characterization under different carrier gases at an operating 
frequency of 10 Hz and tidal volume of 50 ml, based on Jan et al  [225]. 
 
Table 7.2 The range of squared Womersley number and stroke length for different carrier 
gases. 
Carrier gas 
α2 L/a 
G7 Trachea  G7 Trachea  
He 1.79  29.48 173.62  289.07 
air 13.44 219.92 128.59 275.68 
SF6-O2 38.84 639.08 122.03  247.19 
 
 
7.3.2. Flow Structures  
 The use of various carrier gases revealed significant differences on the flow 
structures, respiratory mechanics and gas transport features during HFOV.   
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7.3.2.1. Spatial and Temporal Evolution of ETT-jet 
The presence of intubation (i.e., ETT) caused a strong jet (henceforth referred to 
as the ETT jet) that was released in the trachea region and impacted at the first carina 
ridge. The spatial and temporal evolution and the stability of the jet could be influenced 
by the carrier gas properties, which subsequently affect the inhalation therapy outcomes. 
Fig. 7.3 compares the flow structure and ETT-jet evolution in the case of using He and 
compared the results with simulations that used air. The snapshots of the velocity 
contours were taken at different times corresponding to 4%, 6%, 9% and 25% (peak 
inspiration) of the cycle time. To illustrate the spatial differences of the jet development, 
the vertical distance (Z) of the developed jet from the ETT exit at each time was labeled 
in Fig. 7.3 in terms of ETT diameter. The ETT jet was observed to develop rapidly in the 
case of using He gas, which has a density 7.3-fold lower than air. At the beginning of the 
cycle, the jet had similar features in both cases. As the cycle advanced (t/T =0.06), the 
lighter He jet traveled a longer distance (2.13DETT compared to 1.5DETT of the air jet, see 
Fig. 7.3) than the heavier air jet. At t/T =0.09, the air jet approached the tracheal crania 
ridge (no impingement yet) while the He jet had already impinged on the flow divider, 
bifurcated and penetrated into the main bronchi (see demarcated areas 1 and 2 in Fig. 
7.3a and b). As the inspiratory flow reached the peak acceleration phase, the jet in both 
cases was fully developed, and deeper penetration occurred for the He jet. The rapid 
development of the He jet indicates that for a given driving pressure, using a low-density 
gas mixture such as Heliox could deliver more tidal volume, which may enhance gas 
exchange. The turbulence inside the ETT, the core region of the ETT jet and the jet 
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surrounding area was evident, particularly in the case of using air. It was initiated as the 
jet developed and was more pronounced at peak inspiratory flow. This was due to the 
difference in constituent properties, which resulted in a Reynolds number that was 4.5-
fold higher in the case of using air. The turbulence when using air could have a strong 
effect on the particle transport, which will be discussed later. The observation of the 
higher jet velocity with lower turbulence when using He gas is consistent with the 
reported observation by Sandeau et al  [220] in their study of flow in a extrathoracic 
model under Heliox and air for normal breathing conditions.   
 
Figure 7.3 Velocity contour and ETT-jet evolution at different inspiratory flow 
cycles, (a) He and (b) air. The labeled distance is a measure of the vertical distance from 
the ETT exit to the location where the arrows point out. 
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7.3.2.2. Turbulence and Airways Resistance under Different Gases  
To investigate the influence of gas density on the turbulence inside the domain, 
turbulence kinetic energy was plotted in Fig. 7.4 as a function of inspiration time. The 
data is shown for the lowest and highest carrier gases and compared to air. The TKE was 
computed and averaged at a vertical plane that cuts throughout the ETT, trachea and main 
bronchia. In all cases, TKE increased as the flow accelerated; due to higher disturbance 
during the deceleration phase, a further increase in the TKE was also observed [135, 
166]. The TKE in the case of the highest density mixture (SF6-O2) was ~1.55-fold and 
~1.9-fold higher than air and the lowest gas density (He), respectively. This corresponded 
to an increase of the mean Reynolds number by a factor of 4.64 and 20.77 respectively in 
the case of SF6-O2 mixture when compared to air and He respectively. The occurrence of 
the turbulence in the trachea and the main bronchi, even with low-density gas like He, 
was due to three significant factors. Firstly, the presence of the ETT released a strong jet 
in the trachea region, which created a flow reversal along the jet sides. The interaction 
between the jet and flow reversal formed a free shear layer, which initiated the turbulence 
in this region [95]. Secondly, the transition to turbulence is determined by the Stokes 
layer Reynolds number ( Re ) that is defined as  /Re U , where f / is the 
Stokes layer thickness [135]. Eckmann and Grotberg [136] found that the transition to 
turbulence occurs when 856Re500    for oscillatory flow in a straight pipe. 
Furthermore, Winter et al  [135] determined the critical Reynolds number to be between 
400 and 575 for a purely oscillatory flow in a circular tube. The Stokes-layer Re based on 
the present HFOV flow conditions for (He) was higher than the critical value (i.e., 
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589,810~Re  and 501 in the trachea, right and left bronchus, respectively), indicating 
turbulence at the trachea and main bronchi. This was confirmed by the flow regimes 
characteristic based on Jan et al  [225], as discussed previously in section 7.3.2. Thirdly, 
the ETT and complexity in geometry due to curvatures, asymmetry, successive branching 
angle, and nonuniform cross-sections contribute additional disturbances to the flow. 
Consequently, the critical values of Re , where the transition to turbulence is initiated, 
become lower in bifurcated tubes [135]. Nerem et al [228] reported critical Re value of 
150 for a blood flow in the aorta of dogs.  
 
 
Figure 7.4 Temporal variation of the turbulence kinetic energy for different carrier gases 
during the inspiration phase. 
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To examine the effect of the carrier gas on the respiratory mechanics, the global 
tracheobronchial resistance (RTB) was computed for each case following Miyawaki et 
al  [177]:   
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 (7.1) 
where inp  and inQ are the pressure and the inlet flow rate at the ETT entrance, 
respectively. koutp , is the pressure at the k
th
 outlet, and outN is the total number of the 
outlets. RTB is plotted in Fig. 7.5 and was normalized by the highest computed value, i.e., 
RTB (SF6-O2) = 2.454 cm of H2O/l/s. The value of RTB increased as the Re increased (i.e., 
density increases) which was strongly correlated with the associated turbulence with each 
carrier gas. It was observed that the RTB in the case of SF6-O2 is ~5.10-fold and ~1.74-flod 
higher than He and air due to higher Re number. Furthermore, an 18% decrease in the 
TKE when using He rather than air led to a ~65% decrease in the RTB. This could play a 
major role in gas and particle transport, which may reduce the respiratory effort and 
increase aerosol-drug delivery. The values of RTB and its observed linear behavior with 
Re number agreed with earlier reported trends by Miyawaki et al. [177] for the same 
range of Re numbers.  In their study of flow in a realistic model extending from the 
mouthpiece to G7, RTB was 0.421 and 0.732 cm of H2O/l/s corresponding to Re numbers 
of 1300 and 2800, respectively. For a similar Re range of 1305 (for He) and 3039 (for 
He-O2 mixture), RTB was estimated as 0.4811 and 0.8989 cm of H2O/l/s, respectively. The 
difference was due to the variations in the models configurations and complexity.     
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Figure 7.5 The predicted airways global resistance under different carrier gases. RTB was 
normalized by the highest computed value, i.e., RTB (SF6-O2) = 2.454 cmH2O/l/s. 
 
7.3.2.3. Secondary Flow   
Temporal variation of the secondary flow strength for the cases of He, air and 
SF6-O2 are presented in Fig. 7.6. SFS is defined as the ratio of the radial component of 
velocity (Vr) to the axial velocity component at a given location [161, 166]. SFS was 
characterized as strong when the ratio was greater than 0.6, moderate when 0.3 ≤ SFS ≤ 
0.6, and weak when SFS < 0.3 [166]. SFS was averaged at two different cross-sectional 
planes, T at the trachea and L at left bronchus (see Fig. 7.1 for locations). At location T in 
the trachea, a moderate secondary flow SFS < 0.6 existed for all cases; however, strong 
enhancement in secondary motion was observed at the beginning and end of the 
inspiration and expiration phases (i.e. SFS > 0.6). Comparing secondary flow at the flow 
reversal, the SFS was ~30% higher for the cases of air and SF6-O2 than He. As expected, 
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the secondary flow was strong (SFS > 0.6) at location L in the left bronchus due to the 
effect of the curvature. The enhancement of secondary flow at flow reversal was evident 
as well, and its strength was comparable in all cases. This observation indicated that 
geometry features dominate the secondary flow motion more than the properties of the 
gas. As a result, the contribution of secondary motion to the gas dispersion and mixing 
could have the same significance in all carrier gases, except at the flow reversal where a 
decrease in SFS values was observed for He-gas. 
 
Figure 7.6 Temporal variation of the secondary flow strength (SFS) for different carrier 
gases at different locations. 
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   7.3.3. Pendelluft Mechanism  
The regional gas exchange between adjacent branches or units is referred to as a 
pendelluft flow. The heterogeneity of the time constant ( CR ) causes the flow to 
alternate between the units at the end of inspiration/expiration phases  [168, 184]. In 
chapter 5, using coupled resistance-compliance boundary conditions [184], the pendelluft 
flow in different lung regions was captured and characterized in terms of pendelluft 
intensity as a pendelluft volume percent. For any unit consisting of a mother tube that 
bifurcated into two branches (daughter tubes), VP is defined as the ratio of the volume 
exchanged between daughter branches during pendelluft time-period to the total volume 
delivered to the unit in one cycle [184]. The results of the pendelluft flow for different 
carrier gases in the present study were obtained and compared in terms of the pendelluft 
volume ratio (Vratio) in Fig. 7.7. The pendelluft volume ratio is defined as 
21
/
gasPgasPratio
VVV  , where the 1gasPV  and 2gasPV are the pendelluft volume percent of the 
first selected carrier gas to the pendelluft volume percent of the second selected carrier 
gas. In Fig. 7.7, Gas 1 was selected to be He (lowest density) and compared to Gas 2 (air 
and SF6-O2 mixture). It was found that, in general, the carrier gas with a lower density 
increased the pendelluft flow, signifying enhancement of the gas exchange. This is 
attributed to the lower gas density and higher kinematic viscosity [223, 224], which 
increases the gas velocity and modifies the system time constants  [229, 230]. The 
magnitude of the increasing pendelluft intensity, however, strongly depends on the unit 
location. For example, in unit 4, VP when using He was ~1.55-fold higher than air while 
in unit 26 it was ~15-fold higher. This is attributable to the flow conditions and the 
184 
 
regional geometry features, such as branching angle, diameter, unit orientation, and 
structure abnormity, which could play a major role in the pendelluft intensity  [184]. 
Comparing the Vratio of He to denser gas mixtures than air (i.e., SF6-O2), the ratio further 
increased, depending on the location, which emphasizes the impact of the gas density on 
the gas exchange (see Fig. 7.7).         
 
 
Figure 7.7 The pendelluft volume ratio (Vratio) for He to air and He to SF6-O2. The ratio is 
defined as 21 / gasPgasPratio VVV  . 1gasPV  and 2gasPV are the pendelluft volume percent of gas 
1(He) and  gas 2 (air and  SF6-O2). 
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   7.3.4. Particle Deposition  
The role of carrier gas properties in particle transport and deposition at the ETT and 
tracheobronchial tree during HFOV were explored and presented in terms of global and 
local deposition fractions.   
 7.3.4.1. Global Deposition  
The global deposition fraction was defined as the total particles deposited in the 
whole domain to the total particles entering the ETT [222]. The global deposition 
characteristics under different carrier gases were presented in Table 7.3. The deposition 
associated with inspiratory flow was always higher than with the expiration phase as 
found in chapter 6. However, the ratio of the deposition during inspiration phase (In) to 
expiration (Ex) phase (In/Ex ratio) significantly increased as the carrier gas density 
increased, ranging from 2.51 to 6.77 for the lowest to highest gas density (see Table 7.3). 
A decreasing gas density minimizes the particle relaxation time, as well as the turbulence 
and flow resistance, which effectively reduces the impaction role and particle 
dispersion [120]. Consequently, the particle deposition during the inspiration phase 
increases (decreases) for higher (lower) carrier gas density. This resulted in the wide 
range of In/Ex ratios, which significantly affected the total global deposition throughout 
the whole domain. For example, He and Heliox reduced the deposition on the upper 
tracheobronchial tree by ~32% and ~25.36% (relative difference) compared to air. This 
suggests that using Heliox with high concentrations of Helium could deliver more 
particles into deeper regions of the pulmonary tract. The total deposition for the highest 
density carrier gases (i.e., Xe-O2 and SF6-O2) was significantly enhanced and was 
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identical for both gases. It was ~70% higher than the lowest density gas (see Table 7.3). 
The identical deposition indicates that by increasing density beyond that of Xe-O2, the 
deposition rate becomes independent of the density under HFOV conditions. The 
deposition in the right lung is consistently higher than the left lung with insignificant 
differences between considered carrier gases.  
 
Table 7.3 Details of global particle deposition under different carrier gases. 
Carrier Gas 
DFG% 
In Ex In/Ex ratio
a 
R/ L ratio
b 
Total
 
He 22.35 8.91 2.51 1.31 31.26 
He-O2 26.46 7.83 3.38 1.36 34.29 
air 38.65 7.30 5.30 1.29 45.94 
Xe-O2 45.33 8.30 5.46 1.18 53.63 
SF6-O2 46.49 6.87 6.77 1.23 53.36 
a
In/Ex ratio is the ratio of the total deposition during inspiratory flow to the total 
deposition during expiratory flow.
 
b
R/ L ratio is the ratio of total deposition in the right lung to the total deposition in the left 
lung. 
 
For further insight on the role of the carrier gas on the deposition, the global 
deposition for various particle size ranges under He-gas (lowest density) is compared to 
air in Table 4. Katz et al [120] derived a formula for the relaxation time ratio ( R ) of the 
particles in the case of Heliox to air (applicable to any carrier gas), and it is defined as the 
following: 
gasairairgas dCdCR  )(/)(  
where )(dC is a factor that accounts for non-continuum slip effects of the interaction 
between particles and the gas. )(dC  is a function of the Knudsen number, pdKn /2 , 
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where  is the gas mean free path. Based on the observation of Katz et al [120], the 
deposition is enhanced for the particles with 1R  and vice versa. For the Heliox mixture, 
R < 1 was found for the particle diameter greater than 0.4 µm. For the range of the 
particle size (5> dp > 0.5 µm) used in the present study, the deposition under air was ≥ 
40% higher than He (see Table 4). This is due lower relaxation time ratio ( R < 1) as 
indicated by the theoretical formula of Katz et al [120] when using Heliox in addition to 
the reduction in turbulence and flow resistance. 
Table 7.4 Comparison of the total global deposition for a wide range of the particles’ 
diameters in the case of He and air carrier gases. 
dp  range 
(µm) 
DFG 
100
DF
DFDF
%difference Relative
He
airHe 

  
He air 
0.5< dp<1 1.26 2.12 68.25 
1< dp<2 4.56 6.78 48.68 
2< dp<3 5.99 8.73 45.74 
3< dp<4 7.17 11.60 61.79 
4< dp<5 12.50 17.44 39.52 
 
7.3.4.2. Local Deposition under Different Carrier Gases 
The local deposition in the major lobes of the lung was quantified during 
inspiratory, expiratory, and whole cycle flow and presented in Fig. 7.8. The local 
deposition fraction is defined as the total particles deposited in a selected region to the 
total particles entering the ETT [222]. The local deposition behavior had similar trends 
regardless of the carrier gas type. During the inspiration phase, the main bronchi received 
the majority of the particle deposition, due to enhancement of the impaction role and 
ETT-jet impingement [222], followed by the lower lobes; however, the deposition in any 
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lobe was consistently lower as the gas density decreased. Consequently, in the case of 
using a carrier gas with low density such as Heliox (He-O2), the aerosol-drug could 
penetrate deeper into the lung and have a better chance to deposit in the lower region of 
the pulmonary tract. During expiratory flow, the local deposition was almost the same in 
all lung lobes without any significant differences between all carrier gases. The 
deposition in the ETT was highest during the expiration phase. This is because a high 
population of the particles stayed active and were convected with the flow that 
experienced sudden contraction, which may have enhanced impaction and particle 
dispersion in this region. The total local deposition trend  
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Figure 7.8 Particle local deposition for different carrier gases: (a) during the 
inspiration phase, (b) during the expiration phase, and (c) the total deposition during the 
whole cycle. 
 
 
followed the trend during inspiratory flow due to high deposition that occurred during 
this phase  [222]. However, the differences in the deposition fraction magnitude in each 
lobe diminished as the carrier gas density increased, and the differences became 
insignificant for gases with densities higher than the density of air. The ventilatory circuit 
is a key factor for reducing the aerosol-drug, and allows only a small portion of the drug 
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to reach the lung  [41]. It is therefore essential to reduce the deposition in the circuit to 
maximize the drug delivery to the lung.  
For deeper insight on the role of the carrier gas on the aerosol particles deposited 
in the ventilator circuit, the local particle deposition and pattern of the deposition on the 
ETT are presented in Fig. 7.9. Employing carrier gases with low gas density was 
observed to drastically change the deposition rate in the circuit (see Fig. 7.9). The 
deposition was highly concentrated around the ETT in the case of high gas density (i.e., 
air and SF6-O2).  
 
Figure 7.9 Comparison of the deposition pattern at the endotracheal tube wall for 
different carrier gases. 
 
The local deposition factor DFL in the ETT was drastically reduced by ~79% and ~83% 
in the case of using He-gas compared to air and SF6-O2, respectively. Likewise, DFL was 
reduced by ~65% and ~72% when using Heliox rather than air and SF6-O2, respectively. 
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Table 7.5 compares the decreased deposition fraction in the ventilator circuit 
between the current study and existing experimental studies when using Heliox instead of 
air. A mean reduction of 38% of the deposition at the ETT was observed by Katz et 
al  [120] in their clinical measurement of using Heliox as a carrier gas. Similarly, Goode 
et al [231]  achieved 50% reduction of the lost particles in the ventilator circuit. The 
difference between the current predictions (65%) to their measurement arises from a 
couple of factors. First, the reported local deposition in the present CFD study was only 
for a part of ETT. Second, their studies were conducted under conventional mechanical 
ventilation, i.e., lower flow rate and longer respiratory cycle time.  
 
Table 7.5 Comparison between current prediction and experimental studies of the 
decreased deposition fraction in the ventilator circuit due to the use of Heliox 
as a carrier gas 
Study Approach 
Flow rate 
(L/min) 
Ventilation 
mode 
Decreased DF* 
 
Katz et al [120]
 In vivo
 
18  CMV 38%
+ 
 
Goode et al  [231] 
In vitro  40  CMV 50% 
 
Present study 
 
CFD 94  HFOV 65% 
+
It is a mean value for different cases.  
 
*
Decreased DF is calculated as  100

air
Helioxair
DF
DFDF
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 7.3.4.3. Deposition Pattern  
The pattern of the deposition, which illustrates the most localized and 
concentrated deposition sites, is displayed in Fig. 7.10 for the cases of He, He-O2, air, and 
SF6-O2. The reduction of the localized deposition when using a low-density carrier gas 
was evident. The relaxation time of the particles, the turbulence intensity, and the airways 
resistance decreased as the density decreased, which reduced the role of the deposition 
mechanisms, i.e., impactions and particle diffusion. Consequently, more particles escaped 
the domain and had a greater chance to deposit in the lower region of the lung. This can 
be seen by comparing the pattern of the deposition in the case of low-density gas (He and 
Heliox) to high-density gas (air and SF6-O2) in Fig. 7.10. The particles were more 
concentrated at the main bronchi covering the inner walls in all cases, however, as the gas 
density increases, the concentration increases. When using He or Heliox, mostly large 
particles deposited in the tracheobronchial domain; in contrast, the dense gases led to a 
deposition of a wide range of particle sizes. In general, the deposition on the usual sites 
was reduced by utilizing a carrier gas with low density. This can be observed by 
comparing the deposition in the encircled region of the domain (1-4) in Fig. 7.10 in all 
cases. Furthermore, the deposition on the sharp transition region (constrictions) are 
compared in the enlarged plot (see insets in Fig. 7.10).  
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Figure 7.10 Deposition pattern at the tracheobronchial tree as a function of the particle 
diameter for different carrier gases. 
Clearly, lower localized deposition occurred when using He and He-O2 compared to air 
and SF6-O2, where highly concentrated deposition was observed. This affirms the 
importance of the role of the carrier gas on aerosol-drug delivery and the requirement for 
lower density gas to deliver more drug to deeper regions of the lung under rapid 
ventilation cycles.     
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7.3.5. Enhancement of HFOV Therapy  
The carrier gas properties were found to have significant impact on the gas 
transport and drug delivery under HFOV conditions. Several past studies recognized an 
enhancement of drug delivery using a helium-oxygen mixture, yet the majority of these 
studies have been conducted under normal breathing conditions in an extrathoracic 
model  [220, 232]. In our previous study of drug delivery under HFOV parameters, it was 
found that the strong dependency of the global and regional deposition rate on the 
operating frequency could be used for targeted drug delivery [222]. For further insight on 
the role of coupled ventilator frequency and carrier gas on particle deposition, a 
simulation of HFOV frequency of 6 Hz was carried out using helium gas. The deposition 
was found to be significantly affected with reductions of ~35% and ~ 56% observed in 
the global deposition in the tracheobronchial tree for the cases of He and air when 
compared to the case of 10 Hz frequency. This implies that more particles penetrated 
deeper into the pulmonary tract and increased the chance of higher deposition in the 
lower generations. Consequently, systemic drug delivery could be enhanced under 
coupled low-density gas and low operating frequency. Furthermore, during the 
inspiration phase the local deposition on the considered portion of the ETT was 
drastically reduced by decreasing ventilator frequency to 6 Hz. A ~13-fold reduction of 
the deposition in ETT occurred indicating that higher amounts of the aerosol-drug could 
pass the ventilator circuit and be delivered to the lung. This is because decreasing 
frequency reduces the flow rate, which, along with low density, tend to stabilize the flow 
field. As reported in section 3.3.2, a reduction of 18% in the TKE effectively decreased 
the airways’ resistance, which reduced the deposition in the ETT and upper 
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tracheobronchial tree. The effectiveness of reducing the TKE on decreasing particle 
deposition on the extrathoracic region has been observed by Ari et al [221] even with 
very low difference in TKE between cases of using Heliox and air (i.e., 5%). The 
improvement of the gas exchange under HFOV management employing low-density gas 
was observed by different studies in animal models  [223, 224]. However, the effect of 
utilizing different carrier gases on the flow mechanisms cannot be quantified during in 
vivo studies. In contrast, the current CFD study successfully quantified the effect of 
carrier gas on the pendelluft flow in different lung regions. Great enhancement of the 
pendelluft flow occurred by reducing (increasing) carrier gas density (kinematic 
viscosity) and indicated improvement of the regional ventilation and gas mixing during 
HFOV. The reduction of the airways’ resistance by employing low-density carrier gas not 
only improves drug delivery, it is most likely to reduce the risk of hyperinflation of the 
lung  [229].   
 
7.4. Conclusion 
The effects of carrier gas properties on HFOV therapy outcomes were studied. A 
large eddy simulation model was used to simulate the continuous phase while user-
defined Fortran subroutines were used to implement a Lagrangian approach model for the 
dispersed phase. A physiological pressure boundary was employed using resistance and 
compliance of the airways. Gases with a wide range of densities and kinematic viscosities 
were used and compared to the use of air. The main conclusions can be summarized as 
the follows:  
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1. The carrier gas density was found to play a major role on the flow structures 
under HFOV conditions. A reduction (increase) of 7-fold in the gas density 
(kinematic viscosity) reduced the turbulence kinetic energy by 18%, which 
significantly decreased the tracheobronchial tree resistance by 65%. The 
significant reduction of the airways resistance could effectively reduce the risk 
of lung hyperinflation. 
2. The pendelluft flow was significantly enhanced by reducing the carrier gas 
density. An increase of 15-fold of the pendelluft flow in some lung regions 
was observed, indicating improvement of the gas exchange under HFOV 
when employing low-density gas.     
3. Use of low-density helium, which has the lowest gas density, significantly 
reduced deposition in the "hot-spots" and constriction sites in the upper 
tracheobronchial, and resulted in a ~32% reduction of the global deposition 
factor, indicating that the more Helium concentration in the Heliox, the 
greater benefit of the gas mixture.  
4. Heliox can be effectively used to enhance lung periphery aerosol-drug 
delivery under HFOV therapy, whereas carrier gases with higher density can 
be used to enhance lobar- to-segmental airways treatment.   
5. Significant reduction of aerosol-drug deposited in the ETT was achieved by 
using a low-density carrier gas; this implies that Heliox could improve drug 
delivery to the lung during HFOV. 
6. Coupling low-frequency ventilation with a Heliox carrier gas resulted in 
further decreasing the deposition throughout the ETT and upper 
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tracheobronchial tree, and indicated further enhancement of lung periphery 
delivery.   
  
198 
 
CHAPTER 8 
CONCLUSIONS AND FUTURE 
WORKS 
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8.1. CONCLUSIONS 
The gas transport and drug delivery by high frequency oscillatory ventilation were 
computationally investigated and validated against available measurements in the 
literature. The lung model was reconstructed from CT- scans data set for a mechanically 
ventilated patient. Large eddy simulation along with WALE subgrid scale model were 
implemented to model the airflow inside the lung model. Lagrangian approach was used 
to model the solid particle transport.  The main results can be summarized as follows: 
 
(i) Flow Transport and Gas Mixing during Invasive High Frequency 
Oscillatory Ventilation 
Gas transport and mixing in HFOV for three different waveform shapes and 
frequencies. The primary focus was to understand how different flow mechanisms were 
altered as a result of changes to waveform and frequencies. It is concluded from the study 
that: 
1- The coaxial counter flow existed near flow reversal for all three waveforms with 
different features. The non-sinusoidal waveforms exhibited a uniform coaxial 
counter flow compared to the sinusoidal case at End-Inspiration/Early Expiration 
phase.  
2- Pendelluft flow was present for the sinusoidal waveform at all frequencies but 
occurred only at early inspiration for the square waveform at highest frequency, 
whereas this was absent in the case of using exponential waveform. 
3- A square waveform shape resulted in higher secondary flow strength (SFS>0.6) 
and higher turbulence intensity, which could lead to more efficient mixing.  
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4- A reduction of ~87% in the wall shear stress occurred during inspiration phase 
when the intubation was absent. The turbulence kinetic energy in the case of using 
ETT was found to be 20 times greater than when the ETT was absent. 
5- The square waveform resulted in the least wall shear stress on the lung epithelium 
layer and may be used in patients without the risk of barotrauma to both airways 
and the alveoli.  
 
(ii) The Role of Coupled Resistance-Compliance in Upper Tracheobronchial 
Airways under High Frequency Oscillatory Ventilation  
 
The gas transport under HFOV conditions with physiologically relevant outlet 
BCs was studied. A time-dependent pressure was employed as a function of the 
instantaneous flow rate and coupled airways resistance-compliance. A significant change 
in the regional flow distribution was observed when using coupled R&C BCs for healthy 
and diseased lungs. In addition, the pressure drop throughout the lung domain 
demonstrated a significant deviation from the case of MF BCs due to the ability of the 
applied physiological resistance-compliance BCs to account for the geometry features of 
the model. Unlike traditional BCs, the coupled R&C BCs successfully captured 
pendelluft flow in all of the lungs’ major lobes and terminal units, which enables accurate 
HFOV modeling. Varying compliance between the right and left lungs demonstrated a 
significant effect on the flow distribution, and it was more pronounced for the highest 
HFOV frequency. Increasing the CR locally between lung units induced maximum 
pendelluft flow with a five-fold increase in some units. The coaxial counter flow and 
flow structures were significantly influenced by the modified BCs. The pendelluft flow 
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significantly induced a WSS surrounding carina due to gas exchange between the units’ 
branches. The pendelluft intensity in different regions may be used as an important 
indication of the respiratory diseases and the severity of lung pathway diseases. The 
intensity of the pendelluft flow associated with the ventilator setting (e.g., frequency, 
tidal volume, and waveform shape) could help in improving treatment protocols for 
patients undergoing HFOV treatment. 
 
 
 
(iii) Aerosolized Drug Delivery in Specific-Patient Lung Model during 
Invasive High Frequency Oscillatory Ventilation 
The aerosol-drug delivery under high frequency oscillatory ventilation was 
carried out under various ventilator settings and lung conditions. The Lagrangian tracking 
method was implemented to model the dispersed phase. User-enhanced FORTRAN 
subroutines were compiled with the solver to implement the Lagrangian model. A 
physiological time-dependent pressure boundary condition was employed as a function of 
the coupled airways resistance-compliance and compared to the traditional boundary 
condition. The main observations can be summarized as the follows: 
 The particle deposition during the inspiration phase was five-fold greater than 
expiration phase, and the asymmetric lung compliance was found to significantly affect 
the deposition, especially during expiration phase. Furthermore, the deposition fraction 
was strongly influenced by the release time of the particles’ injection.  
 The existence of the pendelluft flow and airflow redistribution due to resistance-
compliance BCs application demonstrated a significant influence on the local deposition 
magnitude and pattern compared to the traditional mass fraction BCs. 
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 The ETT-jet was observed to have a major impact in enhancing the inertial 
impaction, resulting in highly localized deposition at the main bronchi and the few 
subsequent generations. The lower lung lobes significantly received more aerosol-drug 
compared to the upper lobes, which was consistent with existing results in the literature 
for normal breathing.  
 The asymmetric compliance ratio between adjacent regional units was found to 
enhance the regional deposition as a consequence of the flow redistribution and effect of 
the pendelluft flow.    
 A 2.5-fold increase of the operating frequency resulted in a 2.1-fold increase in 
the global deposition fraction in the upper tracheobronchial tree. Meanwhile, a 2.5-fold 
reduction in the frequency resulted in 3.88-fold reduction of the local deposition at the 
main bronchi allowing more particles to penetrate deeply in the lung and reduce the drug 
side effect risk associated with sites of high deposition concentrations. This indicates that 
the operating frequency has strongly influence the global and local particle deposition 
fractions and the deposition magnitude could be controlled by changing the frequency, 
which could be beneficial for targeted drug delivery.  
 Considering the particle deposition relative to the injected particle at the ETT 
inlet, aerosol drug delivery during HFOV could be equivalent to and as efficient as 
normal breathing and conventional mechanical ventilation, despite rapid ventilation 
cycles.   
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(iv) Effect of Carrier Gases on Transport And Aerosol Drug Delivery By 
Invasive High Frequency Oscillatory Ventilation  
The effects of carrier gas properties on HFOV therapy outcomes were studied. A 
large eddy simulation model was used to simulate the continuous phase while user-
defined Fortran subroutines were used to implement a Lagrangian approach model for the 
dispersed phase. A physiological pressure boundary was employed using resistance and 
compliance of the airways. Gases with a wide range of densities and kinematic viscosities 
were used and compared to the use of air. The main conclusions can be summarized as 
the follows:  
1. The carrier gas density was found to play a major role on the flow structures 
under HFOV conditions. A reduction (increase) of 7-fold in the gas density 
(kinematic viscosity) reduced the turbulence kinetic energy by 18%, which 
significantly decreased the tracheobronchial tree resistance by 65%. The 
significant reduction of the airways resistance could effectively reduce the risk 
of lung hyperinflation. 
2. The pendelluft flow was significantly enhanced by reducing the carrier gas 
density. An increase of 15-fold of the pendelluft flow in some lung regions 
was observed, indicating improvement of the gas exchange under HFOV 
when employing low-density gas.     
3. Use of low-density helium, which has the lowest gas density, significantly 
reduced deposition in the "hot-spots" and constriction sites in the upper 
tracheobronchial, and resulted in a ~32% reduction of the global deposition 
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factor, indicating that the more Helium concentration in the Heliox, the 
greater benefit of the gas mixture.  
4. Heliox can be effectively used to enhance lung periphery aerosol-drug 
delivery under HFOV therapy, whereas carrier gases with higher density can 
be used to enhance lobar- to-segmental airways treatment.   
5. Significant reduction of aerosol-drug deposited in the ETT was achieved by 
using a low-density carrier gas; this implies that Heliox could improve drug 
delivery to the lung during HFOV. 
6. Coupling low-frequency ventilation with a Heliox carrier gas resulted in 
further decreasing the deposition throughout the ETT and upper 
tracheobronchial tree, and indicated further enhancement of lung periphery 
delivery.   
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8.2. FUTURE WORKS 
Several related topics are suggested for the future work: 
1. The lung airways (up to 15 generations) are lined with thin liquid layers 
consisting of a Newtonian fluid layer attached to the airways wall (watery serous 
layer) and a non- Newtonian fluid layer (MUCUS) between the serous layer and 
the gas  [70]. The mucus layer drastically increases due to the exacerbation of the 
mucus secretion in diseased lung and could lead to airflow obstructions [233]. It is 
considered as a Bingham fluid [234]. Strong interaction between the mucus layer 
and the gas transport during the breathing cycle is expected. A wavy motion exists 
at interface between the high viscous layer and the gas flow  [235]. It is then 
expected to have a crucial role on the gas transport and the drug delivery [236]. 
Therefore, modeling mucus layer with different thickness could reveal important 
results that help in advancing our understanding of HFOV therapy.     
2. The use of coupled resistance-compliance BCs has successfully captured the 
pendelluft flow between the lung units. The pendelluft characteristics in terms of 
pendelluft time and volume percent demonstrated strong dependences on the 
geometry features. Moreover, R&C BCs properly predicted the flow ratio 
between lung major lobes. These two results can be used to develop an 
appropriate diagnostic tool for lung pathway diseases in two steps. First, conduct 
in vivo study for sample group of patients with different diseases, using gamma 
scintigraphy imaging technique before and after recovering, where the flow ratio 
can be obtained. Second, obtain CT- scan sets and reconstruct lung models for the 
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same patients; and then preform a systemic study to characterize the pendelluft 
intensity in all obtained models.  
3. The use of mechanical ventilation is often associated with humidifier [236]. Thus, 
the particles are affected by the gas and lung status (e.g. temperatures & 
humidity). The temperature and concentration differences between the gas and the 
particles cause a heat and mass transfer [236, 237]. It is then essential to model 
particle transport with evaporation/condensation process, which affects the 
particle size.   
4. Most of the aerosolized drug is lost in the ventilator circuit components (e.g. 
spacer chamber, the ventilator circuit and the endotracheal tube [37, 41]) and only 
a small fraction of the drug successfully reaches the lung. Longest et al  [209, 
238] have observed the ventilator components of conventional mechanical 
ventilator. They redesigned T-connectors, Y-connector and ETT. Furthermore, 
they studied the components of both invasive and non-invasive ventilator. 
Significant enhancement of the drug delivery was achieved through the modified 
circuits. Similar approach could be used to minimize the lost particles in the 
ventilator circuit of the HFOV ventilator machine. In addition, the aerosol 
nebulizer devices should also be tested for efficient drug delivery.   
5. The invasive ventilation entails many complications due to the intubation, which 
could lead to serious injury or damage of the patient lung. Segmentation of the 
extrathoracic passages could be used to investigate gas and particle transport 
under non-invasive HFOV with different nasal, oral and facial devices. The 
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results will be compared to the invasive ventilation, which could result in a better 
ventilation strategy.  
6. The airways are compliant structures. Considering fluid-structure interactions 
could reveal important effects in the lung ventilation and the particle trajectory. 
Starting with simple bifurcation and then increasing the geometry complexity may 
result in more accurate modeling.     
7. Experimental work: Develop a 3D realistic multi-generation lung model including 
the larynx, and fabricate a physical model with a material that satisfies the 
experimental and optical conditions. Design experiment components to allow for 
advanced diagnostics and to allow investigation of a wide range of lung 
ventilation strategies (i.e. normal breathing, conventional mechanical ventilation 
(CMV), and high frequency ventilation (HFOV)). The physical model can be 
made with separate regions and connected with appropriate methods such that it 
allows for local particle deposition measurements. Furthermore, to include the 
effect of resistance and compliance, rubber tubes with different lengths and 
material properties can be connected to the model outlets.    
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Table A.1 and A.2 present detailed descriptions of the model outlets’ dimensions, 
generation, and the anatomical parts the outlet belongs to. The outlet numbers provided in 
Table A.1 and A.2 correspond to the labels shown in Figure 2.17 in chapter 2. The 
generation in the table represents the location of the outlet inside the tracheobronchial 
tree, with a higher generation number indicating a deeper site. The diameter of the airway 
is based on the hydraulic diameter defined as:  
WP
A
Dh
4
                                               (A.1) 
Where A is the cross-sectional area and WP is the wetted perimeter of a plane cut 
perpendicular to the centerline of the airway.   
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Table A.1 Detailed description of the model outlets in left lung. 
Anatomical part Outlet No. Generation Diameter (mm) 
Trachea - G0 14.82 
LUL: Anterior 
 
1 G5 2.01 
2 G5 2.3 
3 G5 2.2 
4 G5 2.98 
LUL: Posterior 
 
5 G6 2.65 
6 G6 1.96 
7 G6 1.52 
8 G6 2.74 
LUL: Lingula-Superior 
9 G4 1.68 
10 G4 2.05 
LUL: Lingula-Inferior 
11 G4 2.42 
12 G4 2.27 
LLL: Superior 
13 G4 1.27 
14 G4 1.16 
15 G4 2.34 
LLL: Posterior basal 
16 G6 2.85 
17 G6 2.37 
18 G6 2.28 
19 G6 3.2 
LLL: Anterior Basal 
20 G7 2.36 
21 G7 2.07 
22 G7 2.35 
23 G7 2.35 
24 G7 1.59 
25 G7 1.61 
LLL: Lateral basal 
26 G6 2.56 
27 G6 2.5 
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Table A.2 Detailed description of the model outlets in right lung. 
Anatomical part Outlet No. Generation Diameter (mm) 
RUL: anterior 
 
28 G5 2.35 
29 G5 1.44 
RUL: Posterior 
 
30 G6 3.88 
31 G6 3.02 
32 G5 4.7 
RUL: Apical 
 
33 G5 2.59 
34 G5 5.01 
35 G4 3.77 
36 G5 2.02 
37 G5 2.72 
RML: Lateral 38 G4 1.75 
RML: Medial 
 
39 G5 0.97 
40 G5 1.86 
RLL: Meddle basal 
 
41 G6 3.09 
42 G7 2.72 
43 G7 2.75 
44 G6 3 
45 G6 1.78 
RLL: Posterior basal 
46 G6 3.92 
47 G7 2.89 
48 G7 3.25 
RLL: Anterior basal 
 
49 G6 2.79 
50 G6 1.85 
51 G6 3.01 
RLL: Superior 
 
52 G6 3.12 
53 G6 1.81 
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APPENDIX B 
 SINGLE IDEALIZED GEOMETRY 
CREATION 
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Figure B.1 Cross-sections of the single bifurcation in different directions [88]. Adopted 
with permission from ASME publishing. 
 
The single bifurcation used for the validation purpose in current dissertation was created 
following the method by Zhao and Lieber  [88]. The equations that define all points, lines 
and curves in the above illustration are as follows: 
Point A )0,cos)5.0(,sin)5.0((  dRdRL   
(B.1) 
Point B )0,tan2/,2/( LL  
Point C )0,0,(L  
Point G )0,0,2/(L  
Line ME Dxbxay 5.081
2
1   (B.2) 
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 21 )sin(6
4tan)sin(cos8


dL
DdLd
a


  (B.3) 
 81 )sin(6
4cos2tan)sin(


dL
DddL
b


  (B.4) 
Line EF 
22 }sin)5.0(()5.0{(cos)5.0(  dRLxdRDRy   (B.5) 
Line GK 
)5.0( Lxay   (B.6) 
 

)sin5.05.0(
cos5.0
dL
d
a

  (B.7) 
 



cos
)sin(tan
d
dL 
  (B.8) 
Line KJ 
2/122 })sin)5.0(({cos)5.0(  dRLxRDRy   (B.9) 
Line CH 
2/122 })sin)5.0(()5.0{(cos)5.0(  dRLxdRDRy 
 
(B.10) 
Line PN D
dL
xDd
Z 5.0
sin5.0
)(5.0





 (B.11) 
 Note: Point P and K share same x coordinate.   
The flow divider is described as follows:   
 
2/)tan/tan1( x  
0y  
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2
2
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 
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 2
sintan2


 
L
 (B.15) 
The variables 
1 and 2 are found be solving the following equations:  
DLbLaL 5.0)sin2/()sin2/(costan2/ 811
2
111    (B.16) 
 )sin(costan2/ 22 aL   (B.17) 
cmD 81.3  
DL 5.2  
o702   
o18  
1/2 22 Dd  
dR 7  
 
 
The MATLAB code used to solve the described equations:  
Function []=geometry() 
al=35; 
be=18; 
D=3.81; 
d=D/sqrt(2); 
L=2.5*D; 
R=7*d; 
a1=(8*d*cosd(be)-(L-d*sind(be))*tand(be)-4*D)/(6*(L-d*sind(be))^2); 
b1=((L-d*sind(be))*tand(be)-2*d*cosd(be)+D)/(6*(L-d*sind(be))^8); 
la=tand(be)*(L-d*sind(be))/(d*cosd(be)); 
a=0.5*d*cosd(be)/(0.5*L-0.5*d*sind(be))^la; 
Ax=L-(R+0.5*d)*sind(be); 
Mx=0; 
Nx=0; 
Cx=L; 
Gx=L/2; 
Ex=Cx-d*sind(be); 
Kx=Cx-d/2*sind(be); 
Px=Kx; 
Jx=Kx+2*R*sind(0.5*(al-be))*cosd(be+0.5*(al-be)); 
Fx=Jx-0.5*d*sind(al); 
Hx=Jx+0.5*d*sind(al); 
dx=0.01; 
dt=0.1; 
%line ME 
xme=(Mx:dx:Ex)'; 
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yme=a1*xme.^2+b1*xme.^8+0.5*D; 
zme=zeros(size(xme)); 
%line EF 
xef=(Ex:dx:Fx)'; 
yef=(R+0.5*d)*cosd(be)-((R-0.5*d)^2-(xef-L+(R+0.5*d)*sind(be)).^2).^(1/2); 
zef=zeros(size(xef)); 
%line GK 
xgk=(Gx:dx:Kx)'; 
ygk=a*(xgk-0.5*L).^la; 
zgk=zeros(size(xgk)); 
%line KJ 
xkj=(Kx:dx:Jx)'; 
ykj=(R+0.5*d)*cosd(be)-(R^2-(xkj-L+(R+0.5*d)*sind(be)).^2).^(1/2); 
zkj=zeros(size(xkj)); 
%line CH 
xch=(Cx:dx:Hx)'; 
ych=(R+0.5*d)*cosd(be)-((R+0.5*d)^2-(xch-L+(R+0.5*d)*sind(be)).^2).^(1/2); 
zch=zeros(size(xch)); 
%line NP 
xng=(Nx:dx:Gx)'; 
xnp=[xng;xgk]; 
ynp=[zeros(size(xng));ygk]; 
znp=0.5*(d-D)*xnp/(L-0.5*d*sind(be))+0.5*D; 
plot3(xme,yme,zme,'.','Color',[rand(1) rand(1) rand(1)]); 
hold on 
plot3(xef,yef,zef,'.','Color',[rand(1) rand(1) rand(1)]); 
plot3(xgk,ygk,zgk,'.','Color',[rand(1) rand(1) rand(1)]); 
plot3(xkj,ykj,zkj,'.','Color',[rand(1) rand(1) rand(1)]); 
plot3(xch,ych,zch,'.','Color',[rand(1) rand(1) rand(1)]); 
plot3(xnp,ynp,znp,'.','Color',[rand(1) rand(1) rand(1)]); 
xlim([-15,15]); 
ylim([-15,15]); 
zlim([-15,15]); 
plot3(xme,-yme,zme,'.','Color',[rand(1) rand(1) rand(1)]); 
plot3(xef,-yef,zef,'.','Color',[rand(1) rand(1) rand(1)]); 
plot3(xgk,-ygk,zgk,'.','Color',[rand(1) rand(1) rand(1)]); 
plot3(xkj,-ykj,zkj,'.','Color',[rand(1) rand(1) rand(1)]); 
plot3(xch,-ych,zch,'.','Color',[rand(1) rand(1) rand(1)]); 
plot3(xnp,ynp,-znp,'.','Color',[rand(1) rand(1) rand(1)]); 
plot3(xnp,-ynp,-znp,'.','Color',[rand(1) rand(1) rand(1)]); 
plot3(xnp,-ynp,znp,'.','Color',[rand(1) rand(1) rand(1)]); 
hold off 
figure; 
plot(xme,yme,'.','Color',[rand(1) rand(1) rand(1)]); 
hold on 
plot(xef,yef,'.','Color',[rand(1) rand(1) rand(1)]); 
plot(xgk,ygk,'.','Color',[rand(1) rand(1) rand(1)]); 
plot(xkj,ykj,'.','Color',[rand(1) rand(1) rand(1)]); 
plot(xch,ych,'.','Color',[rand(1) rand(1) rand(1)]); 
xlim([0,15]); 
ylim([0,15]); 
hold off 
xmef=[xme;xef]; 
ymef=[yme;yef]; 
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zmef=[zme;zef]; 
file=fopen('curveMEF.txt','wt'); 
for i=1:length(xmef) 
    fprintf(file,'%1.8f %1.8f %1.8f\n',xmef(i),ymef(i),zmef(i)); 
end 
fclose(file); 
xgkj=[xgk;xkj]; 
ygkj=[ygk;ykj]; 
zgkj=[zgk;zkj]; 
file=fopen('curveGKJ.txt','wt'); 
for i=1:length(xgkj) 
    fprintf(file,'%1.8f %1.8f %1.8f\n',xgkj(i),ygkj(i),zgkj(i)); 
end 
fclose(file); 
file=fopen('curveCH.txt','wt'); 
for i=1:length(xch) 
    fprintf(file,'%1.8f %1.8f %1.8f\n',xch(i),ych(i),zch(i)); 
end 
fclose(file); 
xnpkj=[xnp;xkj]; 
ynpkj=[ynp;ykj]; 
znpkj=[znp;zkj+d/2]; 
file=fopen('curveNPKJ1.txt','wt'); 
for i=1:length(xnpkj) 
    fprintf(file,'%1.8f %1.8f %1.8f\n',xnpkj(i),ynpkj(i),znpkj(i)); 
end 
fclose(file); 
xnpkj=[xnp;xkj]; 
ynpkj=[-ynp;-ykj]; 
znpkj=[znp;zkj+d/2]; 
file=fopen('curveNPKJ2.txt','wt'); 
for i=1:length(xnpkj) 
    fprintf(file,'%1.8f %1.8f %1.8f\n',xnpkj(i),ynpkj(i),znpkj(i)); 
end 
fclose(file); 
xnpkj=[xnp;xkj]; 
ynpkj=[ynp;ykj]; 
znpkj=[-znp;-(zkj+d/2)]; 
file=fopen('curveNPKJ3.txt','wt'); 
for i=1:length(xnpkj) 
    fprintf(file,'%1.8f %1.8f %1.8f\n',xnpkj(i),ynpkj(i),znpkj(i)); 
end 
fclose(file); 
xnpkj=[xnp;xkj]; 
ynpkj=[-ynp;-ykj]; 
znpkj=[-znp;-(zkj+d/2)]; 
file=fopen('curveNPKJ4.txt','wt'); 
for i=1:length(xnpkj) 
    fprintf(file,'%1.8f %1.8f %1.8f\n',xnpkj(i),ynpkj(i),znpkj(i)); 
end 
fclose(file); 
function []=pr(xl,dx,th,yl,wh) 
al=35; 
be=18; 
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D=3.81; 
d=D/sqrt(2); 
L=2.5*D; 
R=7*d; 
a1=(8*d*cosd(be)-(L-d*sind(be))*tand(be)-4*D)/(6*(L-d*sind(be))^2); 
b1=((L-d*sind(be))*tand(be)-2*d*cosd(be)+D)/(6*(L-d*sind(be))^8); 
la=tand(be)*(L-d*sind(be))/(d*cosd(be)); 
a=0.5*d*cosd(be)/(0.5*L-0.5*d*sind(be))^la; 
ps1=(xl(1):dx:xl(2))'; 
ps2=(xl(1):dx:xl(2))'; 
y=L/2*tand(be)-ps1.*cosd(th)-a1.*(L/2+ps1.*sind(th)).^2-b1.*(L/2+ps1.*sind(th)).^8-0.5*D; 
%w=- cosd(th) - 2*a1*sind(th)*(L/2 + ps1*sind(th)) - 8*b1*sind(th)*(L/2 + ps1*sind(th)).^7; 
z=L/2*tand(be)-ps2.*cosd(th)-a.*(ps2.*sind(th)).^(la); 
w=- cosd(th) - a*la*sind(th)*(ps2*sind(th)).^(la - 1); 
if(wh==0) 
    plot(ps1,z); 
elseif(wh==1) 
    plot(ps1,w); 
elseif(wh==2) 
    plot(ps1,z,ps1,w); 
end 
if(yl) 
    ylim([-.1,.1]); 
end 
function [y]=ps1eq(th,ps1) 
be=18; 
D=3.81; 
d=D/sqrt(2); 
L=2.5*D; 
a1=(8*d*cosd(be)-(L-d*sind(be))*tand(be)-4*D)/(6*(L-d*sind(be))^2); 
b1=((L-d*sind(be))*tand(be)-2*d*cosd(be)+D)/(6*(L-d*sind(be))^8); 
y=L/2*tand(be)-ps1.*cosd(th)-a1.*(L/2+ps1.*sind(th)).^2-b1.*(L/2+ps1.*sind(th)).^8-0.5*D; 
function [y]=ps2eq(th,ps2) 
be=18; 
D=3.81; 
d=D/sqrt(2); 
L=2.5*D; 
la=tand(be)*(L-d*sind(be))/(d*cosd(be)); 
a=0.5*d*cosd(be)/(0.5*L-0.5*d*sind(be))^la; 
y=L/2*tand(be)-ps2.*cosd(th)-a.*(ps2.*sind(th)).^(la); 
 
The FORTRAN subroutine code used to impose Womersley velocity 
profile at the single bifurcation model inlet:  
       
SUBROUTINE WOMTEST (  
     &  NLOC, NRET, NARG, RET, ARGS, CRESLT, CZ,DZ,IZ,LZ,RZ ) 
      IMPLICIT NONE 
CD User routine: template for user CEL function 
CC -------------------- 
CC        Input 
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CC -------------------- 
CC  NLOC   - size of current locale 
CC  NRET   - number of components in result 
CC  NARG   - number of arguments in call 
CC  ARGS() - (NLOC,NARG) argument values 
CC -------------------- 
CC      Modified 
CC -------------------- 
CC  Stacks possibly. 
CC -------------------- 
CC        Output 
CC -------------------- 
CC  RET()  - (NLOC,NRET) return values 
CC  CRESLT - 'GOOD' for success 
CC -------------------- 
CC       Details 
CC -------------------- 
C ------------------------------ 
C     Preprocessor includes 
C ------------------------------ 
C        Global Parameters 
C ------------------------------ 
C ------------------------------ 
C        Argument list 
C ------------------------------ 
      INTEGER NLOC,NARG,NRET 
      CHARACTER CRESLT*(*) 
      REAL ARGS(NLOC,NARG), RET(NLOC,NRET) 
      INTEGER IZ(*) 
      CHARACTER CZ(*)*(1) 
      DOUBLE PRECISION DZ(*) 
      LOGICAL LZ(*) 
      REAL RZ(*) 
C ------------------------------ 
C        External routines 
C ------------------------------ 
C ------------------------------ 
C        Local Parameters 
C ------------------------------ 
      COMPLEX I 
      PARAMETER(I=(0,1)) 
C ------------------------------ 
C        Local Variables 
C ------------------------------ 
      INTEGER ILOC 
      REAL AL(1:NLOC,1), R(1:NLOC,1), T(1:NLOC,1), 
     &  A(1:NLOC,1), W(1:NLOC,1), P(1:NLOC,1) 
      COMPLEX B, C 
C --------------------------- 
C    Executable Statements 
C --------------------------- 
      R(1:NLOC,1) = ARGS(1:NLOC,1) 
      T(1:NLOC,1) = ARGS(1:NLOC,2) 
      A(1:NLOC,1) = ARGS(1:NLOC,3) 
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      W(1:NLOC,1) = ARGS(1:NLOC,4) 
      P(1:NLOC,1) = ARGS(1:NLOC,5) 
      AL(1:NLOC,1) = ARGS(1:NLOC,6) 
C Initialise RET(1:NLOC*NRET) to zero. 
      DO ILOC = 1, NLOC 
        CALL CBESSJ(COMPLEX(AL(ILOC,1)* 
     &    R(ILOC,1)/0.0381,0.)*(I**(3./2.)),0,B) 
        CALL CBESSJ(COMPLEX(AL(ILOC,1),0.)*(I**(3./2.)),0,C) 
        B=(COMPLEX(A(ILOC,1)/(P(ILOC,1)*W(ILOC,1)),0.)/I) 
     &   *(COMPLEX(1.0,0.)-B/C)*EXP(I*COMPLEX(W(ILOC,1) 
     &   *(T(ILOC,1)+18.6603434349),0.)) 
        RET(ILOC,1)=REAL(B) 
      ENDDO 
      WRITE(*,*)EXP(I*COMPLEX(W(1,1) 
     &   *(T(1,1)+18.6603434349),0.)) 
C 
C Set success flag. 
      CRESLT = 'GOOD' 
C 
C======================================================================= 
      END SUBROUTINE WOMTEST 
C 
        real*8 Function Fact(K) 
        integer i 
        real*8  f 
          F=1.d0 
          do i=2, k  
            f=f*dfloat(i) 
          end do 
          Fact=f 
        return 
        End Function Fact 
*           FUNCTION  GAMMA(X)            * 
* --------------------------------------- * 
* Returns the value of Gamma(x) in double * 
* precision as EXP(LN(GAMMA(X))) for X>0. * 
      real*8 Function Gamma(xx) 
      parameter(ONE=1.d0,FPF=5.5d0,HALF=0.5d0) 
        real*8 xx 
        real*8 cof(6) 
        real*8 stp,x,tmp,ser 
        integer j 
        cof(1)=76.18009173d0 
        cof(2)=-86.50532033d0 
        cof(3)=24.01409822d0 
        cof(4)=-1.231739516d0 
        cof(5)=0.120858003d-2 
        cof(6)=-0.536382d-5 
        stp=2.50662827465d0 
        x=xx-ONE 
        tmp=x+FPF 
        tmp=(x+HALF)*LOG(tmp)-tmp 
        ser=ONE 
        do j=1, 6 
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          x=x+ONE 
          ser=ser+cof(j)/x 
        end do 
        Gamma = EXP(tmp+LOG(stp*ser)) 
      return 
      End function gamma 
      Subroutine CBESSJ(z, nu, z1) 
C!--------------------------------------------------- 
C!                       inf.     (-z^2/4)^k 
C!   Jnu(z) = (z/2)^nu x Sum  ------------------ 
C!                       k=0  k! x Gamma(nu+k+1) 
C!  (nu must be >= 0). 
C!--------------------------------------------------- 
        Parameter(MAXK=20,ZERO=0.d0) 
        Complex z,z1 
        Integer k 
        Complex sum,tmp 
        Real*8 Fact, Gamma 
        sum = CMPLX(ZERO,ZERO) 
        do k=0, MAXK 
          !calculate (-z**2/4)**k 
      tmp = (-z*z/4.d0)**k 
          !divide by k! 
      tmp = tmp / Fact(k) 
          !divide by Gamma(nu+k+1) 
          tmp = tmp / Gamma(dfloat(nu+k+1)) 
          !actualize sum 
      sum = sum + tmp 
        end do 
        !calculate (z/2)**nu 
        tmp = (z/2)**nu 
        !multiply (z/2)**nu by sum 
        z1 = tmp*sum 
      return 
      End 
C!end of file wom.F 
  
237 
 
APPENDIX C 
MATLAB SCRIPT USED FOR 
VENTILATION WAVEFORMS 
CREATION 
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function [Vmax,Qmax,Qmin]=wave2(pvq,n,R,C,Tp,nmcycles,sc) 
%pvq-control type ('p','v',or 'q') 
%n-waveform function number 
%R-resistance (4.333333333) 
%C-compliance (0.126666667) 
%Tp-total breathing cycle time 
%nmcycles-number of cycles to produce 
%sc-scale factor (needs to be iteratively adjusted until desired tidal 
%     volume is reached) 
global TI 
global T 
global trans 
T=Tp; 
trans=0.005;%time to transition from inspiration to expiration  
TI=0.5*T-0.5*trans; 
T2=0.5*T; 
Ain=pi/4*(8*10^(-3))^2;%area of the inlet 
dt=0.0002; 
t1=(0:dt:TI);%inspiration time (or length of time to apply the specified control function) 
ttrans=(TI+dt:dt:T2); 
t2=(T2+dt:dt:T);%expiration time 
t=[t1,ttrans,t2]; 
disp([length(t1),length(ttrans),length(t2),length(t)]) 
tpart=(0.3+dt:dt:4*TI); 
P=zeros(size(t)); 
V=zeros(size(t)); 
Q=zeros(size(t)); 
 
if(pvq=='p')%pressure controlled 
    %P(1:length(t1))=PC(t1,sc,n);%set the pressure for inspiration 
    V(1:length(t1))=runkut(V(1),t1,@DE,R,C,@PC,sc,n);%find volume for inspiration by 
Runga-Kutta 
    Q(1:length(t1))=DE(t1,V(1:length(t1)),R,C,@PC,sc,n);%find flow rate for inspiration 
by differential equation 
    Q(length(t1)+1:length(t1)+length(ttrans))=Q(length(t1))*rsig(ttrans,TI);%smoothly 
transition the flowrate to zero 
    if(mod(length(t),2)) 
      extra=-1 
    end 
     %extra=0 
    Q(length(t1)+length(ttrans)+1:length(t))=-
fliplr(Q(1:length(t1)+length(ttrans)+extra));%set expiration flow as the inverse of 
inspiration flow 
    V(1)=0;%find volume by integration 
    for i=2:length(t) 
        V(i)=V(i-1)+(Q(i)+Q(i-1))*(t(i)-t(i-1))/2; 
    end 
    P=Q*R+V/C;%find pressure for cycle 
elseif(pvq=='v')%volume controlled 
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    V(1:length(t1))=VC(t1,sc,n);%set volume for inspiration (needs to be modified later to 
include sigmoid for flow) 
    for i=1:length(t1)-1%find flow by finite difference and apply sigmoid to it 
        Q(i)=((V(i+1)-V(i))/(t1(i+1)-t1(i)))*sig(t1(i)); 
    end 
    Q(length(t1))=(V(length(t1))-V(length(t1)-1))/(t1(end)-t1(end-1)); 
    Q(length(t1)+1:length(t1)+length(ttrans))=Q(length(t1))*rsig(ttrans,TI);%smoothly 
transition the flowrate to zero 
    if(mod(length(t),2)) 
      extra=-1 
    end 
    Q(length(t1)+length(ttrans)+1:length(t))=-
fliplr(Q(1:length(t1)+length(ttrans)+extra));%set expiration flow as the inverse of 
inspiration flow 
    V(1)=0;%find volume by integration 
    for i=2:length(t) 
        V(i)=V(i-1)+(Q(i)+Q(i-1))*(t(i)-t(i-1))/2; 
    end 
    P=Q*R+V/C;%find pressure for cycle 
elseif(pvq=='q')%flow controlled 
    Q(1:length(t1))=QC(t1,sc,n);%find flow rate for inspiration 
    Q(length(t1)+1:length(t1)+length(ttrans))=Q(length(t1))*rsig(ttrans,TI);%smoothly 
transition the flowrate to zero 
    if(mod(length(t),2)) 
      extra=-1 
    end 
    Q(length(t1)+length(ttrans)+1:length(t))=-
fliplr(Q(1:length(t1)+length(ttrans)+extra));%set expiration flow as the inverse of 
inspiration flow 
    V(1)=0;%find volume by integration 
    for i=2:length(t) 
        V(i)=V(i-1)+(Q(i)+Q(i-1))*(t(i)-t(i-1))/2; 
    end 
    P=Q*R+V/C;%find pressure for cycle 
else 
    error('invalid waveform control type'); 
end 
 
V=V*1000; 
Q=Q*60; 
 
Vmax=max(V); 
Qmax=max(Q); 
Qmin=min(Q); 
 
vfrr=153846153.846154; 
 
np=ceil(Q*0.000016666666667*vfrr*dt); 
Np=V*10^(-6)*vfrr*.5; 
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disp(sum(np(1:ceil(length(np)*1.042/4)))); 
disp(ceil(length(np)*1.042/4)); 
 
po='b'; 
subplot(3,1,1); 
plot(t,P,po); 
title('Pressure'); 
xlabel('time(s)'); 
ylabel('Pressure(cm H_2O)'); 
subplot(3,1,2); 
plot(t,V,po); 
title('Volume'); 
xlabel('time(s)'); 
ylabel('Volume(mL)'); 
subplot(3,1,3); 
plot(t,Q,po); 
title('Flow'); 
xlabel('time(s)'); 
ylabel('Flow(L/min)'); 
 
K=Q/60/1000/Ain; 
 
%figure; 
%plot(t,Np,'b.'); 
 
filename=strcat(pvq,num2str(n),'.csv'); 
file=fopen(filename,'wt'); 
fprintf(file,'[name]\ninlet\n\n[Spatial Fields]\nt\n\n[Data]\nt [s],Velocity [m s^-1]\n'); 
for j=1:nmcycles 
  for i=1:length(t) 
      fprintf(file,'%1.6E,%1.6E\n',t(i)+(j-1)*T,K(i)); 
  end 
end 
fclose(file); 
 
filename=strcat('N',pvq,num2str(n),'.csv'); 
file=fopen(filename,'wt'); 
fprintf(file,'[name]\nRealPartNum\n\n[Spatial Fields]\nt\n\n[Data]\nt [s],NPR []\n'); 
for i=1:length(t1) 
    fprintf(file,'%1.6E,%1.6E\n',t(i),Np(i)); 
end 
fclose(file); 
 
function [z]=PC(t,sc,n) 
global T 
 
if(n==1) 
    z=sc*ones(size(t)).*sig(t); 
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elseif(n==2) 
    z=sc*(1-exp(-4*t/.0335)); 
    elseif(n==3) 
    z=sc*sin(2/T*pi*t); 
end 
 
function [z]=VC(t,sc,n) 
global TI 
if(n==1) 
    z=sc*t; 
elseif(n==2) 
    z=sc*(1/2-1/2*cos(pi*t/TI)); 
end 
 
function [z]=QC(t,sc,n) 
global T 
if(n==1) 
    z=sc*(2*t); 
elseif(n==2) 
    z=sc*(2-2*t).*sig(t); 
elseif(n==3) 
    z=sc*sin(2/T*pi*t); 
end 
 
%sigmoid function (for a smooth start up) 
function [z]=sig(t) 
td=0.0025; 
z=(1/2-1/2*cos(t*pi/td)).*(1-heaviside(t-td))+1*heaviside(t-td); 
%sigmoid function (for a smooth transition to expiration) 
function [z]=rsig(t,s) 
global trans 
z=cos((t-s)*pi/trans); 
 
function [z]=Pout(t,p) 
global TI 
z=p*rsig(t,TI); 
 
%differential equation 
function [Vdot]=DE(t,V,R,C,Pr,varargin) 
Vdot=Pr(t,varargin {:})/R-V/(C*R); 
 
function [w]=runkut(y0,t,f,varargin {:}) 
w=zeros(size(t)); 
w(1)=y0; 
for i=1:length(w)-1 
    dt=(t(i+1)-t(i)); 
    k1=dt*f(t(i),w(i),varargin); 
    k2=dt*f(t(i)+dt/2,w(i)+k1/2,varargin{:}); 
    k3=dt*f(t(i)+dt/2,w(i)+k2/2,varargin{:}); 
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    k4=dt*f(t(i)+dt,w(i)+k3,varargin{:}); 
    w(i+1)=w(i)+1/6*(k1+2*k2+2*k3+k4); 
end  
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APPENDIX D 
FORTRAN SUBROUTINES USED 
FOR PARTICLE TRACKING 
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i. Particle injection code 
#include "cfx5ext.h" 
dllexport(pinject) 
      SUBROUTINE PINJECT (  
     &  NLOC, NRET, NARG, RET, ARGS, CRESLT, CZ,DZ,IZ,LZ,RZ ) 
      IMPLICIT NONE 
#include "parallel_partitioning.h" 
      INTEGER NLOC,NARG,NRET 
      CHARACTER CRESLT*(*) 
      REAL ARGS(NLOC,NARG), RET(NLOC,NRET) 
      INTEGER IZ(*) 
      CHARACTER CZ(*)*(1) 
      DOUBLE PRECISION DZ(*) 
      LOGICAL LZ(*) 
      REAL RZ(*) 
C ------------------------------ 
C        Local Variables 
C ------------------------------ 
      INTEGER I,NPI,TOLD,TNEW 
      LOGICAL FLAG 
      REAL RLAST 
      SAVE NPI,TOLD,RLAST,FLAG 
      DATA FLAG/.TRUE./ 
C --------------------------- 
C    Executable Statements 
C --------------------------- 
      IF(FLAG)THEN 
        NPI=INT(ARGS(1,1)+0.001) 
        FLAG=.FALSE. 
      END IF 
      RET(1,1)=0.0 
      TNEW=INT(ARGS(1,2)+0.1) 
      IF(TNEW.EQ.1)THEN 
        TOLD=1 
        RLAST=0.0 
      END IF 
      IF(TOLD.NE.TNEW)THEN 
        I=INT(ARGS(1,1))-NPI 
        IF((ARGS(1,1)-NPI).LT.1)THEN 
          RLAST=0.0 
        ELSE 
          RLAST=REAL(I)-0.45 
          NPI=NPI+I 
          TOLD=TNEW 
        END IF 
      ELSE 
        RET(1,1)=RLAST 
      END IF       
Set success flag. 
      CRESLT = 'GOOD' 
      END SUBROUTINE PINJECT 
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C!end of file Pinject.F 
 
ii. Particle tracking code 
#include "cfx5ext.h" 
dllexport(ptrack) 
C  CFX subroutine 
      SUBROUTINE PTRACK(NLOC,NRET,NARG,RET,ARGS,CRESLT, 
     &                         CZ,DZ,IZ,LZ,RZ) 
      IMPLICIT NONE 
c     inputs 
      INTEGER NLOC,NARG,NRET,I,J 
      REAL ARGS(NLOC,NARG), RET(NLOC,NRET) 
      CHARACTER CRESLT*(*) 
      INTEGER IZ(*) 
      CHARACTER CZ(*)*(1) 
      DOUBLE PRECISION DZ(*) 
      LOGICAL LZ(*) 
      REAL RZ(*) 
#include "parallel_partitioning.h" 
C     ARGS(1:NLOC,1)     -Air.Density 
C     ARGS(1:NLOC,2)     -Air.Dynamic Viscosity 
C     ARGS(1:NLOC,3:5)   -Air.Velocity 
C     ARGS(1:NLOC,6)     -MyDrg.Mean Particle Diameter 
C     ARGS(1:NLOC,7)     -MyDrg.Particle Integration Timestep 
C     ARGS(1:NLOC,8:10)  -MyDrg.Velocity 
C     ARGS(1:NLOC,11)    -Wall Distance 
C     ARGS(1:NLOC,12:14) -wall normal 
C     ARGS(1:NLOC,15:17) -MyDrg.Particle Position 
C     ARGS(1:NLOC,18)    -MyDrg.Particle Time 
C     locals 
      REAL CCF,A,B,TMP,LA,KB,FS(1:NLOC,3) 
      REAL FD(1:NLOC,3), FB(1:NLOC,3) 
      CHARACTER FILENM*8!3!-------------------------------------------------------------------------  
      INTEGER GETPID,SEED!-------------------------------------------------------------------------- 
      SAVE TMP,LA,KB,SEED 
      DATA TMP/298.15/ 
      DATA LA/65.0E-9/ 
      DATA KB/1.38E-23/ 
      DATA SEED/15846/ 
!      CALL NORM([ARGS(1,12),ARGS(1,13),ARGS(1,14)]) 
      CALL FSAFF(ARGS(1,1),ARGS(1,6),ARGS(1,11), 
     &          [ARGS(1,12),ARGS(1,13),ARGS(1,14)], 
     &          [ARGS(1,3),ARGS(1,4),ARGS(1,5)], 
     &          [ARGS(1,8),ARGS(1,9),ARGS(1,10)],FS(1,:)) 
      A=CCF(ARGS(1,6),LA) 
      CALL FDRAG(ARGS(1,1),ARGS(1,6),ARGS(1,2),A, 
     &          [ARGS(1,3),ARGS(1,4),ARGS(1,5)], 
     &          [ARGS(1,8),ARGS(1,9),ARGS(1,10)],FD(1,:)) 
      CALL FBROWN(TMP,ARGS(1,7),A,ARGS(1,2), 
     &                ARGS(1,6),KB,SEED,FB(1,:)) 
      RET=(FS+FD+FB) 
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C 
!       open(8,FILE="NLOC.TXT",POSITION="APPEND") 
!       WRITE(8,*)'ARGS             ',(',',ARGS(1,J),J=1,NARG) 
!       WRITE(8,*)'LIFT FORCE       ',(',',FS(1,J),J=1,3) 
!       WRITE(8,*)'DRAG FORCE       ',(',',FD(1,J),J=1,3) 
!       WRITE(8,*)'BROWNIAN FORCE   ',(',',FB(1,J),J=1,3) 
!       CLOSE(8) 
C 
C      WRITE(FILENM,'(i8)')GETPID()!--------------------------------------------- 
C      OPEN(9,FILE=FILENM,POSITION="APPEND") 
C      WRITE(9,*)ARGS(1,6),ARGS(1,18),ARGS(1,15) 
C     &         ,ARGS(1,16),ARGS(1,17),ARGS(1,11) 
C      CLOSE(9) 
      END SUBROUTINE PTRACK 
C---------------------------------------------------------------------------- 
C  PARTICLE FORCE SUBROUTINES 
C     SHEAR INDUCED SAFFMAN LIFT FORCE IS PUT INTO FS 
      SUBROUTINE FSAFF(RF,DP,HP,N,U,V,FS) 
      IMPLICIT NONE 
C     inputs-fluid density, particle diameter, particle wall distance, 
C            wall normal vector, fluid velocity, particle velocity, (output) saffman lift force 
      REAL RF, DP, HP, N(3), U(3), V(3), FS(3) 
C     locals 
      REAL KA, LA, GA, US, THAT(3), FDOT, G, A, B 
      INTEGER I 
      CALL FINDTHAT(V,N,THAT) 
      US=FDOT(V,THAT)-FDOT(U,THAT) 
      IF(US*HP .NE. 0.0)THEN 
        GA=FDOT(U,THAT)/HP 
        KA=DP/(2.0*HP) 
        B=GA*DP/2.0 
        IF(ABS(US).LT.ABS(B))THEN 
          LA=SIGN(1.0,B*US) 
        ELSE 
          LA=B/US 
        END IF 
        A=-RF*(DP/2.0)**2.0*(US**2.0*G(KA,LA)) 
        DO I=1,3 
          FS(I)=A*N(I) 
        END DO 
      ELSE 
        FS(1)=0.0 
        FS(2)=0.0 
        FS(3)=0.0 
      ENDIF 
      END SUBROUTINE FSAFF 
C     DRAG FORCE WITH CUNNINGHAM CORRECTION FACTOR IS PUT INTO FD 
      SUBROUTINE FDRAG(RF,DP,MU,CCF,U,V,FD) 
      IMPLICIT NONE 
C     inputs-fluid density, particle density, particle diameter, fluid viscosity, cunningham correction factor, 
C            fluid velocity, particle velocity, (output) drag force 
      REAL RF, DP, MU, CCF, U(3), V(3), FD(3) 
C     locals 
      REAL A, RE, MAG, CD 
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      INTEGER I 
      RE=RF*MAG(U-V)*DP/MU 
      A=0.39269908*CD(RE)*RE*DP*MU/CCF!PI/8 
      DO I=1,3 
        FD(I)=A*(U(I)-V(I)) 
      END DO 
      END SUBROUTINE FDRAG 
C     BROWNIAN MOTION FORCE IS PUT INTO FB 
      SUBROUTINE FBROWN(T,DT,CCF,MU,DP,KB,SEED,FB) 
      IMPLICIT NONE 
C     inputs-fluid temperature, particle integration time step, cunningham correction factor, 
C            fluid viscosity, particle diameter, Boltzman constant,(output) brownian motion force 
      REAL T,DT,CCF,MU,DP,KB,FB(3) 
      INTEGER SEED 
C     local 
      REAL D,ZE,A 
      INTEGER I 
      D=(KB/(9.424777961))*(T/DP)*(CCF/MU)!3*PI 
      A=SQRT(2.0/D*KB*T**2.0*KB/DT) 
      DO I=1,3 
        CALL GET_RANDOM_NORM(ZE,1,0.0,1.0,-3.0,3.0,SEED) 
        FB(I)=ZE*A 
      END DO 
      END SUBROUTINE FBROWN 
C----------------------------------------------------------------------------  
C  SUBROUTINES FOR PARTICLE FORCE CALCULATIONS 
C     CUNNINGHAM CORRECTION FACTOR SUBROUTINE 
      REAL FUNCTION CCF(DP,LA) 
      IMPLICIT NONE 
C     inputs-diameter of the particle, mean free path 
      REAL DP,LA 
      CCF=1.0+LA/DP*(2.34+1.05*EXP(-0.39*DP/LA)) 
      END FUNCTION CCF 
C     DRAG FACTOR SUBROUTINE 
      REAL FUNCTION CD(RN) 
      IMPLICIT NONE 
C     inputs-particle reynolds number 
      REAL RN 
      IF(RN.LE.0.0)THEN 
            CD=0.0 
      ELSEIF(RN.LE.0.1)THEN 
            CD=24.0/RN 
      ELSEIF(RN.LE.1.0)THEN 
            CD=22.73/RN+0.0903/RN**2.0+3.69 
      ELSEIF(RN.LE.10.0)THEN 
            CD=29.1667/RN-3.8889/RN**2.0+1.222 
      ELSEIF(RN.LE.100.0)THEN 
            CD=46.5/RN-116.67/RN**2.0+0.6167 
      ELSEIF(RN.LE.1000.0)THEN 
            CD=98.33/RN-2778.0/RN**2.0+0.3644 
      ELSEIF(RN.LE.5000.0)THEN 
            CD=148.62/RN-4.75E4/RN**2.0+0.357 
      ELSEIF(RN.LE.10000.0)THEN 
            CD=-490.546/RN+57.87E4/RN**2.0+0.46 
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      ELSEIF(RN.GT.10000.0)THEN 
            CD=-1662.5/RN+5.4167E6/RN**2.0+0.5191 
      ENDIF 
      END FUNCTION CD 
C     INTEGRAL CURVE FIT FOR SAFFMAN LIFT FORCE 
      REAL FUNCTION G(KA,LA) 
      IMPLICIT NONE 
      REAL KA, LA 
      G=(1.7631+0.3561*KA-1.1837*KA**2.0+0.845163*KA**3.0) 
      G=G-(3.24139/KA+2.6760+0.8248*KA-0.4616*KA**2.0)*LA 
      G=G+(1.8081+0.8796*KA-1.9009*KA**2.0+0.98149*KA**3.0)*LA**2.0 
      END FUNCTION G 
C     FIND THE DIRECTION VECTOR OF THE WALL TANGENT PARTICLE VELOCITY 
      SUBROUTINE FINDTHAT(V,N,T) 
      IMPLICIT NONE 
C     inputs-particle velocity vector, wall normal vector, (outputs) wall tangent particle velocity vector 
      REAL N(3), V(3), T(3), A(3), W 
      CALL CRS(N,V,A) 
      CALL CRS(A,N,T) 
      CALL NORM(T) 
      END SUBROUTINE FINDTHAT 
C----------------------------------------------------------------------------  
C   VECTOR OPERATION SUBROUTINES 
C     CROSS PRODUCT 
      SUBROUTINE CRS(A,B,C) 
      IMPLICIT NONE 
      REAL A(3), B(3), C(3) 
      C(1)=A(2)*B(3)-A(3)*B(2) 
      C(2)=A(3)*B(1)-A(1)*B(3) 
      C(3)=A(1)*B(2)-A(2)*B(1) 
      END SUBROUTINE CRS 
C     DOT PRODUCT 
      SUBROUTINE DOT(A,B,C) 
      REAL A(3), B(3), C 
      INTEGER I 
      DO I=1, 3 
        C=C+A(I)*B(I) 
      END DO 
      END SUBROUTINE DOT 
C     DOT PRODUCT 
      REAL FUNCTION FDOT(A,B) 
      IMPLICIT NONE 
      REAL A(3), B(3) 
      INTEGER I 
      DO I=1, 3 
        FDOT=FDOT+A(I)*B(I) 
      END DO 
      END FUNCTION FDOT  
C     NORMALIZES THE VECTOR A 
      SUBROUTINE NORM(A) 
      IMPLICIT NONE 
      REAL A(3),MAG 
      IF(MAG(A) .NE. 0.0)THEN 
      A=A/MAG(A) 
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      ENDIF 
      END SUBROUTINE NORM 
C     RETURNS THE MAGNITUDE OF THE VECTOR A 
      REAL FUNCTION MAG(A) 
      IMPLICIT NONE 
      REAL A(3) 
      MAG=SQRT(A(1)**2.0+A(2)**2.0+A(3)**2.0) 
      END FUNCTION MAG 
 
 
 
 
iii. Particle deposition code 
#include "cfx5ext.h" 
dllexport(pdep) 
      SUBROUTINE PDEP(NLOC,NRET,NARG,RET,ARG,CRESLT, 
     &                      CZ,DZ,IZ,LZ,RZ) 
 
#include "cfd_sysdep.h" 
#include "cfd_constants.h" 
C ------------------------------ 
C        Argument list 
C ------------------------------ 
      INTEGER            NARG, NRET, NLOC 
      REAL               ARG(NLOC,NARG), RET(NLOC,NRET) 
      CHARACTER*(4)      CRESLT 
      INTEGER IZ(*) 
      CHARACTER CZ(*)*(1) 
      DOUBLE PRECISION DZ(*) 
      LOGICAL LZ(*) 
      REAL RZ(*) 
C     Return variables: 
C     Perpendicular Coefficient of Restitution (dummy)     : RET(1,1) 
C     Argument variables  
C     Particle Diameter                                : ARG(1,1) 
C     Particle time                                    : ARG(1,2) 
C     Particle Position                                : ARG(1,3:5) 
      CHARACTER FILENM*20 
      INTEGER GETPID 
      WRITE(FILENM,*)'DEP',GETPID()!--------------------------------------------- 
      OPEN(9,FILE=FILENM,POSITION="APPEND") 
      WRITE(9,*)ARG(1,1),ARG(1,2),ARG(1,3),ARG(1,4),ARG(1,5) 
      CLOSE(9) 
      RET(1,1)=0.0 
      END SUBROUTINE PDEP 
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